{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.18615"}, {"@name": "filename", "#text": "25626_Campos_MariaGabrielaNogueira_D.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "UNIVERSIDADE ESTADUAL DE CAMPINAS \n\nFACULDADE DE ENGENHARIA QU\u00cdMICA \n\n\u00c1REA DE CONCENTRA\u00c7\u00c3O / / \nCI\u00caNCIA E TECNOLOGIA DE MATERIAIS / \n\nDesenvolvimento e Caracteriza\u00e7\u00e3o de Membranas de Quitosana para \nRecobrimento de Feridas e Libera\u00e7\u00e3o Controlada de F\u00e1rmacos \n\nAutor Maria Gabriela Nogueira Campos \nOrientador Lucia Helena lnnocentini-Mei \n\n/ \n/ \n\nTese de Doutorado apresentada \u00e0 Faculdade de Engenharia Qu\u00edmica como parte \ndos requisitos exigidos para a obten\u00e7\u00e3o do t\u00edtulo de Doutor em Engenharia 1 \nQu\u00edmica. \n\nCampinas - S\u00e3o Paulo \nAgosto 2007 \n\nUN1CAMI' \nBIBLIOTH_~A C~NTR.A.l. \n\n(fS\u00b7\\fl. LAlTES \n\nOEs~:svoLVJMENTo DE CoLE\u00e7,\\o \n\n\n\nUNIDADE?&amp;,. \nN' CHAMADA: '---,.,\"-. \"'\"1.\u00b7:,1 \u00b7 \n\nT/UNICAMP \nV. EX. \n\nTOMBO BC Cl \\i -::c;\"(\"') {)\"\"\"' ('\"') \nPROC 1 h\u00b7 (<{5 -o.\\-\nC D ,<. \nPRE\u00c7O )1 \n\n1 \nIQ 0::-\"''---\n\nDATA l 4- jp _ 0 )-\nBIB-ID L\\ lijl-13<j \n\nI FICHA CATALOGR\u00c1FICA ELABORADA PELA \nBIBLIOTECA DA \u00c1REA DE ENGENHARIA E ARQUITETURA - BAE \n\nUNICAMP \n\nCl57d \nCampos, Maria Gabriela Nogueira \n\nDesenvolvimento e caract,;,riza\u00e7\u00e3o de membranas de \nquitosana para recobriment\u00f3\u00a7.'de feridas e libera\u00e7\u00e3o \ncontrolada de f\u00e1tmacos. I Maria Gabriela Nogueira \nCampos.--Campinas, SP: [s.n.], 2007. \n\n01ientador: Lucia Helena Innocentini Mei \nTese (Doutorado)- Universidade Estadual de \n\nCampinas, Faculdade de Engenharia Qu\u00edmica. \n\nL Membranas (Tecnologia). 2.Cicatriza\u00e7\u00e3o de \nferidas. 3. Quitosana. 4. Tecnologia de libera\u00e7\u00e3o \ncontrolada. L Mei, Lucia Helena innocentini. IL \nUniversidade Estadual de Campinas. Faculdade de \nEngenharia Qu\u00edmica. III. T\u00edtulo. \n\nT\u00edtulo em Ingl\u00eas: Development and Characterization of Chitosan \nMembranes for W ound Dressing and Drug Controlled \nRelease \n\nPalavras-chave em Ingl\u00eas: Membranes, Wound dressing, Chitosan, \nControlled release \n\n\u00c1rea de concentra\u00e7\u00e3o: Ci\u00eancia e Tecnologia de Materiais \nTitula\u00e7\u00e3o: Doutora em Engenharia Qu\u00edmica \nBanca examinadora: Arnaldo Rodrigues dos Santos Junior, Rodrigo \n\nLambe1i Or\u00e9fice, Fernanda Paula Collares Queiroz, \nLeila Peres \n\nData da defesa: 14/08/2007 \nPrograma de P\u00f3s-Gradua\u00e7\u00e3o: Engenharia Qu\u00edmica \n\n\n\nTese de Doutorado defendida por Maria Gabriela Nogueira Campos e aprovada \nem 14 de agosto de 2007 pela banca examinadora constitu\u00edda pelos doutores: \n\nProfa. Ora. Lucia Helena lnnocentini Mei- Orientador I \n\nProf. Dr. Rodrigo Lambert Or\u00e9fice / \n\ns Santos J\u00fanior /' \n\n---:P:::-r-o..,.fa-.-=o,--ra-. ...,F=e-r_n_a_n-:d-a-=P=-a-u-=-la--::C:-o-cll-a-re_s_Q;::-u-e:-iro-z--1 \n\nUNICAMP \nBIBLIOTECA CHHRAL \n\nC\u00c9SAR LATTES \n\nDESENVOLVIMENTO DE COLE\u00c7\u00c3O \n\n\n\nEste exemplar corresponde \u00e0 vers\u00e3o final da Tese de Doutorado em Engenharia \nQulmi~. I \n\ndL \nProfa. Dra. Lucia Helena lnnocentini-Mei \n\n\n\nDedicat\u00f3ria \n\nDedico este trabalho a todas as pessoas que amo e que me apoiaram \n\ndurante esta longa jornada: \n\n\u2022 Elza Aparecida Lapadulla Coelho Caldas, Nona, que me incentivou e \n\namou durante toda sua vida, mas que infelizmente n\u00e3o est\u00e1 mais aqui \n\nentre n\u00f3s; \n\n\u2022 Cleonice Maria Coelho Caldas, Dinha, que esteve presente em todos \n\nos momentos da minha vida e que at\u00e9 hoje me ap\u00f3ia e incentiva em tudo \n\nque fa\u00e7o; \n\n\u2022 Maria Carolina Caldas Nogueira, Mariana Caldas Nogueira e Maria \n\nLuiza Caldas Nogueira, irm\u00e3s queridas, companheiras de todos os \n\nmomentos da minha vida; \n\n\u2022 Fernando Ferraz de Campos, marido e amigo, que trabalhou muito \n\npara que eu chegasse at\u00e9 aqui; \n\n\u2022 Gabriel Nogueira Ferraz de Campos, meu filho amado, fortaleza e \n\nraz\u00e3o da minha vida; \n\nE principalmente aos meus pais, Cleuza Maria Coelho Caldas Nogueira e \n\nOswaldo Nogueira Junior, pessoas incr\u00edveis que atrav\u00e9s de seu amor \n\nincondicional, me incentivaram a dar o melhor de mim, sempre! \n\n11 \n\n\n\nAgradecimento \n\n\u2022 Agrade\u00e7o a orienta\u00e7\u00e3o e amizade da Profa. Dra. Lucia Helena \n\nlnnocentini-Mei; \n\n\u2022 Agrade\u00e7o a acolhida e orienta\u00e7\u00e3o dos professores Ralph Henry \n\nRawls e Neera Satsangi da University of Texas Health Science Center at \n\nSan Antonio; \n\n\u2022 Agrade\u00e7o o apoio financeiro do Conselho Nacional de Pesquisa -\n\nCNPq e da Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel \n\nSuperior; \n\n\u2022 Agrade\u00e7o a todos que, direta ou indiretamente, contribu\u00edram para a \n\nrealiza\u00e7\u00e3o deste trabalho. \n\n111 \n\n\n\nRESUMO \n\nO tratamento de feridas de pele (queimaduras, \u00falceras, feridas cir\u00fargicas e \n\nde diabetes) \u00e9 uma problem\u00e1tica mundial que vem sendo amplamente \n\ndiscutida e estudada devido \u00e0s complica\u00e7\u00f5es decorrentes do processo de \n\ncicatriza\u00e7\u00e3o, tais como infec\u00e7\u00f5es, septicemia e at\u00e9 \u00f3bito. \n\nA pele \u00e9 a interface do organismo humano com o meio externo e quando \n\nesta barreira \u00e9 ferida, a infec\u00e7\u00e3o por microorganismos, bem como a perda \n\nde fluidos e desidrata\u00e7\u00e3o s\u00e3o conseq\u00fc\u00eancias tem\u00edveis. \n\nPortanto, um recobrimento de ferida deve ser utilizado afim de proteger a \n\nmesma da invas\u00e3o de microorganismos e da perda de fluidos, al\u00e9m de \n\nsubstituir as fun\u00e7\u00f5es da pele. \n\nOs recobrimentos de ferida dispon\u00edveis comercialmente s\u00e3o \n\nprincipalmente \u00e0 base de col\u00e1geno. Entretanto, devido ao alto custo desta \n\nmat\u00e9ria-prima, a busca de novos materiais para a confec\u00e7\u00e3o de \n\nrecobrimentos de ferida vem sendo constante. \n\nA quitosana \u00e9 um biopol\u00edmero derivado da quitina, o polissacar\u00eddeo mais \n\nabundante na natureza depois da celulose, encontrada principalmente no \n\nexoesqueleto de insetos e crust\u00e1ceos. Al\u00e9m de biocompat\u00edvel e \n\nbiodegrad\u00e1vel, a quitosana apresenta interessantes propriedades \n\nbiol\u00f3gicas, tais como atividades bactericida, fungicida, hemost\u00e1tica, \n\nantitumoral e imuno-adjuvante. \n\nO processo de produ\u00e7\u00e3o de quitosana \u00e9 econ\u00f4mica e ambientalmente \n\nvi\u00e1vel, pois utiliza subprodutos da ind\u00fastria pesqueira como mat\u00e9ria-prima. \n\nSendo assim, o pre\u00e7o da quitosana purificada \u00e9 cerca de 20 vezes menor \n\nque o do col\u00e1geno na mesma condi\u00e7\u00e3o. \n\nPor estas raz\u00f5es, a quitosana vem sendo amplamente estudada e \n\nempregada no tratamento de feridas, nas formas de filmes, membranas, \n\nmatrizes porosas, g\u00e9is e at\u00e9 mesmo solu\u00e7\u00f5es. \n\ni v \n\n\n\nNo sentido de melhorar suas propriedades, plastificantes, reticulantes e \n\noutros pol\u00edmeros tamb\u00e9m s\u00e3o utilizados em associa\u00e7\u00e3o com a quitosana \n\nafim de se obter um material vi\u00e1vel para utiliza\u00e7\u00e3o. \n\nNo presente trabalho, membranas de quitosana para recobrimento de \n\nferidas foram desenvolvidas, caracterizadas e testadas in vitro e in vivo. O \n\nefeito do D-sorbitol como plastificante e o do hexametileno diisocianato \n\ncomo agente reticulante tamb\u00e9m foi estudado. Al\u00e9m disso, sistemas de \n\nlibera\u00e7\u00e3o controlada de drogas \u00e0 base de quitosana foram desenvolvidos \n\ne a libera\u00e7\u00e3o de gentamicina e sulfadiazina de prata foi avaliada in vitro. \n\nO D-sorbitol mostrou-se um bom plastificante para as membranas de \n\nquitosana, pois melhorou as propriedades mec\u00e2nicas e aumentou a \n\npermeabilidade ao vapor de \u00e1gua. Al\u00e9m disso, n\u00e3o apresentou \n\ncitotoxicidades direta e indireta. \n\nO hexametileno diisocianato foi utilizado como agente reticulante da \n\nquitosana e foi previamente bloqueado com bissulfito de s\u00f3dio, afim de \n\nproteger os grupos reativos e aumentar o rendimento da rea\u00e7\u00e3o de \n\nreticula\u00e7\u00e3o. \n\nAs membranas reticuladas de quitosana n\u00e3o apresentaram citotoxicidade \n\ne mostraram-se eficientes sistemas de libera\u00e7\u00e3o controlada de \n\ngentamicina e sulfadiazina de prata. \n\nv \n\n\n\nABSTRACT I \nSkin wounds treatment (burns, ulcers, surgical and diabetes wounds) is a \n\nworld-wide problem that has been widely argued and studied due to the \n\nhealing process complications, such as infections, septicemia and death. \n\nThe skin is the interface of the human organism with the externai \n\nenvironment and when this barrier is wounded, microorganism infections, \n\nas well as the loss of fluids and dehydration are possible consequences. \n\nTherefore, a wound dressing must be used to protect the wound from \n\nmicroorganisms' invasion and loss of fluids, besides substituting functions \n\nof the los! skin. Commercially available wound dressings are mainly based \n\non collagen. However, because of the high cost of this raw material, the \n\nsearch for new materiais for wound dressings has been continuous. \n\nChitosan is a biopolymer derived from chitin, the most abundant \n\npolysaccharide found in nature after cellulose, found mainly in insects and \n\ncrustaceans exoskeletons. Beyond biocompatible and biodegradable, \n\nchitosan also presents interesting biological properties, such as \n\nbactericida!, fungicida!, hemostatic, immune-adjuvant and anti-tumor \n\nactivities. The process of chitosan production is economic and \n\nenvironmentally viable; since it uses fishing industry by-products as raw \n\nmaterial. Thus, pure chitosan price is about 20 times cheaper than \n\ncollagen one. For these reasons, chitosan has been widely studied and \n\nemployed in the treatment of wounds like film, membrane, porous matrix, \n\ngel and solution. Moreover, plasticizers cross linkers and other polymers \n\nare also used in association with chitosan to improve the obtained material \n\nproperties. In this present work, chitosan membranes for wound dressing \n\nhad been developed and characterized. The use of D-sorbitol as plasticizer \n\nand hexamethylene diisocyanate as cross-linker also was investigated. \n\nMoreover, chitosan based drug release systems based was developed and \n\nthe releases of gentamicin and silver sulfadiazine were in vitro evaluated. \n\nD-sorbitol revealed a good plasticizer for chitosan membranes: it improved \n\nmechanical properties and increased water vapor permeability. Moreover, \n\nit did not show direct and indirect cytotoxicity. \n\nVI \n\n\n\nHexamethylene diisocyanate was previously blocked with sodium bisulfite \n\nto protect reactive groups and to increase chitosan cross linking reaction \n\nyield. Cross linked membranes had not shown cytotoxicity and had \n\nrevealed to be efficient systems for controlled release of gentamicin and \n\nsilver sulfadiazine. \n\nV li \n\n\n\nSUM\u00c1RIO \n\n1. APRESENTA\u00c7\u00c30 ..........\u2022.................\u2022\u2022............................................................... 2 \n2. INTRODU\u00c7\u00c3O .....................................\u2022..\u2022........................\u2022................................ 3 \n\n2.1 Problem\u00e1tica .....................................\u2022.....\u2022........................................... 3 \n\n2.2 A Quitosana ...\u2022..............................\u2022\u2022..\u2022..............\u2022...................\u2022............... 6 \n\n2.3 O Agente Reticulador ...............\u2022.\u2022\u2022...\u2022.............................\u2022.\u2022.................. 9 \n\n2.4 Os F\u00e1rmacos ................\u2022................\u2022...\u2022.................................................. 12 \n\n3. REVIS\u00c3O BIBLIOGR\u00c1FICA .......................................\u2022.........\u2022...................... 14 \n4. OBJETIVOS .......\u2022...\u2022.......\u2022.....................................................\u2022......\u2022.................... 19 \n5. TRABALHOS CIENT\u00cdFICOS .......\u2022...\u2022..\u2022........................\u2022......................\u2022......... 21 \n\n4.1 Effects of Neutralization Process on Preparation and Characterization \n\nof Chitosan Membranes for Wound Dressing ...\u2022.................\u2022.\u2022.....\u2022...\u2022....... 21 \n\n4.2 Antibacterial Activity of Chitosan Solutions for Wound \n\nDressing .............................................................................\u2022......\u2022................ 31 \n\n4.3 In vitro Cytotoxicty Evaluation of Chitosan Membranes for Wound \n\nDressing ..........................................................\u2022................. 38 \n\n4.4 In vitro Cytotoxicity of Chitosan Membranes against Vero \n\ncells .................................................................................. 44 \n\n4.5 Crystallinity versus Water Vapor Permeability of Chitosan \n\nMembranes for Wound Dressing ..\u2022............................\u2022........ 60 \n\n4.6 In Vitro Gentamicin Sustained and Controlled Release from Chitosan \n\nCross Linked Films ............................................................... 70 \n\n4.7 In vitro Silver sulfadiazine Controlled Release from Chitosan cross \n\nlinked Films ........................................................................ 85 \n\n4.8 In Vitro Wound Healing Responses to Drug Loaded Cross Linked \n\nChitosan Films.............................................................. .... 96 \n\n6. CONCLUS\u00d5ES ............................................................................................... 108 \n7. SUGEST\u00d5ES PARA TRABALHOS FUTUROS ........................................ 111 \n8. REFER\u00caNCIAS .......\u2022...................\u2022...\u2022...\u2022..\u2022.............................................\u2022........ 112 \n9. AP\u00caNDICES ................................................................................................... 117 \n9.1 TESTEINVIV0 ........................................................................................... 117 \n9.2 CURVAS DE DSC ........................................................................................ 119 \n\n1 \n\n\n\n1. APRESENTA\u00c7\u00c3O \n\nEsta tese de Doutorado \u00e9 um dos requisitos exigidos para a obten\u00e7\u00e3o do \n\nT\u00edtulo de Doutor em Engenharia Qu\u00edmica e ser\u00e1 apresentada com os \n\ncap\u00edtulos no formato de trabalhos cient\u00edficos. \n\nA primeira parte do conte\u00fado apresentado (Desenvolvimento e \n\nCaracteriza\u00e7\u00e3o de Membranas de Quitosana para Recobrimento de \n\nFeridas) foi realizada na Universidade Estadual de Campinas, na \n\nFaculdade de Engenharia Qu\u00edmica, Departamento de Tecnologia de \n\nPol\u00edmeros, com apoio de outras unidades, tais como a Faculdade de \n\nEngenharia de Alimentos e os Institutos de Biologia e Qu\u00edmica. \n\nA segunda parte, Desenvolvimento e Caracteriza\u00e7\u00e3o de Membranas de \n\nQuitosana Reticulada para Libera\u00e7\u00e3o Controlada de F\u00e1rmacos, foi \n\nrealizada na University of Texas Health Science Center at San Antonio, na \n\nDivis\u00e3o de Biomateriais da Escola de Odontologia, apoiada pelo Programa \n\nde Doutorado com Est\u00e1gio no Exterior- PDEE/CAPES, sob orienta\u00e7\u00e3o do \n\nProf. Dr. Ralph Rawls e da Prata. Ora. Neera Satsangi. \n\n2 \n\n\n\n2. INTRODU\u00c7\u00c3O I \n2.1 Problem\u00e1tica \n\nA exist\u00eancia de uma variedade de tipos de feridas com diversos modos e \n\nfases de cicatriza\u00e7\u00e3o contribuiu para a evolu\u00e7\u00e3o dos recobrimentos \n\natualmente existentes. \n\nAt\u00e9 aos anos 60 (s\u00e9culo XX), os recobrimentos de ferida eram \n\nconsiderados produtos passivos, com m\u00ednima influ\u00eancia no processo de \n\ncicatriza\u00e7\u00e3o. Por\u00e9m, a pesquisa pioneira de Winter (1 960) iniciou uma \n\nnova fase, onde foi considerado o envolvimento ativo do recobrimento com \n\na ferida, com a finalidade de estabelecer e manter um ambiente \u00f3timo \n\npara a cicatriza\u00e7\u00e3o da mesma. Assim, foi dado in\u00edcio a um novo conceito \n\nde recobrimento, que resultou na evolu\u00e7\u00e3o dos materiais passivos para os \n\nfuncionalmente ativos, onde a intera\u00e7\u00e3o do recobrimento com a ferida a \n\nser coberta e cicatrizada foi enfatizada (PURNA e BABU, 2000). \n\nO recobrimento de feridas continua sendo uma \u00e1rea de interesse de \n\npesquisadores do mundo todo devido a sua grande import\u00e2ncia no \n\ntratamento de traumas, queimaduras, ferida de diabetes, \u00falceras de pele e \n\noutros danos teciduais, tais como as feridas p\u00f3s-cir\u00fargicas. \n\nNos Estados Unidos, cerca de 70.000 pessoas s\u00e3o hospitalizadas a cada \n\nano, com ferimentos graves causados por trauma t\u00e9rmico (BLACK, 1 996). \n\nNo Brasil, n\u00e3o se t\u00eam dados estat\u00edsticos precisos, mas estima-se que \n\nquase um milh\u00e3o de acidentes com queimaduras ocorre por ano, e destes, \n\naproximadamente 200 mil s\u00e3o notificados pelos hospitais e cerca de 1 O mil \n\ncausam falecimento das v\u00edtimas (Cidade Sustent\u00e1vel, 2004). De acordo \n\ncom os dados do Minist\u00e9rio da Sa\u00fade, o Sistema \u00danico de Sa\u00fade (SUS) \n\natendeu 27.906 pacientes queimados em 1 998 e 27.694 em 1 999. No ano \n\nseguinte, o governo brasileiro gastou 55 milh\u00f5es de reais no tratamento de \n\nqueimaduras (Portal Sa\u00fade.Gov, 2005). \n\nO diabetes atinge cerca de dez milh\u00f5es de pessoas no Brasil, e a \n\nincid\u00eancia desta doen\u00e7a s\u00f3 tende a aumentar devido aos fatores de risco \n\nda popula\u00e7\u00e3o, tais como: sedentarismo, estresse, tabagismo e obesidade \n\n3 \n\n\n\n(LAVA, 2005). Dentre os poss\u00edveis dist\u00farbios, o diabetes pode causar \n\n\u00falceras no p\u00e9 (feridas) e infec\u00e7\u00f5es que podem evoluir para o caso extremo \n\nde amputa\u00e7\u00e3o. \n\nNo caso das \u00falceras de pele, estas podem ser causadas por diversos \n\nfatores: varizes, hipertens\u00e3o arterial, anemia falciforme, diabetes, isquemia \n\ne infec\u00e7\u00f5es. Devido \u00e0 grande incid\u00eancia de anemia e infec\u00e7\u00f5es nas \n\npopula\u00e7\u00f5es mais carentes, este tipo de ferida apresenta grande incid\u00eancia \n\nno Brasil e nos demais pa\u00edses subdesenvolvidos. \n\nNo \u00e2mbito da sa\u00fade mundial, as feridas p\u00f3s-cir\u00fargicas apresentam grande \n\npreocupa\u00e7\u00e3o pelo fato de serem consideradas alvos f\u00e1ceis para a \n\ninstala\u00e7\u00e3o de infec\u00e7\u00e3o, principalmente da temida infec\u00e7\u00e3o hospitalar. Nos \n\nEstados Unidos, estima-se que das 23 milh\u00f5es de cirurgias realizadas por \n\nano, 920 mil desenvolvem infec\u00e7\u00f5es da ferida operat\u00f3ria, o que est\u00e1 \n\nassociado ao aumento do tempo de interna\u00e7\u00e3o, das taxas de letalidade e \n\ndos gastos hospitalares (KLUYTMANS, 1997). No Brasil, de acordo com o \n\nestudo prospectivo efetuado em um hospital universit\u00e1rio entre 1995 e \n\n1999 por FERRAZ et ai. (2001) aproximadamente 1 O% das feridas \n\ncir\u00fargicas apresentam infec\u00e7\u00e3o. \n\nO tratamento da ferida infectada exige, al\u00e9m de um maior tempo de \n\ninterna\u00e7\u00e3o do paciente, o uso de antibi\u00f3ticos de terceira gera\u00e7\u00e3o que, no \n\nBrasil, custam em m\u00e9dia R$ 600/dose (lnventaBrasiiNet, 2001 ). \n\nNeste contexto, o desenvolvimento de um recobrimento de feridas \n\neficiente tem um papel fundamental no tratamento das les\u00f5es de pele, na \n\npreven\u00e7\u00e3o de infec\u00e7\u00f5es, bem como na melhoria da qualidade de vida dos \n\npacientes e na redu\u00e7\u00e3o dos gastos, especialmente do governo, com \n\ninterna\u00e7\u00f5es hospitalares e tratamentos. \n\nPara tanto, um recobrimento de ferida ideal deve substituir as fun\u00e7\u00f5es da \n\npele perdida: proteger a ferida da perda de fluidos e prote\u00ednas; prevenir a \n\ninvas\u00e3o de bact\u00e9rias; dissipar o estresse mec\u00e2nico externo; e, bem como \n\nmelhorar e estimular a cicatriza\u00e7\u00e3o da ferida. Al\u00e9m disso, o material deve \n\n4 \n\n\n\nser biocompat\u00edvel para evitar rejei\u00e7\u00e3o e apresentar um custo acess\u00edvel, \n\npara que sua utiliza\u00e7\u00e3o seja economicamente vi\u00e1vel. \n\n5 \n\n\n\n2.2 A Quitosana \n\nA quitosana \u00e9 um pol\u00edmero derivado da quitina, o segundo polissacar\u00eddeo \n\nmais abundante na natureza, encontrado principalmente no exoesqueleto \n\nde insetos e nas carapa\u00e7as de crust\u00e1ceos. Pode ser encontrada na \n\nparede celular de algumas esp\u00e9cies de fungos, por\u00e9m sua maior fonte de \n\nobten\u00e7\u00e3o \u00e9 atrav\u00e9s da desacetila\u00e7\u00e3o da quitina. No Brasil, foi criada, em \n\n1997, uma empresa de base tecnol\u00f3gica, incubada no Parque de \n\nDesenvolvimento Tecnol\u00f3gico da Universidade Federal do Cear\u00e1 e \n\nespecializada na extra\u00e7\u00e3o de quitina e produ\u00e7\u00e3o de quitosana, obtidas a \n\npartir de carapa\u00e7as de camar\u00e3o, lagosta e caranguejo extra\u00eddos da costa \n\nbrasileira (Polymar, 2004). O baixo custo de produ\u00e7\u00e3o, a abund\u00e2ncia de \n\nmat\u00e9ria-prima (fonte renov\u00e1vel) e o aproveitamento dos subprodutos da \n\npesca de crust\u00e1ceos tornam o processo de produ\u00e7\u00e3o de quitosana \n\necologicamente interessante e economicamente vi\u00e1vel. \n\nAl\u00e9m de ser biocompat\u00edvel, a quitosana \u00e9 biodegrad\u00e1vel e apresenta baixa \n\ntoxicidade. Tamb\u00e9m apresenta atividades antimicrobiana, antitumoral e \n\nimuno-adjuvante (KURITA, 1998). Ela \u00e9 capaz de acelerar o processo de \n\ncicatriza\u00e7\u00e3o, atrav\u00e9s da ativa\u00e7\u00e3o de macr\u00f3fagos e fibroblastos, \n\naumentando a s\u00edntese de \u00e1cido hialur\u00f4nico e sua deposi\u00e7\u00e3o no tecido \n\nconjuntivo regenerativo, bem como influenciando no dep\u00f3sito de col\u00e1geno \n\nnas matrizes extra-celulares durante a reconstru\u00e7\u00e3o do tecido invalidado \n\n(SYNOWIECKI e AL-KHATEEB, 2003). \n\nPor todas estas raz\u00f5es, a quitosana foi escolhida como material de estudo \n\ndo presente projeto, que envolve a caracteriza\u00e7\u00e3o deste material, bem \n\ncomo o desenvolvimento de um recobrimento de ferida baseado no \n\nmesmo. \n\nNas Figuras (1) e (2) t\u00eam-se as f\u00f3rmulas estruturais da quitina e da \n\nquitosana, apresentando como principal diferen\u00e7a entre elas, a presen\u00e7a \n\nde grupos acetil em maior n\u00famero na cadeia de quitina. \n\n6 \n\n\n\nFigura 1: Estrutura da quitina. \n\nFigura 2: Estrutura da quitosana. \n\nO grau de desacetila\u00e7\u00e3o, ou seja, a quantidade de grupos acetil removidos \n\nna desacetila\u00e7\u00e3o da quitina, \u00e9 um importante par\u00e2metro de classifica\u00e7\u00e3o \n\nda quitosana, assim como o peso molecular. \n\nEstes par\u00e2metros t\u00eam influ\u00eancia direta nas atividades antibacteriana, \n\nantitumoral e imuno-adjuvante, bem nas propriedades mec\u00e2nicas da \n\nquitosana. \n\nMAEDA e KIMURA (2004) avaliaram o efeito do peso molecular da \n\nquitosana na sua atividade antitumoral e observaram que as mol\u00e9culas de \n\nmenor peso molecular promoveram uma diminui\u00e7\u00e3o no crescimento dos \n\ntumores. \n\nKURITA (1998) avaliou o efeito do peso molecular na atividade \n\nantibacteriana da quitosana contra algumas esp\u00e9cies de Streptococcus e \n\nconstatou que quanto maior o peso molecular, maior a repress\u00e3o do \n\ncrescimento desta bact\u00e9ria. \n\nWELING e colaboradores (2005) estudaram o efeito do grau de \n\ndesacetila\u00e7\u00e3o da quitosana na cristalinidade, tra\u00e7\u00e3o e compatibilidade com \n\nc\u00e9lulas Schawnn e conclu\u00edram que, para um mesmo peso molecular, o \n\n7 \n\n\n\naumento do grau de desacetila\u00e7\u00e3o promove um aumento na cristalinidade, \n\ntra\u00e7\u00e3o e afinidade com c\u00e9lulas Schawnn. \n\nA quitosana \u00e9 sol\u00favel em meio \u00e1cido e insol\u00favel em meio alcalino e na \n\n\u00e1gua. Em pH fisiol\u00f3gico, apresenta carga positiva, o que promove a \n\nbioades\u00e3o da mesma. Devido \u00e0 protona\u00e7\u00e3o em meio \u00e1cido dos grupos \n\namino presentes em sua cadeia carb\u00f4nica, al\u00e9m das hidroxilas \n\nprovenientes dos grupos \u00e1lcool, a quitosana apresenta car\u00e1ter \n\nhigrosc\u00f3pico e \u00e9 capaz de formar gel, podendo absorver at\u00e9 400% da sua \n\nmassa inicial em meio aquoso. \n\nDessa forma, o desenvolvimento de sistemas de libera\u00e7\u00e3o controlada de \n\nf\u00e1rmacos por difus\u00e3o \u00e0 base de quitosana seria invi\u00e1vel sem a utiliza\u00e7\u00e3o \n\nde um agente reticulador, que manteria as mol\u00e9culas interligadas e \n\ndiminuiria o grau de inchamento da mesma. \n\n8 \n\n\n\n2.3 O Agente Reticulador \n\nA reticula\u00e7\u00e3o entre cadeias polim\u00e9ricas \u00e9 obtida atrav\u00e9s da rea\u00e7\u00e3o \n\nqu\u00edmica entre os grupos funcionais das mesma. Ela pode ocorrer atrav\u00e9s \n\nda adi\u00e7\u00e3o de um iniciador, quando a pr\u00f3pria cadeia polim\u00e9rica apresenta \n\ngrupos funcionais reativos entre si; ou pela a adi\u00e7\u00e3o de mol\u00e9culas reativas \n\ne multifuncionais (reticulantes ou agentes reticuladores). Quando \n\nintroduzidos no meio polim\u00e9rico, os agentes reticulantes reagem em suas \n\nextremidades funcionais com determinados grupos funcionais presentes \n\nnas cadeias polim\u00e9ricas, fazendo a liga\u00e7\u00e3o entre as mesmas. Dessa \n\nforma, uma rede polim\u00e9rica \u00e9 formada, promovendo uma maior intera\u00e7\u00e3o \n\nentre as mol\u00e9culas e significativas mudan\u00e7as nas propriedades f\u00edsicas e \n\nqu\u00edmicas do pol\u00edmero inicial. \n\nNo caso da quitosana, as rea\u00e7\u00f5es de reticula\u00e7\u00e3o podem ocorrer em dois \n\ngrupos funcionais da mol\u00e9cula, isto \u00e9, nos grupos amino e nas hidroxilas. \n\nAl\u00e9m disso, modifica\u00e7\u00f5es qu\u00edmicas tamb\u00e9m podem ser feitas a partir do \n\ngrupo N-acetil, de acordo com o grau de desacetila\u00e7\u00e3o da quitosana. \n\nDiferentes propriedades s\u00e3o obtidas de acordo com o grupo funcional \n\nenvolvido, bem como com o agente reticulador utilizado e com o grau de \n\nreticula\u00e7\u00e3o da rea\u00e7\u00e3o. \n\nA epicloridrina \u00e9 um exemplo de agente reticulador que se interliga \u00e0s \n\nhidroxilas da quitosana. J\u00e1 o glutaralde\u00eddo, um dos reticulantes mais \n\nusados, \u00e9 respons\u00e1vel pela rea\u00e7\u00e3o entre os grupos amino da quitosana e \n\nos grupos alde\u00eddos do glutaralde\u00eddo. Entretanto, esta rea\u00e7\u00e3o, apesar de \n\nmelhorar as propriedades qu\u00edmicas do material, promove uma diminui\u00e7\u00e3o \n\ndas propriedades mec\u00e2nicas, deixando o material mais quebradi\u00e7o. \n\nDessa forma, o principal desafio deste projeto foi encontrar um agente \n\nreticulante capaz de interligar as cadeias polim\u00e9ricas sem interferir \n\nnegativamente nas propriedades do pol\u00edmero. Al\u00e9m disso, o material \n\nresultante da reticula\u00e7\u00e3o deveria manter ou aumentar a biocompatibilidade \n\ndo pol\u00edmero inicial. \n\n9 \n\n\n\nOs diisocianatos (Figura 3) s\u00e3o mol\u00e9culas bifuncionais e de elevada \n\nreatividade, amplamente utilizadas como agentes reticulantes, \n\nprincipalmente na produ\u00e7\u00e3o de poliuretanos, incluindo os utilizados na \n\n\u00e1rea m\u00e9dica. Na Figura 3, o radical R pode ser um grupo alif\u00e1tico ou \n\narom\u00e1tico e tem uma forte influ\u00eancia nas propriedades do material \n\nresultante da rea\u00e7\u00e3o. Dessa forma, \u00e9 poss\u00edvel controlar as caracter\u00edsticas \n\ndo produto final, variando-se o radical R do diisocianato utilizado. \n\nI \u00dc=C=N-R-N=C=O I \nFigura 3. F\u00f3rmula molecular geral dos diisocianatos. \n\nNeste presente trabalho, o 1 ,6-Diisocianato hexano ou Hexametileno \n\ndiisocianato (Figura 4) foi escolhido por ser uma mol\u00e9cula linear, flex\u00edvel, \n\ndevido \u00e0 presen\u00e7a dos grupos -CH 2 , e sim\u00e9trica, com os dois grupos \n\ncianatos (- N =C= O) de igual reatividade. Al\u00e9m disso, a escolha de um \n\nradical alif\u00e1tico insaturado aumenta a estabilidade do produto final, \n\nevitando o amarelamento do mesmo com o tempo de estocagem. \n\nFigura 4. F\u00f3rmula molecular do hexametileno diisocianato. \n\nO hexametileno diisocianato, bem como a maioria dos isocianatos, \u00e9 \n\ninsol\u00favel em \u00e1gua, al\u00e9m de reagir com a mesma. Dessa forma, \u00e9 \n\nnecess\u00e1ria uma rea\u00e7\u00e3o pr\u00e9via de prote\u00e7\u00e3o dos grupos reativos (cianatos) \n\npara evitar a rea\u00e7\u00e3o com a \u00e1gua e, ao mesmo tempo, promover a \n\ndissolu\u00e7\u00e3o do mesmo em meio aquoso, uma vez que a rea\u00e7\u00e3o com \n\nquitosana ocorreria em solu\u00e7\u00e3o aquosa de \u00e1cido ac\u00e9tico. \n\nOs bissulfitos s\u00e3o exemplos de sais utilizados nas rea\u00e7\u00f5es de prote\u00e7\u00e3o \n\ndos diisocianatos. O bissulfito de s\u00f3dio (Na2S20 5), um sal bastante reativo \n\ne sol\u00favel em \u00e1gua, foi utilizado na rea\u00e7\u00e3o de bloqueio dos grupos cianatos \n\ndo hexametileno diisocianato, obtendo-se o hexametileno -1 ,6 - di -\n\n(aminocarboxisulfonato) como produto principal da rea\u00e7\u00e3o (Figura 5) \n\n(WELSH et ai., 2002). \n\nlO \n\n\n\nFigura 5. F\u00f3rmula estrutural do hexametileno -1 ,6 -di -\n\n(aminocarboxisulfonato). \n\nO hexametileno - 1,6 - di - (aminocarboxisulfonato) \u00e9 sol\u00favel em \u00e1gua e \n\nal\u00e9m disso, est\u00e1vel em solu\u00e7\u00f5es aquosas \u00e1cidas. Dessa forma, a rea\u00e7\u00e3o \n\nde reticula\u00e7\u00e3o da quitosana ocorre a partir da forma\u00e7\u00e3o de liga\u00e7\u00f5es ur\u00e9ia, \n\nj\u00e1 que a taxa de rea\u00e7\u00e3o do hexametileno 1 ,6 -di \n\n(aminocarboxisulfonato) com o grupo amina em meio \u00e1cido \u00e9 muito maior \n\ndo que a taxa de rea\u00e7\u00e3o competitiva com os grupos \u00e1lcool ou \u00e1gua. \n\n11 \n\n\n\n2.4 Os F\u00e1rmacos \n\nO tratamento de feridas de pele, na maioria dos casos, exige a aplica\u00e7\u00e3o \n\nde um medicamento anti-microbiano para evitar ou combater a infec\u00e7\u00e3o. \n\nDevido \u00e0 grande exposi\u00e7\u00e3o da pele ao meio externo, o contato com os \n\nmicroorganismos \u00e9 constante e inevit\u00e1vel. Os microorganismos mais \n\ncomumente encontrados em feridas de pele s\u00e3o o Staphylococcus aureus \n\ne a Pseudomonas aeruginosa, esp\u00e9cies gram positivo e gram negativo, \n\nrespectivamente. Dessa forma, seria interessante encontrar um agente \n\nantimicrobiano capaz de matar ou inibir o crescimento de pelo menos \n\nessas duas esp\u00e9cies de bact\u00e9ria. \n\nDentre os agentes antimicrobianos dispon\u00edveis, a gentamicina \u00e9 um \n\nantibi\u00f3tico pertencente \u00e0 fam\u00edlia dos aminoglicos\u00eddeos, isolada em 1963, a \n\npartir do fungo de solo Micromonospora purpura, por Weinstein e seus \n\ncolaboradores. Foi introduzida nos Estados Unidos da Am\u00e9rica em 1969 e, \n\ndesde ent\u00e3o, tem sido utilizada muito no tratamento de diversas infec\u00e7\u00f5es, \n\ndevido ao seu baixo custo e ampla faixa de atividade antibacteriana. \n\nA gentamicina tem dois aminoglicoses ligados a um n\u00facleo hexose atrav\u00e9s \n\nde uma liga\u00e7\u00e3o glicos\u00eddea e tem sua f\u00f3rmula estrutural apresentada na \n\nFigura 6: \n\nFigura 6. F\u00f3rmula estrutural do sulfato de gentamicina. \n\nO sulfato de gentamicina \u00e9 altamente sol\u00favel em \u00e1gua; moderadamente \n\nsol\u00favel em etano!, metano! e acetona e praticamente insol\u00favel em \n\nbenzeno e hidrocarbonetos halogenados. Uma solu\u00e7\u00e3o a 4% em \u00e1gua \n\napresenta pH entre 3,5 e 5,5. \n\n12 \n\n\n\nAs concentra\u00e7\u00f5es m\u00ednimas (CMI) de gentamicina para a inibi\u00e7\u00e3o do \n\ncrescimento de Pseudomonas aeruginosa e Escherichia co/i variam de \n\n0,06 a 8 11g/ml e de O, 12 a 1 ,O 11g/ml para o Staphylococcus aureus. \n\n(SKUNDRIC et ai., 2002) \n\nOutro agente antibacteriano testado no presente trabalho foi a sulfadiazina \n\nde prata. A sulfadiazina (Figura ?a) \u00e9 um antibi\u00f3tico que elimina as \n\nbact\u00e9rias atrav\u00e9s da inibi\u00e7\u00e3o da produ\u00e7\u00e3o de \u00e1cido f\u00f3lico no interior de \n\nsuas c\u00e9lulas. Ela \u00e9 comumente usada em associa\u00e7\u00e3o com prata (Figura \n\n7b) no tratamento de feridas de pele, sendo um tratamento padr\u00e3o para \n\nqueimaduras, \u00falceras e feridas infectadas devido ao seu amplo espectro \n\nde atividade bactericida contra as esp\u00e9cies gram positivo e negativo. \n\n(a) (b) \n\nFigura 7. F\u00f3rmula estrutural da (a) sulfadiazina e (b) da sulfadiazina de \n\nprata. \n\nAs concentra\u00e7\u00f5es m\u00ednimas de inibi\u00e7\u00e3o da sulfadiazina de prata s\u00e3o de \n\n32,0 11g/ml para a Escherichia co/i, 44,8 11g/ml para a Pseudomonas \n\naeruginosa e 57,6 jlg/ml para o Staphylococcus aureus. Al\u00e9m disso, as \n\nconcentra\u00e7\u00f5es m\u00ednimas para efeito bactericida (CMB) s\u00e3o de 40,2 jlg/ml e \n\n51,2 119/ml para Escherichia co/i e Pseudomonas aeruginosa, \n\nrespectivamente. Para a Staphylococcus aureus a CMB \u00e9 igual \u00e0 CMI. \n\n(SHANMUGASUNDARAM et ai., 2005) \n\n13 \n\n\n\n3. REVIS\u00c3O BIBLIOGR\u00c1FICA \n\nRecobrimento de feridas ou pele artificial \u00e9 atualmente uma interessante \n\n\u00e1rea de pesquisa devido \u00e0 sua grande import\u00e2ncia no tratamento de \n\ntraumas, queimaduras, feridas de diabete, \u00falceras de pele e outros danos \n\ncut\u00e2neos, tais como feridas cir\u00fargicas. (DENKBAS et ai., 2004) \n\nAs principais fun\u00e7\u00f5es de um recobrimento de ferida s\u00e3o: \n\n\u2022 Substituir a fun\u00e7\u00e3o da pele perdida; \n\n\u2022 Proteger a ferida da perda de fluidos e prote\u00ednas; \n\n\u2022 Prevenir a invas\u00e3o de bact\u00e9rias; \n\n\u2022 Dissipar o stress mec\u00e2nico; \n\n\u2022 Melhorar e estimular a cicatriza\u00e7\u00e3o; \n\n\u2022 Promover adequadas trocas gasosas e de calor com o ambiente \n\nexterno; \n\n\u2022 Ser biocompat\u00edvel e n\u00e3o-t\u00f3xico. \n\nPesquisas desenvolvidas na \u00e1rea biom\u00e9dica geraram v\u00e1rias op\u00e7\u00f5es \n\ncomerciais de recobrimentos de ferida , tais como: Bioprocess\u00ae, Opsite\u00ae \n\ne Biobrane\u00ae, produzidos a partir de col\u00e1geno, \u00e1cido hialur\u00f4nico e outros \n\nbiomateriais. Entretanto, tais produtos apresentam alto custo, o que \n\ndificulta a aplica\u00e7\u00e3o e comercializa\u00e7\u00e3o dos mesmos, principalmente nos \n\npa\u00edses emergentes. \n\nA Tabela 1 descreve outros exemplos de recobrimentos utilizados no \n\ntratamento de feridas, entretanto, estes tamb\u00e9m apresentam alto custo, \n\nal\u00e9m de outros inconvenientes. \n\nNeste contexto, a busca por produtos econ\u00f4mica e funcionalmente vi\u00e1veis \n\nainda \u00e9 uma realidade nesta \u00e1rea de pesquisa. \n\nA quitosana \u00e9 um biomaterial que v\u00eam sendo extensivamente estudado \n\ndevido \u00e0s suas interessantes propriedades. Al\u00e9m de biodegrad\u00e1vel e \n\nbiocompat\u00edvel, a quitosana apresenta atividades antibacteriana, fungicida, \n\n14 \n\n\n\nhemost\u00e1tica, imuno-adjuvante e antitumoral. (KURITA, 1998) \n\nA quitosana tamb\u00e9m apresenta vantagens econ\u00f4mico-ambientais, uma \n\nvez que a mesma \u00e9 produzida a partir da desacetila\u00e7\u00e3o da quitina, \n\nextra\u00edda principalmente dos subprodutos da ind\u00fastria pesqueira e cuja \n\nprodu\u00e7\u00e3o biol\u00f3gica anual \u00e9 de cerca de 1 bilh\u00e3o de toneladas. Al\u00e9m disso, \n\no pre\u00e7o da quitosana purificada \u00e9 cerca de 20 vezes menor que o do \n\ncol\u00e1geno na mesma condi\u00e7\u00e3o, o que a torna ainda mais atrativa em um \n\npa\u00eds em desenvolvimento como o Brasil. \n\nTabela 1 -Alternativas ao tratamento de feridas. \n\nTIPO DESCRI\u00c7\u00c3O INCONVENIENTES \n\nBiobrane: borracha de siliconei \nnylonlpeptideos derivados de Os recobrimentos \n\nSint\u00e9ticos \ncol\u00e1geno de porco; polim\u00e9ricos somente s\u00e3o \n\nusados em feridas pequenas, \ne \n\nEpigard: poliuretano reticulado/ capazes de cicatrizar \nSemi-\n\nfilme de poliuretano poroso; pelo movimento das c\u00e9lulas \nsint\u00e9ticos epiteliais atrav\u00e9s da ferida, \n\nOutros: poli-tetra-fl\u00faor-etileno a partir das bordas; \nou poliuretano/pectina ou metil Alto custo. \n\ncelulose. \n\nCompostos \nYannas: camada externa de Substituto tempor\u00e1rio; \n\nde \nsi li cone e sub camada esponjosa Necessita de enxerto \n\nCol\u00e1geno \nde col\u00e1geno reticulado com posterior; \n\nglutaraldeido. Alto custo do col\u00e1geno. \n\nC\u00e9lulas de derme e Consiste em uma matriz de 21 dias para o crescimento \nepiderme c\u00e9lulas epidermais e fibroblastos da cultura de c\u00e9lulas \n\nsemeados. epidermais; Alto custo. \n\nDiversos trabalhos envolvendo o uso de quitosana na prepara\u00e7\u00e3o de \n\nrecobrimento de feridas j\u00e1 foram publicados. Dentre eles, o estudo de Ml e \n\nseus colaboradores (2001) relatou o desenvolvimento de uma membrana \n\nassim\u00e9trica de quitosana composta por duas camadas, sendo uma densa \n\ne a outra porosa, com o intuito de melhor controlar as trocas gasosas e de \n\nflu\u00eddo com o meio externo. \n\nSILVA e colaboradores (2004) tamb\u00e9m prepararam membranas de \n\nquitosana, por\u00e9m utilizaram o glutaralde\u00eddo como agente reticulador. Al\u00e9m \n\n15 \n\n\n\nda aplicabilidade na \u00e1rea biom\u00e9dica, os autores tamb\u00e9m avaliaram as \n\npropriedades mec\u00e2nicas do material obtido. \n\nLIN-GIBSON (2003) e WELSH et ai. (2002) investigaram a cin\u00e9tica da \n\nrea\u00e7\u00e3o de reticula\u00e7\u00e3o de quitosana com hexametileno diisocianato nas \n\nfases l\u00edquida e s\u00f3lida, com a finalidade de utilizar o produto obtido para \n\nrecobrir feridas. \n\nUm trabalho tamb\u00e9m interessante foi desenvolvido por OSKAYANAK e \n\ncolaboradores (2005), os quais prepararam membranas para \n\nrecobrimentos de feridas \u00e0 base de poliuretano, obtido a partir de fontes \n\nalternativas ao petr\u00f3leo. \n\nAl\u00e9m destes, diversos outros trabalhos sobre blendas polim\u00e9ricas, \n\ntamb\u00e9m utilizadas na prepara\u00e7\u00e3o de membranas para recobrimento de \n\nferidas, v\u00eam sendo publicados. Dentre os pol\u00edmeros naturais, o col\u00e1geno, \n\no alginato e o \u00e1cido hialur\u00f4nico s\u00e3o os principais exemplos de materiais \n\nmisturados com quitosana. \n\nAl\u00e9m disso, pol\u00edmeros sint\u00e9ticos tamb\u00e9m est\u00e3o sendo usados na \n\nprepara\u00e7\u00e3o de substitutos de pele. MANGALA e colaboradores (2003) \n\ndesenvolveram uma membrana para recobrimento de queimaduras \u00e0 base \n\nde quitosana e poli (\u00e1lcool vin\u00edlico). \n\nOs recobrimentos de feridas tamb\u00e9m podem ser utilizados como suporte \n\npara libera\u00e7\u00e3o controlada de drogas, uma vez que as feridas s\u00e3o grandes \n\nfocos para a instala\u00e7\u00e3o de infec\u00e7\u00e3o por microorganismos. Staphylococcus \n\naureus, Pseudomonas aeruginosa e Escherichia co/i s\u00e3o os potenciais \n\npat\u00f3genos encontrados em ferida de pele. \n\nAs drogas mais comuns associadas ao tratamento de feridas de pele s\u00e3o \n\nos antibi\u00f3ticos. DENKBAS e colaboradores (2004) desenvolveram \n\nesponjas de quitosana impregnadas de norfaloxina para recobrimento de \n\nferida e, ao mesmo tempo, libera\u00e7\u00e3o controlada do antibi\u00f3tico. LOKE e \n\ncolaboradores (1999) desenvolveram um recobrimento de ferida \u00e0 base de \n\nquitosana capaz de liberar clorexidina. CRUZ e colaboradores (2004) \n\nestudaram a libera\u00e7\u00e3o controlada de oxitetraciclina em matrizes de \n\n16 \n\n\n\nquitosana e quitosana/alginato em diferentes pHs, por\u00e9m o sistema de \n\nlibera\u00e7\u00e3o n\u00e3o foi aplicado como recobrimento de ferida. \n\nA gentamicina (Figura 6) \u00e9 um antibi\u00f3tico pertencente \u00e0 fam\u00edlia dos \n\naminoglicos\u00eddeos, introduzido nos Estados Unidos da Am\u00e9rica em 1969 e, \n\ndesde ent\u00e3o, \u00e9 mundialmente utilizada no tratamento de diversas \n\ninfec\u00e7\u00f5es, devido ao seu baixo custo e ampla faixa de atividade \n\nantibacteriana. ZHANG e ZAHANG (2002) desenvolveram um suporte \u00e0 \n\nbase de quitosana e c\u00e1lcio, impregnado com gentamicina, para ser usado \n\nno tratamento de osteomielite. Al\u00e9m deste, diversos outros trabalhos \n\nforam encontrados na literatura abordando a libera\u00e7\u00e3o controlada de \n\ngentamicina para o tratamento de infec\u00e7\u00f5es \u00f3sseas (VIRTO et ai., 2002; \n\nNARAHARISETTI et ai., 2005 e ZHANG et ai., 1994). Entretanto, nenhum \n\ntrabalho abordando a libera\u00e7\u00e3o controlada de gentamicina a partir de \n\nrecobrimentos de feridas de pele foi encontrado, mesmo sendo o \n\ntratamento de feridas com gentamicina um procedimento muito comum. \n\nOutro medicamento bastante utilizado como agente antimicrobiano, \n\nprincipalmente no tratamento de queimaduras, \u00e9 a sulfadiazina de prata \n\n(Figura ?b). Devido a sua ampla faixa de atividade antibacteriana, a \n\nsulfadiazina de prata tem sido um dos f\u00e1rmacos mais estudados na \u00e1rea \n\nde recobrimentos de feridas e libera\u00e7\u00e3o controlada. Em 2003, Ml e \n\ncolaboradores apresentaram um novo tipo de recobrimento de ferida \n\ncarregado com sulfadiazina, enquanto que YU et ai. (2005) investigou a \n\natividade antibacteriana de esponjas de quitosana e alginato incorporadas \n\ncom sulfadiazina de prata. \n\nAlguns trabalhos relatam o uso de antibi\u00f3ticos no tratamento de feridas e \n\nos efeitos delet\u00e9rios que eles podem causar ao crescimento celular. CHO \n\nLEE e colaboradores (2002) mostraram o efeito citot\u00f3xico da sulfadiazina \n\nde prata, bem como o atraso no processo de epiteliza\u00e7\u00e3o, em um modelo \n\nde queimadura de segundo grau em animais. \n\nDevido \u00e0 grande complexidade que envolve o processo de cicatriza\u00e7\u00e3o de \n\nferidas, diversos fatores devem ser considerados na elabora\u00e7\u00e3o de um \n\n17 \n\n\n\nrecobrimento para as mesmas. Os recobrimentos cientificamente \n\npropostos muitas vezes atendem somente a algumas das exig\u00eancias e, \n\nportanto, a busca por um recobrimento de feridas ideal ainda \u00e9 cont\u00ednua. \n\nSendo assim, este trabalho teve como objetivo principal contribuir para o \n\ndesenvolvimento de um recobrimento de ferida que fosse econ\u00f4mica, \n\ncient\u00edfica e funcionalmente vi\u00e1vel. \n\n18 \n\n\n\n4. OBJETIVOS \n\nO objetivo geral deste trabalho foi o desenvolvimento e a caracteriza\u00e7\u00e3o \n\nde membranas \u00e0 base de quitosana para recobrimento de feridas \n\nlibera\u00e7\u00e3o controlada de f\u00e1rmacos \u00e0 base de quitosana. \n\nOs objetivos espec\u00edficos foram: \n\n\u2022 Aprimoramento da t\u00e9cnica de prepara\u00e7\u00e3o de membranas de \n\nquitosana, atrav\u00e9s da defini\u00e7\u00e3o de par\u00e2metros, tais como: \n\ntemperatura e tempo de secagem; \n\n\u2022 Avalia\u00e7\u00e3o do efeito da neutraliza\u00e7\u00e3o na prepara\u00e7\u00e3o e nas \n\ncaracter\u00edsticas finais das membranas de quitosana; \n\n\u2022 Avalia\u00e7\u00e3o do efeito da adi\u00e7\u00e3o de plastificante; \n\n\u2022 Avalia\u00e7\u00e3o da citotoxicidade das membranas de quitosana; \n\n\u2022 Avalia\u00e7\u00e3o da atividade antibacteriana das solu\u00e7\u00f5es de quitosana; \n\n\u2022 Caracteriza\u00e7\u00e3o morfol\u00f3gica das membranas por Microscopia \n\nEletr\u00f4nica de Varredura e Difractometria de Raios- X; \n\n\u2022 Caracteriza\u00e7\u00e3o das membranas por Calorimetria Diferencial \n\nExplorat\u00f3ria, afim de se obter os valores das temperaturas de fus\u00e3o \n\ne transi\u00e7\u00e3o v\u00edtrea e entalpia de fus\u00e3o; \n\n\u2022 Avalia\u00e7\u00e3o da permeabilidade ao vapor de \u00e1gua das membranas de \n\nquitosana, bem como par\u00e2metros de solubilidade e umidade; \n\nOs objetivos do est\u00e1gio de doutorado no exterior, realizado na divis\u00e3o \n\nde biomateriais da Universidade do Texas em San Antonio - EUA, \n\nforam: \n\n\u2022 Estudo da aplica\u00e7\u00e3o de um agente reticulante alternativo para a \n\nreticula\u00e7\u00e3o da quitosana; \n\n\u2022 Desenvolvimento das t\u00e9cnicas de reticula\u00e7\u00e3o da quitosana e de \n\nprepara\u00e7\u00e3o de membranas reticuladas; \n\n19 \n\n\n\n\u2022 Avalia\u00e7\u00e3o dos efeitos da reticula\u00e7\u00e3o da quitosana, bem como \n\ncaracteriza\u00e7\u00e3o das membranas reticuladas; \n\n\u2022 Avalia\u00e7\u00e3o do uso das membranas de quitosana reticuladas como \n\nsistema de libera\u00e7\u00e3o controlada de f\u00e1rmacos; \n\n\u2022 Avalia\u00e7\u00e3o da libera\u00e7\u00e3o controlada dos f\u00e1rmacos estudados; \n\n\u2022 Caracteriza\u00e7\u00e3o in vitro das membranas reticuladas de quitosana \n\ncomo sistemas de libera\u00e7\u00e3o controlada de f\u00e1rmacos. \n\n20 \n\n\n\n5. TRABALHOS CIENT\u00cdFICOS \n\n4.1 Effects of Neutralization Process on Preparation and \n\nCharacterization of Chitosan Membranes for Wound Dressing \n\nPublicado na Revista Macromolecular Symposia, Vol. 229, p. 253-257, \n\n2005 DOI: 10.1 002/masy.200551131. \n\nEfeitos do processo de neutraliza\u00e7\u00e3o na prepara\u00e7\u00e3o e caracteriza\u00e7\u00e3o \n\nde membranas de quitosana para recobrimento de feridas \n\nMaria Gabriela Nogueira Campos*1 , Carlos Raimundo Ferreira Grosso2 , \n\nGalo C\u00e1rdenas3 , Lucia Helena lnocentinni Mei 1 \n\n1 \nLaborat\u00f3rio de Biomateriais, Faculdade de Engenharia Qu\u00edmica da Universidade \n\nEstadual de Campinas, Brasil; E-mail: gabi@leq.unicamp.br \n\n2 Departamento de Alimentos e Nutri\u00e7\u00e3o, Faculdade de Engenharia de Alimentos da \n\nUniversidade Estadual de Campinas, Brasil \n\n3 Departamento de Pol\u00edmeros, Faculdade de Ci\u00eancias Qu\u00edmicas da Universidade de \n\nConcepci\u00f3n, Chile \n\nResumo: Os efeitos da neutraliza\u00e7\u00e3o na prepara\u00e7\u00e3o e caracteriza\u00e7\u00e3o de \n\nmembranas de quitosana foram avaliados por Calorimetria Diferencial \n\nExplorat\u00f3ria e por Microscopia Eletr\u00f4nica de Varredura. A solubilidade em \n\n\u00e1gua e a umidade das membranas de quitosana tamb\u00e9m foram \n\nestudadas. A absor\u00e7\u00e3o de \u00e1gua em diferentes pHs foi avaliada e as \n\npropriedades mec\u00e2nicas, tais como tra\u00e7\u00e3o e deforma\u00e7\u00e3o na ruptura foram \n\nmedidas. A neutraliza\u00e7\u00e3o provocou um aumento na temperatura de \n\ntransi\u00e7\u00e3o v\u00edtrea das membranas de quitosana, al\u00e9m de uma diminui\u00e7\u00e3o na \n\nsolubilidade em \u00e1gua, umidade e absor\u00e7\u00e3o de \u00e1gua. Um aumento nas \n\npropriedades mec\u00e2nicas tamb\u00e9m foi observado ap\u00f3s a neutraliza\u00e7\u00e3o. \n\nPalavras-chave: biomateriais; quitosana; membranas; recobrimento de \n\nferidas; processo de neutraliza\u00e7\u00e3o. \n\n21 \n\n---\u00b7\u00b7--\u00b7--\u00b7 -\u00b7\u00b7 ----\u00b7--\u00b7\u00b7\u00b7\u00b7-\u00b7\\ \nUNlCAMf' , \n\nBIBLIOTECA CENTV.l. \n\nC\u00c9SAR LATTES \n\nDESENVOLVIMENTO DE COLE\u00c7AO \n\n\n\nEffects of neutralization process on preparation and characterization \n\nof chitosan membranes for wound dressing \n\nMaria Gabriela Nogueira Campos*\\ Carlos Raimundo Ferreira Grosso2 , \n\nGalo C\u00e1rdenas3, Lucia Helena lnocentinni Mei 1 \n\n1 Laboratory of Biomaterials, Faculty of Chemical Engineering, State \n\nUniversity of Campinas, Brazil; E-mail: gabi@feq.unicamp.br \n\n2 Department of Foods and Nutrition, Faculty of Food Engineering, State \n\nUniversity of Campinas, Brazil \n\n3 Department of Polymers, Faculty of Chemical Science, University of \n\nConcepci\u00f3n, Chile \n\nSummary: Neutralization process effects on preparation and \n\ncharacterization of chitosan membranes were evaluated by Differencial \n\nScanning Calorimetry and Scanning Electron Microscopy. Water solubility \n\nand humidity of chitosan membranes were also studied. Swelling behavoir \n\nin different pH media was evaluated and mechanical properties such as \n\ntensile strength and elongation at break were measured. Neutralization \n\nprocess increased glass transition temperature of chitosan membranes \n\nand decreased their water solubility, humidity and water sorption. An \n\nimprovement in mechanical properties of chitosan membranes was also \n\nobserved after neutralization process. \n\nKeywords: biomaterials; chitosan; membranes; wound dressing; \n\nneutralization process. \n\nlntroduction \n\nWound dressing is an area of current research interest due to its great \n\nimportance in treatment of traumas, burns, diabetes wound, skin ulcers \n\nand other skin damages, such as surgical wounds111. \n\nAn ideal wound dressing should replace the function of lost skin, protect \n\nwounds from fluid and protein losses, preveni bacterial invasion, and \n\ndissipate mechanical stress (externai), and finally, improve and stimulate \n\n22 \n\n\n\nwound healing12l. Moreover, it should promete adequate gaseous and heat \n\nexchange with environment and be biocompatible and non-antigenic to \n\navoid body rejection. 13J \n\nDevelopments in the area of biomaterials offer several commercial wound \n\ndressings like Bioprocess\u00ae, Opsite\u00ae and Biobrane 11\u00ae, based on collagen, \n\nhyaluronic acid and other biomaterials. However, they do not have a very \n\naccessible cost. \n\nChitosan is a biopolymer obtained by the deacetylation of chitin, which is \n\nthe second more abundant polysaccharide found in nature. Chitin is mainly \n\nfound in externai skeleton of insects and in shells of crustaceans. Thus, \n\nchitosan production process is ecologically interesting and economically \n\nviable dueto the use of seafood industry by-products.14l \n\nMoreover, chitosan exhibits various interesting biological activities, which \n\nmade this polysaccharide increasingly important. Typical activities include \n\nantitumoral, immunoadjuvant, antibacterial and hemostatic activities. 15l \n\nChitosan is metabolized by certain human enzymes, especially lysozyme, \n\nand is considered biodegradable.16l lt also can accelerate wound healing.17l \n\nIn addition, due to its positive charges at physiological pH, chitosan is \n\nbioadesive, which increases retention at lhe site of application.l8l For ali \n\nthose reasons, chitosan is one of lhe most important biomaterials for \n\nwound management in lhe recent years. \n\nIn this present study, chitosan membranes for wound dressing were \n\nprepared by a solvent evaporation technique and then neutralized, in order \n\nto evaluate the effects of neutralization process on their preparation and \n\ncharacterization. \n\nExperimental \n\nMateriais \n\nHigh molecular weight chitosan (Mw - 1 00,000), more than 75% \n\ndeacetylated, was purchased from Aldrich Chemical Company (USA). \n\nGlacial acetic acid was purchased from Synth (Brazil). Chitosan was \n\ndissolved in an acetic acid aqueous solution (1.0 % w/w) and then was \n\n23 \n\n\n\nfiltered to remove any undissolved impurities. \n\nPreparation of the membranes \n\nChitosan membranes were prepared by a solvent evaporation technique \n\nby using aqueous acetic acid (1.0 % w/w) as solvent. Chitosan solution \n\nwas prepared by dissolving 1.5g of chitosan in 100 ml of solvent. After \n\ncomplete dissolution, it was filtered and cast on Petri plates. Following this, \n\nchitosan membrane (C1) was obtained by solution evaporation in an oven \n\nat 40\"C. Neutralized chitosan membrane (C2) was prepared by immersion \n\nof C1 into NaOH (2% w/w)- Na2C03 (0.05% w/w) aqueous solution for 1 \n\nhour. After the immersion, it was repeatedly washed with distillated water \n\nand dried at 40 o C. \n\nModulated Differential Scanning Calorimetry \n\nDifferential scanning calorimetry (DSC) measurements were performed on \n\na DSC 2920 -TA lnstruments. DSC curves of chitosan membranes (C1 and \n\nC2) were obtained by heating samples from -130 \"C up to 200 o C, at \n\nheating rate of 2\u00b0 C min\u00b71 and modulation rate \u00b11 o C min\u00b71 , under nitrogen \n\natmosphere, in arder to estimate glass transition and melting temperatures. \n\nScanning Electron Microscopy \n\nChitosan membranes samples were cut and kept in a vacuum desiccator \n\nfor 48 hours. Then, samples were coated with gold/paladium using a SC \n\n7620 Sputter Coater - POLARON under high vacuum and 4 mA for 180 \n\nseconds. Coated samples were examined using a LEO 440i Scanning \n\nElectron Microscopy (SEM). \n\nWater solubility and humidity \n\nPercentage of humidity in chitosan membranes was determined by \n\ngravimetric method. Circular membranes samples (0=2 em) were kept in a \n\nvacuum desiccator for 24 hours and weighed to obtain the initial mass (Mi). \n\nAfter this procedure, they were dried at 100\u00b0 C for 24 hours and weighed \n\nagain \u00b7m arder to determine the final mass (Mf). \n\nThe percentage of humidity was calculated according to the following \n\n24 \n\n\n\nequation: \n\nH(%)= (Mi- Mf) * 100 I Mi (Eq. 1) \n\nChitosan membranes water solubility was determined according to \n\nGontard et al. 191 . Circular samples (D=2 em) were dried at 100\u00b0 C for 24 \n\nhours and weighted to obtain their dry mass (Wi). After this procedure, they \n\nwere immersed into 50 ml of water for 24 hours at 25\u00b0 C by slowly string. \n\nSamples were then taken out and dried (1 00 o C for 24 hours) to determine \n\nthe membrane weight not soluble in water (Wf). The percentage of water \n\nsolubility (W) was calculated from the following equation: \n\nW(%) = (Wi- Wf) * 100 I Wi (Eq. 2) \nEach experiment was repeated three times and the average value was \n\ncalculated. \n\nSwelling behavior \n\nSwelling behavior of chitosan membranes was determined by the \n\ngravimetric method. Square membranes samples (L=2 em) were kept in a \n\nvacuum desiccator for 24 hours and their dry mass (Wo) were determined. \n\nAfter this procedure, they were immersed in pH 7.4 and 5.6 of phosphate \n\nbuffer saline solution at 37 CC. After pre-determined periods (5, 20, 40, 60, \n\n80, 100, 120 and 180 minutes), wet weights (Ww) of chitosan membranes \n\nwere determined by first blotting the membranes with filter paper to remove \n\nadsorbed water on the surface, then immediately weighted on an electronic \n\nscale. The swelling ratio (S) of chitosan membranes in the media was \n\ncalculated from the following equation: \n\nS(%) = (Ww- Wo) * 100 I Ww (Eq. 3) \nEach experiment was repeated three times and the average value was \n\ntaken as the swelling ratio. \n\nMechanical properties \n\nEletronic Digital Caliper (Fowler &amp; NSK - Max-Cal) was used to measure \n\n25 \n\n\n\nmembranes thickness (\u00f5). TA-XT2 (SMS, Surrey, UK) instrument was used \n\nto measure tensile strength (TS) and percent elongation at break (E). Tests \n\nwere carried out according to ASTM D-882[101 , with initial grip separation of \n\n50 mm and cross head speed of 60 mm/min. TS was calculated by dividing \n\nthe maximum load for breaking film by cross sectional area and E was \n\ndetermined by dividing film elongation at rupture by initial gauge length and \n\nmultiplying by 1 00%. \n\nResults and discussion \n\nOifferential Scanning Calorimetry \n\nDSC results are presented in Table 1. \n\nTable 1. Thermal properties of chitosan membranes. \n\nSample Tg1 Tg2 Tga Tm ~H \n\"C \"C \"C \"C J/g \n\nC1 -81.70 -84.1 o -73.69 101.95 458.70 \nC2 -76.90 -75.63 -73.16 88.39 418.50 \n\nDSC analysis presented lower value of glass transition temperature for C1 \n\nand lower values of enthalpy and melting temperature for C2. lt can be \n\nattributed to acetic acid molecules that act as plastcizer in C1, increasing \n\nits mobility. On the other side, neutralization process removes acetic acid \n\nmolecules from C2 and promotes a molecular rearrangement of polymer \n\nchains, which is responsible for a decrease in the free volume of the \n\nsystem and an increase in its glass transition temperature. \n\nScanning Electron Microscopy \n\nC1 and C2 scanning electron micrographs are presented in Figures 1 and \n\n2, respectively. SEM micrographies showed that C1 surface is more \n\nregular than C2 surface, which presented some rugosity. lt may be \n\nattributed to the neutralization process that removes superficial acetic acid \n\nmolecules from C2. Moreover, they showed that both C1 and C2 are dense \n\nand packed membranes. \n\n26 \n\n\n\nFigure 1. Superficial and Internai morphologies of C1. \n\nFigure 2. Superficial and Internai morphologies of C2. \n\nWater so/ubility and humidity \n\nSome parameters such as percentage of humidity (H) and of water \n\nsolubility (S); thickness (li), tensile strength (TS) and percent elongation at \n\nbreak (E) obtained for C1 and C2 membranes are presented in Table 2. \n\nT able 2. Properties of chitosan membranes. \n\nSample H w \u00f4 TS E \n% % Jlm MPa % \n\nC1 17.42 20.28 40 j 22.31 23.45 \nC2 j 2. j j 2.34 50 140.54 8.04 \n\nChitosan is insoluble in neutral and alkaline media, but it is soluble in acid \n\none. Residual acetic acid of C1 interacts with water and forms a weak acid \n\nsolution. For this reason, C1 is much more soluble than C2. The largest \n\nhumidity of C1 compared to C2 one can be attributed to the presence of \n\nacetic acid molecules in C1, which increases its hydrophilic character. \n\n27 \n\n\n\nSwelling behavior \n\nSwelling behavior of C1 and C2 at different pH's is presented in Figure 3. \n\n100 \n\n\u00b7======~------\u00b7 \u2022 \n90 \u00b7-\u00b7-\u00b7-\u00b7 \u2022 \n80 \n\n70 \n\n~ 60 ~: x::::::=:---=---...-: .. o \n\"\"\u00a7 50 \n\n\"' \u00aa 40 a; ----c1 pH 7.4 ~ 30&lt;f) --+-C1 pH 5.6 \n20 --4>-- C2 pH 7.4 \n\n--T- C2 pH 5.6 \n10 \n\no \no 20 40 60 80 100 120 140 160 180 200 \n\nTime (min) \n\nFigure 3. Swelling behavior of chitosan membranes at pH 7.4 and 5.6. \n\nAccording to Figure 3, C1 presented higher water absorption in acid \n\nmedium (pH 5.6) than in physiological medium (pH 7.4). lt can be \n\nattributed to the protonation of chitosan amine groups in acid medium, that \n\nincreases its hydrophilicity. As soon as C1 was immersed in pH 5.6 \n\nsolution, it swelled and presented a gel aspect, which had lead to a more \n\ndifficult removal of adsorbed water on the surface. Samples immersed in \n\nthat solution for 120 and 180 minutes could not be totally taken off, since \n\npart of them were dissolved. This fact can explain the swelling ratio \n\ndecreasing for those times. When immersed in pH 7.4 solution, C1 also \n\nswelled and got a gel consistence. However, it was only observed in the \n\nfirst three points (5, 20 and 40 minutes). After those periods, C1 probably \n\nreached the equilibrium state with the medium and its water absorption \n\nwas decreased. \n\nC2 swelling ratio was also higher in acid medium due to protonation of \n\namine groups. Nevertheless, when compared to C1 swelling ratio, C2 one \n\nwas lower in both pH solution. This can be attributed to neutralization \n\nprocess that removed acetic acid molecules from C2 and decreased its \n\nhydrophilicity. \n\n28 \n\n\n\nSwelling behavior is an important parameter for wound dressing \n\nmanagement. An ideal wound dressing should absorb fluids excreted by \n\nthe wound to avoid accumulation of fluid between wound and dressing \n\nbecause of the risk of infection[131 . However, wound dressing should \n\nmaintain its properties to continue replacing skin lost functions. In that way, \n\nC2 presented better results than C1, because it maintained its shape and \n\nconsistence when swollen. \n\nMechanical properties \n\nSkin is a viscoelastic material and is permanently subjected to slight stress. \n\nTensile strength of skin is very dependent on the rate of loading and varies \n\nwith the direction of the stress. Moreover, it is different depending on the \n\ngender, age and site. An average tensile strength of 1.8 kgf mm-2 (-17.6 \n\nMPa) was quoted by Wohlish[11 1. However, tensile strength of wounds is \n\nweaker than skin one and varies during wound healing process.l121 \n\nTensile Strength (TS) and percent Elongation at break (E) of C1 and C2 \n\nare presented in Table 2. C1 presented lower tensile strength and higher \n\nelongation at break than C2, what can be explained by the presence of \n\nacetic acid molecules in C1, that act as plasticizer, lowering the tensile \n\nstrength and improving the elongation at break. \n\nAccording to skin tensile strength average, both chitosan membranes can \n\nreplace mechanical functions of lost skin, due to their tensile strength \n\nalmost 1 O times higher than the skin. \n\nConclusions \n\nNeutralization process promoted a molecular rearrangement on C2 due to \n\nacetic acid molecules remova! and decreased free volume around the \n\npolymer chains. In addition, neutralization process reduced water solubility, \n\nhumidity and water sorption of chitosan membrane by removing hydrophilic \n\ngroups (acetic acid). An improvement on chitosan membrane tensile \n\nstrength and a decrease on its elongation at break were observed after \n\nneutralization process and they were also attributed to the remova! of \n\nacetic acid molecules that acted as a plasticizer. \n\n29 \n\n\n\nFinally, neutralization process is an important step on preparation of \n\nchitosan membranes as a biomaterial for wound dressing; and also this \n\nprocess retards acid hidrolysis of chitosan. \n\nReferences \n\n[1] E. B. Denkbas, E. \u00d3zt\u00fcrk, N. \u00d3zdemir, K. Ke\u00e7eci, Journal of \n\nBiomaterials Applications 2004, 18, 291 . \n\n[2] F. H. Silver, in \"Biocompatibility - lnteractions of biological and \n\nimplantable materiais\" 1949, Vol.1: Polymers; \n\n[3] M. Fwu-Long, S. Shyu, V. Wu, S. Lee, J. Shyong, R. Huang , \n\nBiomaterials 2001, 22, 165. \n\n[4] G. Molinaro, J. Leroux, J. Damas, A. Adam, Biomaterials 2002, 23, \n\n2717. \n\n[5] K. Kurita, Polymer Application and Stability 1998, 59, 117. \n\n[6] R. A. A. Muzzarelli, Cell Moi. Life Sei. 1997, 53, 131. \n\n[7] J. Synowiecki, N. A. AI-Khateeb, Food Science and Nutrition 2003, 43, \n\n145. \n\n[8] J. Berger, M. Reist, J. M. Mayer, N. A. Peppas, R. Gurny, European \n\nJournal of Pharmaceutics and Biopharmaceutics 2004, 57, 19. \n\n[9] N. Gontard., C. Duchez, J-L. Cuq, S. Guilbert, lnternational Journal of \n\nFood Science and Technology, 1994, 29, 39. \n\n[1 O]ASTM - Tensile properties of thin plastics sheeting. Annual Book of \n\nASTM Standards, American Society for Testing and Materiais, \n\nPhiladelphia, D 882, 1995. \n\n[11] E. Wollisch, Z. Kolloid, 1943, 14, 104. \n\n[12] H. L. Elden, in \"Byophisical Properties of the Skin\", John Wiley &amp; \n\nSons, Inc. 1971, 13, 453. \n\n[13] K. Matsuda, S. Suzuki, N. lshiki, V. lkada, Biomaterials 1993, 14, \n\n1030. \n\n30 \n\n\n\nAntibacterial Activity of Chitosan Solutions for Wound Dressing \n\nPublicado na Revista Macromolecular Symposia, vai. 245-246, p. 515-\n\n518,2006- DOI: 10.1002/masy.200651373. \n\nAtividade Antibacteriana de Solu\u00e7\u00f5es de Quitosana para \n\nRecobrimento de Feridas \n\nMaria Campos,\u00b7; L\u00edvia Cordi, 1' 2 Nelson Dur\u00e1n, 2 Lucia Mei 1 \n\n1 \nFaculdade de Engenharia Qu\u00edmica, Universidade Estadual de Campinas, Caixa Postal \n\n6066, Campinas/SP, Brasil Fax: (+55)19 3521 3938; \n\nE-mail: gabi@feg.unicamp.br \n\n2 \nInstituto de Qu\u00edmica, Universidade Estadual de Campinas, Caixa Postal 6154, \n\nCampinas/SP, Brasil \n\nResumo: A quitosana tem encontrado ampla aplica\u00e7\u00e3o no campo \n\nbiom\u00e9dico devido \u00e0s suas interessantes propriedades biol\u00f3gicas que \n\nincluem: biocompatibilidade, biodegradabilidade, atividade hemost\u00e1tica e \n\nefeito bacteriost\u00e1tico. Neste presente trabalho, a atividade antibacteriana \n\ndas solu\u00e7\u00f5es de quitosana para recobrimento de feridas foi investigada \n\ncontra Staphylococcus aureus (isolada de um lodo ativado) e Escherichia \n\nco/i (ATCC 25922) que s\u00e3o pat\u00f3genos de feridas em potencial. Al\u00e9m \n\ndisso, os efeitos da adi\u00e7\u00e3o de plastificante e da concentra\u00e7\u00e3o da solu\u00e7\u00e3o \n\nde quitosana na atividade antibacteriana foram avaliados. De acordo com \n\no estudo da atividade antibacteriana, as solu\u00e7\u00f5es de quitosana, \n\nplastificadas ou n\u00e3o, mostraram, atividade inibit\u00f3ria ao crescimento de \n\nEscherichia co/i. Entretanto, elas n\u00e3o inibiram o crescimento de \n\nStaphy/ococcus aureus, possivelmente pelo fato desta cepa de bact\u00e9ria ter \n\nse tornado resistente devido \u00e0 muta\u00e7\u00f5es causadas pela exposi\u00e7\u00e3o a \n\nefluente industrial. \n\nPalavras-chave: quitosana; recobrimento de ferida, atividade \n\nantibacteriana. \n\n31 \n\n\n\nAntibacterial Activity oi Chitosan Solutions for Wound Dressing \n\nMaria Campos, ' 1 L\u00edvia Cordi, 1\u20222 Nelson Our\u00e1n,' Lucia Mei\n1 \n\n1 Faculty of Chemical Engineering, State University of Campinas-\n\nUNICAMP, P.O.Box 6066, Campinas/SP, Brazil Fax: (+55)19 3521 3938; \n\nE-mail: gabi@feg.unicamp.br \n\n2 Chemistry lnstitute, State University of Campinas-UNICAMP, P.O.Box \n\n6154, Campinas/SP, Brazil \n\nSummary: Chitosan has found wide application in lhe biomedical field due \n\nto its interesting biological properties that include: biocompatibility, \n\nbiodegradability, hemostatic activity and bacteriostatic effect. In this \n\npresent study, antibacterial activity of chitosan solutions for wound \n\ndressing were investigated against Staphylococcus aureus (isolated from \n\nan activated sludge) and Escherichia co/i (ATCC 25922) that are potential \n\nwound pathogens. Moreover, the effects of plasticizer addition and \n\nchitosan concentration on antibacterial activity of chitosan solutions were \n\nalso evaluated. According to the antibacterial activity study, chitosan \n\nsolutions, plasticized or not, showed inhibitory activity against Escherichia \n\nco/i. However, they did not inhibit Staphy!ococcus aureus growth, possibly \n\nbecause this bacterium strain would become resistant due to mutations \n\ncaused by industrial effluent exposure. \n\nKeywords: chitosan; wound dressing; antibacterial activity \n\nlntroduction \n\nChitosan is a cationic copolymer obtained by alkaline deacetylation of \n\nchitin, which is a natural polymer derived from marine crustaceans' \n\nexoskeletons. Chitosan exhibits numerous interesting properties, such as \n\nantitumoral, immune-adjuvant, hemostatic and antibacterial activities1' 1\u2022 \n\nMoreover, it is considered as a biocompatible and biodegradable polymer \n\nand has been shown to facilitate wound healingl21. \n\nDue to its interesting biological properties, chitosan has been increasingly \n\n32 \n\n\n\nused in severa! medicai applications such as drug delivery systems, \n\nimplants, injections and wound dressing'' '1\u2022 Chitosan solutions h ave been \n\nused for treatment of skin wounds, such as skin ulcers, burns and surgical \n\nwounds. \n\nThe antimicrobial activity of chitosan has been studied extensively. lt has \n\nbeen shown lha! chitosan acts by disrupting the barrier properties of the \n\nouter membrana of Gram-negative bacteria[61. \n\nIn this present study, the effects of chitosan concentration and plasticizer \n\naddition on the antibacterial activity of chitosan solutions for wound \n\ndressing were investigated. D-sorbitol, a biocompatible poly-alcohol \n\ncommonly used along with chitosan, was added as a plasticizer. Besides, \n\nthe antibacterial activity of chitosan solutions was evaluated against two \n\npotential Gram-negative wound pathogens: Staphy/ococcus aureus and \n\nEscherichia co/i. \n\nStaphy/ococcus aureus, the most common bacteria to cause skin wound \n\ninfections171 , was isolated from an activated sludge. The activated sludge \n\nprocess is a wastewater treatment method in which the carbonaceous \n\norganic matter of wastewater providas an energy source for the production \n\nof new cells for a mixed population of microorganisms in an aquatic \n\naerobic environment. Bacteria constitute the majority of microorganisms \n\npresent in activated sludge. Both aerobic and anaerobic bacteria may exist \n\nin the activated sludge, but the preponderance of species is facultative, \n\nsince they are able to live in either the presence of or lack of dissolved \n\noxygen. In addition, due to the complex environment found in activated \n\nsludge, bacteria may suffer mutation, transformation and recombination. \n\nEscherichia co/i ATCC 25922, widely applied for antibiotic susceptibility \n\nassays, was used as a contrai Gram-negative bacterium!81. \n\nExperimental \n\nMateriais \n\nHigh molecular weight chitosan (Mw - 100,000), more than 75% \n\ndeacetylated, and D-sorbitol were purchased from Aldrich Chemical \n\n33 \n\n\n\nCompany (USA). Glacial acelic acid was purchased from Synlh (Brazil). \n\nStaphy/ococcus aureus was isolaled from an aclivaled sludge (collected \n\nfrom a Wasle Trealmenl Planl) by Seleclive Medium Technique and \n\nidentified by Molecular Melhod. Escherichia co/i American Type Cullure \n\nCollection (ATCC) 25992 was gently supplied by Dr. Marcelo Brocchi from \n\nthe Department of Microbiology-lnstitute of Biology al UNICAMP-Brazil. \n\nPreparation of chitosan so/utions \n\nSolutions were prepared according to T able 1. Acetic acid 1.0% was used \n\nas solvenl and D-sorbitol 1.0% as plasticizer. \n\nChitosan flakes were dissolved in acetic acid aqueous solulion. Then, lhe \n\nsolulion was fillered to eliminale insoluble impurities. Plasticized chitosan \n\nsolulion was prepared by adding D-sorbitol to the filtered chitosan solution \n\nand the plaslicizer solution was prepared by dissolving D-sorbitol in acelic \n\nacid aqueous solution. \n\nTable 1-Solulions contenls and concentrations (w/w). \n\nSolution Chitosan (%) D-sorbitol (%) \n\nAc 1.0% (solvenl) o o \nCh 0.5% 0.5 o \nCh 1.0% 1.0 o \nCh 1.5% 1.5 o \n\nCh 1.5%-So \n1.5 1.0 \n\n1.0% \n\nSo 1.0% o 1.0 \n\nAntibacterial Activity Study \n\nBoth bacteria, Staphy/ococcus aureus and Escherichia co/i, were \n\nindependently grown in nutrienl broth for 24 hours at 37 'C. The number of \n\nColony-Forming Units (CFU/ml) was determined by lhe Serial Dilutions \n\nMethod. According to this method, 3.0\"1 04 CFU/ml of Staphy/ococcus \n\naureus and 2.0\"1 03 CFU/ml of Escherichia co/i were counled. \n\n34 \n\n\n\nThe antibacterial activity study was carried out by agar diffusion technique: \n\n30 ml of PCA (Piate Count Agar) were added to each Petri dish and then \n\ninoculated with 0.1 ml of bacterial solution ( Staphylococcus aureus or \n\nEscherichia cof1). Wells of 0.7 mm diameter were punched in the center of \n\neach Petri dish and 0.1 ml of test solution (Table 1) was applied to each \n\nwell. \n\nAfter 24 hours of incubation at 37\"C, bacterial growth's inhibition zones \n\nwere measured around lhe wells. This antibacterial activity study was \n\ncarried out in triplicates. \n\nResults and Discussion \n\nAccording to antibacterial activity study results presented in Figures 1 and \n\n2, ali solutions inhibited Escherichia coli growth. lt was expected that \n\nhigher concentration of chitosan would inhibit more bacterial growth. \n\nHowever, Ch 0.5% showed the strongest antibacterial activity, while Ch \n\n1.5% showed the weakest one. \n\nThis unexpected behavior can be attributed to the viscosity of chitosan \n\nsolutions, which increases when chitosan concentration rises. Thus, high \n\nviscosity solutions delay chitosan diffusion in agar, while low viscosity \n\nsolutions permit fast flow. \n\nPlasticizer addition decreases solution viscosity 19l that explains stronger \n\ninhibitory activity of Ch 1.5%-So 1.0% when compared to Ch 1.5%. D-\n\nsorbitol and acetic acid also showed antibacterial activity against \n\nEscherichia coli. \n\nChitosan kills bacteria through cell membrane damage. lt increases the \n\npermeability of the outer and inner membranes and ultimately disrupted \n\nbacterial cell membranesl10l. These damages are caused by electrostatic \n\ninteractions between chitosan protonated amino groups and phosphoryl \n\ngroups of phospholipid components of cell membranes. \n\n35 \n\n\n\n2.5 \n\n8 o \n2 -\n\n11.5 +-l;7,fiil- ----1 \n\"O \nv \nc \n2 \n\n:~ \n\"' :.a 05 .5 \u00b7-\n\no \nCh 0.5% Chl.O% Ch 1.5% Ch 1.5%- Ac 1.0% So 1.0% \n\nSo 1.0% \n\nFigure 1-lnhibition zones diameter (em) of chitosan, D-sorbitol and acetic \n\nacid solutions on Escherichia co/i growth. \n\nFor these reasons, it was expected that chitosan solutions would inhibit \n\nStaphylococcus aureus growth. However, inhibition zones were not \n\nobserved in Petri dishes inoculated with this bacterium. Probably, this \n\nbacterium strain, isolated from an activated sludge, would become \n\nresistant to chitosan due to mutations caused by industrial effluent \n\nexposure. \n\nConclusions \n\nChitosan solutions showed antibacterial activity against Escherichia co/i \n\nand their inhibitory activity was inversely proportional to chitosan \n\nconcentration. Moreover, D-sorbitol decreased viscosity of chitosan \n\nsolution and increased its antibacterial activity. \n\nChitosan did not show inhibitory activity against Staphy/ococcus aureus \n\nthat probably has became resistant to chitosan due to mutations caused by \n\nchemical effluent contact. \n\n36 \n\n\n\nFigure 2- (a) Ch 1.0% with Escherichia co/i; (b) Ch. 1.5%-So 1.0% with \n\nEscherichia co/i; (c) Ch 1.5% with Escherichia co/i; (d) So 1.0% with \n\nEscherichia co/i; (e) Ch 1.0% with Staphylococcus aureus. \n\nAcknowledgments \n\nThe authors thank CNPq and CAPES for financiai support. \n\nReferences \n\n[1] K. Kurita. Polym Degrad Stabil. 1998, 59, 117. \n\n[2]J.Berger. Eur J Pharm Biopharm. 2004, 57, 19. \n\n[3] C. Hoemann. Osteoarthr Cartilage. 2005, 13, 318. \n\n[4] E. Denkbas. J Biomater Appl. 2004, 18, 291. \n\n[5] H. Ueno. Adv Drug Deliver Rev. 2001, 52, 105. \n\n[6]1. M.Helander. lnt. J. Food Microbiol. 2001, 71, 235. \n\n[7] P. G. Bowler. Clin Microbiol Rev. 2001, 14, 244. \n\n[8] J. V. Uri. Acta Microbiollmmunol Hung. 1994, 41 (2), 215. \n\n[9] N. Suyatma. J Agr Food Chem. 2005, 53, 3950. \n\n[10] H. Liu. lntJ Food Microbiol. 2004, 95(2), 147. \n\n37 \n\n\n\n4.3 In Vitro Cytotoxicity Evaluation of Chitosan Membranes for Wound \nDressing \n\nPublicado nos Anais do IV Congresso Latino Americano de \u00d3rg\u00e3os \n\nArtificiais e Biomateriais- COLAOB 2006. \n\nAVALIA\u00c7\u00c3O IN VITRO DA CITOTOXICIDADE DE MEMBRANAS DE \n\nQUITOSANA PARA RECOBRIMENTO DE FERIDAS \n\nArnaldo R. Santos Jr1 , Maria G. N. Campos2 , and Lucia H. lnocentinni-Mei2 \n\n1 Deparatmento de Biologia Aplicada, Faculdade de Ci\u00eancias Agr\u00e1rias e Veterin\u00e1ria, \n\nUniversidade do Estado de S\u00e3o Paulo, UNESP, Brasil, arsantosjr@yahoo.com.br \n\n2Departamento de Tecnologia de Pol\u00edmeros, Faculdade de Engenharia Qu\u00edmica, \n\nUniversidade Estadual de Campinas, UNICAMP, Brasil \n\nResumo: Tr\u00eas formula\u00e7\u00f5es de membranas de quitosana para \n\nrecobrimento de feridas foram preparadas variando-se a adi\u00e7\u00e3o de \n\nplastificante e o processo de neutraliza\u00e7\u00e3o. D-sorbitol foi usado como \n\nplastificante e NaOH-Na2C03 como solu\u00e7\u00e3o neutralizadora. O objetivo \n\ndeste presente estudo foi avaliar a citotoxicidade in vitro das membranas \n\nde quitosana usando os testes de citotoxicidade Direta e Indireta. As \n\nc\u00e9lulas Vero, uma linhagem celular derivada do rim do macaco verde \n\nafricano, foram escolhidas para a avalia\u00e7\u00e3o da citotoxicidade. As \n\nmembranas de quitosana n\u00e3o mostraram citotoxicidade indireta, \n\nentretanto, quando em contato direto com as c\u00e9lulas Vero, evid\u00eancias de \n\ncitotoxicidade foram observadas para a membrana n\u00e3o neutralizada. Esta \n\ncitotoxicidade direta foi atribu\u00edda ao \u00e1cido ac\u00e9tico residual, j\u00e1 que o \u00e1cido \n\nac\u00e9tico \u00e9 t\u00f3xico para as c\u00e9lulas. As membranas neutralizada e plastificada \n\nn\u00e3o foram diretamente t\u00f3xicas para as c\u00e9lulas e o D-sorbitol foi \n\nconsiderado um plastificante seguro e n\u00e3o-t\u00f3xico. \n\nPalavras-chave: quitosana, membranas, recobrimento de feridas, \n\ncitotoxicidade, cultivo de c\u00e9lulas, c\u00e9lulas Vero. \n\n38 \n\n\n\nIN VITRO CYTOTOXICITY EVALUATION OF CHITOSAN \n\nMEMBRANES FOR WOUND DRESSING \n\nArnaldo R. Santos Jr1 , Maria G. N. Campos2 , and Lucia H. lnocentinni-Mei2 \n\n1 Department of Applied Biology, Faculty of Agrarian and Veterinary \n\nSciences, S\u00e3o Paulo State University, UNESP, Brazil, \n\narsantosjr@yahoo.com.br \n\n2 Department of Polymer Technology, Faculty of Chemical Engineering, \n\nState University of Campinas, UNICAMP, Brazil \n\nAbstract: Three formulations of chitosan membranes for wound dressing \n\nwere prepared by varing the plasticizer addition and the neutralization \n\nprocess. D-sorbitol was used as plasticizer and NaOH-Na2C03 as \n\nneutralizer solution. The purpose of this present study was to evaluate the \n\nin vitro cytotoxicity of these membranes by using lndirect and Direct \n\nCytotoxixty Tests. Vero cells, a cell line derived from the kidney of the \n\nAfrican green monkey, were chosen for cytotoxicity evaluation. Chitosan \n\nmembranes did not show lndirect cytotoxicity, however, when on direct \n\ncontact to Vero Cells, cytotoxicity evidences were observed for the non-\n\nneutralized membrane. This direct cytotoxicity was attributed to residual \n\nacetic acid present in this membrane, since acetic acid is toxic to cells. \n\nNeutralized and plasticized membranes were not directly toxic to cells and \n\nD-sorbitol was considered a safety and non-toxic plasticizer. \n\nKey words: Chitosan, Wound dressing, Cell culture, D-sorbitol, \n\nMembranes. \n\n1. INTRODUCTION \n\nChitosan is a partially deacetylated derivative of chitin, which is the second \n\nmore abundant polysaccharide found in nature and the primary structural \n\npolymer in arthropod exoskeletons (Yamane et ai., 2005). Chitosan has \n\ngenerated enormous interest as a biomaterial due to its various \n\nadvantages such as (1) low cost, (2) easy availability, (3) biocompatibility \n\n39 \n\n\n\nand (4) anti-microbial activity (Sarasam and Madihally, 2005). \n\nThe potential of chitosan as a wound dressing is based on its cationic \n\nnature and high charge density in solution. lt was reported that the cationic \n\nnature of chitosan allows electrostatic interactions with anionic \n\nglycosaminoglycans and proteoglycans (Madihally et ai., 1999), that may \n\nserve as a mechanism for retaining and recruiting cells, growth factors, and \n\ncytokines in the wound healing process. \n\nChitosan exhibits others interesting biological activities, such as anti-tumor, \n\nimmuneadjuvant, and hemostatic activities (Kurita, 1998) and is considered \n\nbiodegradable (Muzzarelli, 1997). Due to its positive charges at \n\nphysiological pH, chitosan is bio-adhesive, which increases its retention on \n\nthe site of application (Berger, 2004). lt also can accelerate wound healing \n\n(Synowiecki, 2003). For ali those reasons, chitosan is one of the most \n\nimportant biomaterials for wound dressing management in the recent \n\nyears. \n\nChitosan is soluble in acetic acid and can easily form films and \n\nmembranes. However, plasticizers can be used to improve its mechanical \n\nproperties. In this present study, D-sorbitol, a bio-compatible poly-alcohol, \n\nwas used as plasticizer, in arder to evaluate its effects on chitosan \n\nmembranes' cytotoxicity. \n\n2. MATERIALS ANO METHODS \n\nPreparat\u00edon of Ch\u00edtosan Membranes. \n\nChitosan membranes were prepared by solvent evaporation technique by \n\nusing acetic acid (1.0 % w/w) as solvent. Chitosan solution was prepared \n\nby dissolving 1 .5g of chitosan in 1 00 ml of solvent. After total dissolution, it \n\nwas filtered to remove impurities. Chitosan membrane (CA) was obtained \n\nby casting the chitosan solution in a Petri dish and drying in an oven at 40\u00ba \n\nC. Neutralized chitosan membrane (CN) was prepared by immersing CA \n\ninto NaOH (2% w/w)- Na2Co3 (0.05% w/w) aqueous solution for 1 hour. \n\nAfter immersion, CN was repeatedly washed with distillated water and \n\ndried at 40 o C. 1.0g of D-sorbitol was added to chitosan solution in arder to \n\n40 \n\n\n\nprepare the plasticized membrane (CP), which was obtained by casting the \n\nplasticized solution in a Petri dish and drying at 40\u00ba C. Chitosan \n\nmembranes (CA, CP and CN) were sterilized by ethylene oxide exposure \n\nfor 8 hours at 40\"C, according to sterilization procedures. \n\nCytotoxicity Assay. \n\nFor cytotoxicity evaluation, Vero Cell p240, a cell line derived from the \n\nkidney of the African green monkey, Cercopithecus aeothips, was \n\ncultivated in a Ham's F1 O Nutrition Media (Sigma/USA), supplemented with \n\n10% Fetal Calf Serum (Nutriceii/Brazil). Cytotoxicity Tests were carried out \n\naccording to ISO 1 0993-5. \n\nlndirect Cytotoxicity Test was carried out according to Mossmam's \n\nMethodology (Mossmam, 1983). 10% Phenol solution was used as toxicity \n\npositive contrai and polypropylene (culture plate) as negative one. Viable \n\ncells number was determined by Spectrophotometric Analysis (8 = 540 nm) \n\nby using MTT solutions (Sigma/USA) for cell detection. \n\n3. RESUL TS ANO DISCUSSION \n\nCytotoxicity testing is a rapid, standardized, sensitive and inexpensive \n\nmethod to determine if a material contains significant quantities of \n\nbiologically harmful extractable. Besides, it can provide predictive evidence \n\nof material biocompatibility. Direct toxicity test (DT) consisted of assessing \n\npossible toxic effects of chitosan membranes on direct contact to cells, \n\nwhile indirect toxicity test (IT) evaluates potential deleterious effects of \n\nsubstances released in the culture medium by chitosan membranes. \n\nIT results (Fig.1) indicated that CA, CP and CN did not release toxic \n\nsubstances to the culture media. Chitosan membranes (CA, CP and CN) \n\npresented viable cell number higher than negative contrai one, what can \n\nbe attributed to chitosan's biological property of stimulates cell proliferation \n\n(Muzzarelli, 1988). \n\nOn the other side, DT for CA presented cell aggregation, cytoplasm \n\nreduction and cell death after 48 hours of Vero cell incubation. CA direct \n\ntoxicity may be attributed to residual acetic acid, which was found to be \n\n41 \n\n\n\ncytotoxic and unsuitable for wound care (Lineaweaver, 1985). \n\nDirect cytotoxicity evidences were not observed for CP and CN and both \n\nmembranes were considered satisfactory as cell growth scaffolds. \n\nlndirect Cytotoxicity \n\n0.4,----------------------------------------, \n\n0.35 +---------------------.--------..---------1r---1 \n\ne 0.3 +---+--------------\n0 \n\n;i!; 0.25 \n$ \n~ 0.2 \n] \n~ 0.15 \no \n] 0.1 \n&lt;\n\n0,05 \n\no \nNegative \nControl \n\nPnsit\u00edve \nContrai \n\nCN \n\nSampies \n\nCA CP \n\nFigure 1 - lndirect cytotoxicity test for Chitosan Membranes. \n\n4. CONCLUSIONS \n\nChitosan membranes' cytotoxicity was evaluated by direct and indirect \n\ntests. CA, CP and CN did not present indirect cytotoxicity. However, when \n\non direct contact to Vero cells, CA showed cytotoxicity evidences, probably \n\ndue to residual acetic acid. CP and CN did not present direct toxic effects \n\non Vero cells and D-sorbitol was considered a non-toxic plasticizer. \n\nFinally, neutralization is an important step in lhe preparation of chitosan \n\nmembranes for wound dressing, since it removes residual acetic acid, \n\nwhich was found to be toxic to cell's growth. \n\n5. REFERENCES \n\nBerger, J., Reist, M., Mayer, JM, Felt, O. and Gurny, R. (2004) \"Structure and \n\nlnteractions in covalently and ionically crosslinked chitosan hydrogels for \n\nbiomedical applications\", European Journal oi Pharmaceutics and \n\nBiopharmaceutics vol 57, 19\u00b734. \n\n42 \n\n\n\nlnternational Standard (1992): Biological evaluation of medicai devices - Part 5. \n\nTests for cytotoxicity: in vitro methods. \n\nKurita K., (1998) \"Chemistry and Application of chitin and chitosan\", Polymer \n\nApplication and Stability, vol 59,117-120. \n\nLineaweaver W. Seeger J. Andei A. Rumley T. Howard R., (1985) \"Neutrophil \n\ndelivery to wounds of the upper and lower extremities\", Archives of Surgery, vol \n\n120(4),430-431. \n\nMadihally SV, Matthew HW., (1999) \"Porous chitosan scaffolds for tissue \n\nengineering\", Biomaterials, vol20,1133-1142. \n\nMossmam T.J., (1983) \"Rapid colorimetric assay for cellular grow1h and survival: \n\napplication to proliferation and cytotoxicity assays\", Journal of lmmunological \n\nMethods, vol 65, 55-63. \n\nMuzzarelli R, Baldassarre V, Conti F, Ferrara P, Biagini G, Gazzanelli G, et ai., \n\n(1988) \"Biological activity of chitosan: ultrastructural study\", Biomaterials, vol 9(3), \n\n247-252. \n\nMuzzarelli R. A. A., (1997) \"Human enzymic activities related to lhe therapeutic \n\nadministration of chitin derivatives\", Cellular and Molecular Life Sciences, vol 53, \n\n131-140. \n\nSarasam, A., Madihally, S. V., (2005)\"Characterization of chitosan-\n\npolycaprolactone blends for tissue engineering applications\", Biomaterials, vol 26, \n\n5500-5508. \n\nSynowiecki J., (2003) \"Production, Properties, and Some New Applications of \n\nChitin and lts Derivatives\", Food Science and Nutrition, vol 43(2), 145-171. \n\nYamane, S., lwasaki, N., Majima, T., Funakoshi, T., Masuko, T., Harada, K., \n\nMinami, A., Monde, K.,Nishimura, S-1., (2005) \"Feasibility of chitosan-based \n\nhyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue \n\nengineering\", Biomaterials, vol 26, 611-619. \n\nAKNOWLEDGENTS \n\nThe authors thank CNPq and CAPES for financiai support. \n\n43 \n\n\n\n4.4 In vitro Cytotoxicity of Chitosan Membranes against Vero cells \n\nSubmetido ao Journal of Materiais Research- Part B: Materiais in Medicine \n\n- manuscript number: JMSM970. \n\nCitotoxicidade in vitro de Membranas de Quitosana contra c\u00e9lulas \n\nVero \n\nArnaldo R. Santos Jr1, Maria G. N. Campos2, and Lucia H. lnocentinni-Mei2 \n\n1Deparatmento de Biologia Aplicada, Faculdade de Ci\u00eancias Agr\u00e1rias e Veterin\u00e1ria, \n\nUniversidade do Estado de S\u00e3o Paulo, UNESP, Brasil, arsantosjr@yahoo.com.br \n\n2 Departamento de Tecnologia de Polimeros, Faculdade de Engenharia Qu\u00edmica, \n\nUniversidade Estadual de Campinas, UNICAMP, Brasil \n\nResumo: Tr\u00eas formula\u00e7\u00f5es de membranas de quitosana para \n\nrecobrimento de feridas foram preparadas variando-se a adi\u00e7\u00e3o de \n\nplastificante e o processo de neutraliza\u00e7\u00e3o. D-sorbitol foi usado como \n\nplastificante e NaOH-Na2C03 como solu\u00e7\u00e3o neutralizadora. O objetivo \n\ndeste presente estudo foi avaliar a citotoxicidade in v\u00edtro das membranas \n\nde quitosana usando os testes de citotoxicidade Direta e Indireta. As \n\nc\u00e9lulas Vero, uma linhagem celular derivada do rim do macaco verde \n\nafricano, foram escolhidas para a avalia\u00e7\u00e3o da citotoxicidade. As \n\nmembranas de quitosana n\u00e3o mostraram citotoxicidade indireta, \n\nentretanto, quando em contato direto com as c\u00e9lulas Vero, evid\u00eancias de \n\ncitotoxicidade foram observadas para a membrana n\u00e3o neutralizada. Esta \n\ncitotoxicidade direta foi atribu\u00edda ao \u00e1cido ac\u00e9tico residual, j\u00e1 que o \u00e1cido \n\nac\u00e9tico \u00e9 t\u00f3xico para as c\u00e9lulas. As membranas neutralizada e plastificada \n\nn\u00e3o foram diretamente t\u00f3xicas para as c\u00e9lulas e o D-sorbitol foi \n\nconsiderado um plastificante seguro e n\u00e3o-t\u00f3xico. \n\nPalavras-chave: quitosana, membranas, recobrimento de feridas, \n\ncitotoxicidade, cultivo de c\u00e9lulas, c\u00e9lulas Vero. \n\n44 \n\n\n\nIn vitro Cytotoxicity of Chitosan Membranes against Vero Cells \n\nArnaldo Rodrigues Santos Jr1 , Maria Gabriela Nogueira Campos2' and \n\nLucia Helena lnocentinni-Mei2 \n\n1Department of Applied Biology, Faculty of Agrarian and Veterinary \n\nSciences, S\u00e3o Paulo State University, UNESP, Brazil \n\n2Department of Polymer Technology, School of Chemical Engineering, \n\nState University of Campinas, Cidade Universit\u00e1ria \"Zeferino Vaz\" P.O. \n\nBox 6066, Campinas/SP, Brazil. Fax: (+55 19) 3521-3938 E-mail: \n\ngabi@feq.unicamp.br \n\nABSTRACT: Three formulations of chitosan membranes for wound \n\ndressing were prepared by varying plasticizer addition and neutralization \n\nprocess. D-sorbitol was used as plasticizer and NaOH-Na2C03 as \n\nneutralizer solution. The aim of this present study was to evaluate in vitro \n\ncytotoxicity of chitosan membranes by using lndirect and Direct \n\nCytotoxicity Tests. Vero cells, a cell line derived from the kidney of the \n\nAfrican green monkey, were chosen for cytotoxicity evaluation. Chitosan \n\nmembranes did not show indirect cytotoxicity, however, when on direct \n\ncontact to Vero Cells, cytotoxicity evidences were observed for non-\n\nneutralized membrane. This direct cytotoxicity was attributed to residual \n\nacetic acid present in this membrane, since acetic acid is toxic to cells. \n\nNeutralized and plasticized membranes were not directly toxic to cells and \n\nD-sorbitol was considered a safety and non-toxic plasticizer. \n\nKeywords: Chitosan, membranes, wound dressing, cytotoxicity, cell \n\nculture, Vero cells. \n\n1 INTRODUCTION \n\nThe loss or failure of an organ or tissue is one of the most frequent, \n\ndevastating, and costly problems in human health care. Tissue \n\nengineering, is a new research filed that applies the principies of biology \n\nand engineering to the development of functional substitutes for damaged \n\ntissue. \n\n45 \n\n\n\nCentral to successful tissue engineering is the ability of cells to adhere to \n\nan extra cellular material and proliferate. This ability mainly depends on the \n\ninteractions between the cells and the material surface. Thus, an ideal \n\nscaffold for tissue engineering should demonstrate considerable \n\nmechanical properties, suitable biodegradability and, most importantly, \n\ngood biocompatibility. \n\nChitosan is a partially deacetylated derivative of chitin, which is the second \n\nmore abundant polysaccharide found in nature and the primary structural \n\npolymer in arthropod exoskeletons [Yamane et ai., 2005]. Chitosan has \n\ngenerated enormous interest as a biomaterial due to its various \n\nadvantages such as (1) low cost, (2) easy availability, (3) biocompatibility \n\nand (4) anti-microbial activity [Sarasam and Madihally, 2005]. The potential \n\nof chitosan as a tissue engineering scaffold is based on its cationic nature \n\nand high charge density in solution. Due to its cationic nature, chitosan is \n\nallowed for electrostatic interactions with anionic glycosaminoglycans and \n\nproteoglycans [Madihally et ai., 1999]. These ionic interactions may serve \n\nas a mechanism for retaining and recruiting cells, growth factors, and \n\ncytokines within the tissue scaffold. \n\nChitosan exhibits others interesting biological activities, such as anti-tumor, \n\nimmune-adjuvant, and hemostatic activities [Kurita, 1998,]. Moreover, it is \n\nmetabolized by certain human enzymes, especially lysozyme, and is \n\nconsidered biodegradable [Muzzarelli, 1997]. Due to its positive charges at \n\nphysiological pH, chitosan is bio-adhesive, which increases its retention on \n\nthe site of application [Berger, 2004]. lt can also accelerate wound healing \n\n[Synowiecki, 2003]. \n\nDue to ali those properties, chitosan is one of the most important \n\nbiomaterials for wound dressing management in the recent years. Chitosan \n\ncan easily form films and membranes. However, plasticizers can be used \n\nto improve its mechanical properties. In this study, 0-sorbitol, a \n\nbiocompatible poly-alcohol, was used as plasticizer, in order to evaluate its \n\neffects on chitosan membranes' cytotoxicity. \n\n46 \n\n\n\n2 MATERIALS ANO METHODS \n\n2. 1 Chitosan membranes production \n\nChitosan membranes were prepared by solvent evaporation. 1.0% (w/w) \n\nAcetic Acid (Synth/Brazil) solution was used as solvent. 1 .5g of High \n\nMolecular Weight Chitosan (Aidrich/USA) was dissolved in 1 00 ml of \n\nsolvent. Then, chitosan membranes (CA) were obtained by casting \n\nchitosan solution in Petri dishes and drying at 40'C. \n\n1.0 g of D-sorbitol (Aidrich/USA) was added to chitosan solution in order to \n\nprepare plasticized membranes (CP). Neutralized membranes (CN) were \n\nprepared by immersing CA into NaOH (2% w/w)-Na2Co3 (0.05% w/w) \n\naqueous solution for 1 hour. Then, CN were repeatedly washed with \n\ndistillated water and dried at 40\u00b0 C. \n\nChitosan membranes (CA, CP and CN) were sterilized by ethylene oxide \n\nexposure for 8 hours at 40 'C, according to sterilization procedures. \n\n2.2 Ce/1 culture \n\nVero cells are recommended for studies of cytotoxicity and for cell-\n\nsubstratum interactions with biomaterials. This cell line was established \n\nfrom the kidney of the African green monkey (Cercopithecus aethiops) and \n\nobtained from Adolfo Lutz lnstitute, S\u00e3o Paulo, Brazil. \n\nCells were cultured in Ham-F1 O medi um (Sigma) supplemented with 10% \n\nfetal calf serum (FCS, Nutricell Nutrientes Celulares, SP, Brazil) at 37'C \n\nand kept in culture flask of 25ml or 50ml before inoculation (Corning, \n\nCambridge, MA, USA). Nutritional medium was replaced periodically. \n\n2.3 Cytotoxicity assay \n\nVero cells were cultured on different chitosan membranes (CA, CP, and \n\nCN) for 24 hours. Six repetitions were made of ali experiments. Test was \n\ncarried out according to Mossmann's Methodology [Mossmann, 1983]. \n\nBriefly, substrates were incubated in 96 well plates (Corning) with cultured \n\nmedium without FCS for 24h at 37 o C. After this, 1 OOL L of cell suspension \n\n47 \n\n\n\n(2.5 x 105 cells/mL) in Ham F-1 O with 1 O% of FCS was added to the wells \n\ncontaining different chitosan samples. \n\nWells were washed twice with 0.1 M phosphate buffered saline (PBS) pH \n\n7.4, at 37\"C and incubated with 100L L of Ham F-10 medium. The assay \n\nmixture (1 OL L per well) containing 5mg/mL of 3-(4,5-dimetiltiazol-2-il)-2,5 \n\ndiphenyl tetrazolium bromide (MTI, Sigma) was added to each well and \n\nincubated for 4h at 37\"C. \n\nAfter 4h, 100~L of isopropanol acid (lsofar lnd, RJ, Brazil) was added to \n\neach well and 3 hours later, cells were quantified spectrophotometrically, \n\nbased on absorbance at 540nm by using a Biorad Model 550 micro plate \n\nreader Spectrophotometer (Hercules, CA, USA). \n\nAccording to the ISO 1 0993-5, cells on poly-prapylene culture plate by \n\nthemselves were used as positive contrai, while culture medium with \n\nphenol (2%) was used as negative toxicity contrai. Absorbance of ali \n\nexperimental conditions (chitosan samples, negative or positive contrais) \n\nwithout cells was also read for MTI reaction contrai. \n\nComparison of continuous variables for ali graups was dane with ANOVA. \n\nWhen a significant difference was found, Turkey HSD multiple comparison \n\ntest was performed (p&lt;0.05). \n\n2.4 Ce/1 morphology by Light microscopy and Scanning Electron \n\nmicroscopy \n\nFor cell morphologic analysis by light microscopy (LM), 2.5 x 105 cells/mL \n\nwere inoculated in 24 wells culture plate (Corning) containing a chitosan \n\nsample (CA, CP or CN) or one of the contrais (positive or negative). Cells \n\nwere feed with Ham F-1 O medi um with 10% FCS. Alive cells were \n\nobserved and photographed in inverted microscope IX-50 (Oiympus, \n\nHatagaya, Tokyo, Japan) after 48h, 120h and 240h of cultured. For ali \n\nexperiments, n=5. \n\nFor cell morphologic analysis by scanning electron microscopy (SEM), 2.5 \n\nx 105 cells/mL were inoculated on different chitosan membranes (CA, CP \n\nand CN) in 24 well cultured plate (Corning) feed with Ham F-1 O medium \n\n48 \n\n\n\nwith 10% FCS. Cells cultured on a glass cover slip, at the same culture \n\nconditions, were used as contrai. After 48h, samples were fixed in 3% \n\nglutaraldehyde (Sigma) in 0.1 M phosphate buffer at pH 7.2 for 45 minutes \n\nat 4'C, and post-fixed with 1% OS04 (Sigma) for 2h at 4'C. Specimens \n\nwere then dehydrated in graded series of ethanol, criticai point dried \n\n(Balzers CDT 030) and coated with gold in a sputter coater (Balzers CDT \n\n050). The coated specimens were observed and photographed with a \n\nJEOL JSM-5800 scanning electron microscope. \n\n3 RESULTS \n\n3. 1 Cytotoxicity assay \n\nCytotoxicity testing is a rapid, standardized, sensitiva and inexpensive \n\nmethod to determine whether a material contains significant quantities of \n\nbiologically harmful extractable. Besides, it can provide predictive evidence \n\nof material biocompatibility. Direct cytotoxicity test consisted of assessing \n\npossible toxic effects of chitosan membranas on direct contact to cells, \n\nwhile lndirect Cytotoxicity test evaluates potential deleterious effects of \n\nsubstances released in the culture medium by chitosan membranes. \n\nlndirect Cytotoxicity results (Figure 1) indicated that CA, CP and CN did \n\nnot release toxic substances to the culture media. Chitosan membranas \n\n(CA, CP and CN) showed viable cell number higher than negative contrai \n\nthat can be attributed to chitosan's biological property of stimulates cell \n\nproliferation. \n\nOn the other hand, for direct toxicity evaluation, a possible toxic effect of \n\nCA was observed (Figure 2). \n\n3.2 Ce/1 morphology by light microscopy \n\nFor negative control (culture plate), spreading cells growing were found at \n\nali incubation times studied. After 48hs and 120hs, we could observe a \n\nconfluent cells monolayer on the culture plates. Round cells that indicate \n\ncell division could also be seen at these incubation times. Past 240hs, \n\nrounded cells on the substrate were found, indicating lost of viability. \n\n49 \n\n\n\nBesides, numerous cells were observed flouting on the culture medium \n\n(Figures 3A). \n\nFor positive contrai of toxicity (phenol), round and no viable cells on the \n\nsubstrate were observed for ali incubation times. The cell number at ali \n\nperiods was, apparently, the same, indicating no cell proliferation on that \n\nsamples (Figures 3B). \n\nForCA sample, round and aggregated cells on the substrate were found at \n\nthe first 48hs. However, cells aggregation was observed in small number. \n\nAfter 120hs of incubation, more spreading cells could be observed in the \n\ncellular aggregates. These cells were apparently trying to migrate for other \n\nregions of CA. Past 240hs, a no confluent cell layer on CA was observed \n\n(Figures 3C). \n\nSimilar cell behavior was observed for CP and CN. However, at the first \n\n48hs, we observed a no confluent spreading cell monolayer on CP and CN \n\nsamples. After 120hs, a confluent celllayer could be observed. Moreover, \n\npast 240hs of incubation, multi-layers of cells on CP and CN samples were \n\nfound (Figures 3D and 3E, respectively). \n\n3.3 Ce/1 morphology by Scanning E/ectron Microscopy \n\nBy SEM, retracted cell around cell fragments we found on CA. In \n\nsome regions we could observe spreading cell near to cell fragments \n\n(Figures A1 and A2). We also could observe spreading cell on substrate on \n\nCP. In some regions, we found cell connected by thin processes (Figures \n\nB1 and B2). For CN, we observed spreading cells with large processes \n\nlinking them. Many vesicles and/or microvillus were found on cell surface \n\n(Figures C1 and C2). \n\n4 DISCUSSION \n\nThe indirect cytotoxicity indicated that there was no liberation of toxic \n\nsubstances from the different chitosan samples to the culture medium. On \n\nthe other hand, CA showed some direct toxic activity in the MTT assay. \n\nThis result was confirmed by the morphological pattern of Vero cells \n\ncultured on CA. Rounded and aggregated cells in small areas of CA were \n\n50 \n\n\n\nobserved. Morphological pattern was compatible with cells submitted to \n\nsome toxic effect. After initial contact, some cells were capable to \n\nproliferate and migrate from cellular aggregates to CA surface. However, \n\nwhen compared to the other chitosan samples studied (CP and CN), CA \n\nshowed small number of cells. CA direct toxicity can be attributed to \n\nresidual acetic acid, which was found to be cytotoxicity and unsuitable for \n\nwound care [Lineaweaver, 1985]. \n\nlt was not observed direct cytotoxicity evidences for CP and CN and both \n\nmembranes were considered satisfactory as cell growth scaffolds. CP and \n\nCN samples showed viable cell number higher than negativa contrai. Mori \n\net ai. examined the effects of chitin and its derivatives on fibroblasts \n\nproliferation. Their results indicated that chitosan has no proliferation effect \n\non in vitro fibroblasts growth [Mori et ai. 1997]. However, other reports \n\nshowed that chitosan can indirectly accelerate fibroblast proliferation in \n\nvivo [Ueno et ai., 1999]. Ding et ai., when studied chitosan irnmobilization \n\non PLLA surface, did not observe prominent effects of chitosan on cell \n\nproliferation (Ding et ai., 2004). Our results are in accordance to Mori et ai. \n\nand Ding et ai. since a decrease in the number of cells was observed for ali \n\nchitosan substrates (CA, CP and CN) when compared to the negative \n\ncontrai (culture plate). \n\nThus, our in vitro study results suggest that CP and CN can support the \n\ninitial attachment and spreading of Vero cells. These findings are in \n\naccordance to previous reports that showed similar morphological pattern \n\nof cells cultured on chitosan surfaces. \n\nMicroscopic observations at 1 h revealed that osteoblasts were attached \n\nand beginning to spread. In contras!, fibroblasts showed rounded \n\nmorphologies with markedly reduced attachment leveis [Fakhryet ai., \n\n2004]. Previous reports have shown conflicting results about the effects of \n\nchitosan on fibroblasts. While chitosan has been shown to have stimulatory \n\neffect on fibroblast activity [Muzzarelli et ai., 1988; Lahiji et ai., 2000], other \n\nresults have shown some inhibitory effects of chitosan on fibroblasts \n\ngrowth [Mori et ai., 1997; Berschtet ai., 1994]. \n\n51 \n\n\n\nMei et ai. showed the cell morphology on polycaprolactone (PCL) and \n\nchitosan-modified scaffolds. lt was reported that chitosan modification \n\ndramatically enhances cellular affinity and compatibility for PCL scaffolds. \n\nCells were more firmly adhered on chitosan-modified PCL and more \n\nelongated and stretched on this substrate. Moreover, cell adhesion and \n\nproliferation on PCL scaffolds were considerably improved after chitosan \n\nmodification [Mei et ai., 2005]. \n\nConflicting results among published data on chitosan-mediate fibroblast \n\ncells attachment may be explained by differences in cell population \n\nanalyzed and by variation in properties of tested chitosan [Fakhry et ai., \n\n2004]. \n\nAfter 240hs of incubation on chitosan samples, morphological analysis \n\nshowed cells growing such as many layers. That growth pattern indicates a \n\nsatisfactory proliferation of cells on those chitosan substrates. lt also \n\nindicates that CP and CN can support cellular growth after normal \n\ndecrease of viability, as well observed in negative contrai for the same \n\nperiod of incubation. Our morphologic observations showed reduction of \n\ncell spreading in chitosan substrates when compared to culture plate \n\n(negative contrai). Similar trend was previously cited by Sarasam and \n\nMadihally who observed drastic decrease in the cell spreading area from \n\ncontrai to chitosan [Sarasam and Madihally, 2005]. \n\nCell spreading and morphology on chitosan substrates still are an unclear \n\nevent. Structurally, chitosan is a linear polysaccharide consisting of L (1 L 4) \n\nlinked D-glucosamine residues with variable number of randomly located \n\nN-acetyl-glucosamine groups. The average molecular weight ranges from \n\n50 to 1000 kDa [Yamane et ai., 2005]. Chitosan does not have one specific \n\nbinding domain for cell adhesion mediated by integrins receptors. Also, any \n\nintracellular signaling pathway activated by chitosan contact is known \n\n[Hynes and Zhao, 2000]. Cells generally attach to an artificial culture \n\nsubstrate by binding to specific anchoring proteins that become adsorbed \n\nto substrate surface. Chitosan acts as a positively charged center in \n\nsolution, and the outside of the cell membrane carries negative charges. \n\n52 \n\n\n\nFor Ding el ai., lhe eleclronic inleraclion belween cell and subslrate \n\nsurface could modulate the cytoskeleton and cell morphology (Ding et ai., \n\n2004). On lhe other hand, Huang et ai. suggest that cell spreading and \n\nmorphology could be modulated by the structural characteristics of \n\nchitosan scaffolds. In that work, authors seeded cells on bi-dimensional \n\n(2D) and three-dimensional (3D) chitosan substrates. On 2-D condition, \n\ncells were restricted to spread on a flat plane and the important factor \n\naffecting cellular activity was whether the substrate contains or no cell \n\nadhesion binding domains. In contras!, 3-D matrices provided spatial \n\nadvantages for cell-cell and cell-matrix adhesion as well as support for cell \n\ntraction [Huang et ai., 2005). Reduction in cell size was thought to be the \n\nresult of strong electrostatic interactions associated with the deacetylation \n\ndegree [Mao et ai., 2004). Changes on cellular activity induced by different \n\ndeacetylation degrees could not be significantly relative to other adhesive \n\nforces [Huang et ai., 2005). Nevertheless, cells proliferation inhibition found \n\non chitosan scaffolds could be due to reduced adhesion and not to strong \n\nadhesion [Mao et ai., 2004). \n\n5 CONCLUSIONS \n\nChitosan membranes' cytotoxicity was evaluated by Direct and lndirect \n\nTests. CA, CP and CN did not show lndirect Cytotoxicity. However, when \n\non direct contact to Vero Cells, CA showed cytotoxicity evidences that \n\nwere attributed to residual acetic acid. CP and CN did not show direct toxic \n\neffects on Vero Cells and D-sorbitol was considered a non-toxic plasticizer. \n\nFinally, neutralization was an important step in preparation of chitosan \n\nmembranes for wound dressing because it removed residual acetic acid, \n\nwhich was found to be toxic for cells growth. \n\n6 REFERENCES \n\nBerger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny G. 2004, \n\nStructure and interactions in covalently and ionically cross linked chitosan \n\nhydrogels for biomedical applications, Eur J Pharm Biopharm, 57:19-34; \n\n53 \n\n\n\nBerscht PC, Nies B, Liebendorfer A, Kreuter J. 1994, lncorporation of basic \n\nfibroblast growth factor into methylpyrrolidinone chitosan fleeces and \n\ndetermination of the in vitro release characteristics, Biomaterials, 15:593-\n\n600; \n\nDing Z., Chen J., Gao S., Chang J., Zhang J., Kang E. 2004, \n\nlmmobilization of chitosan onto poly-L-Iactic acid film surface by plasma \n\ngraft polymerization to contrai the morphology of fibroblast and liver cells, \n\nBiomaterials, 25:1 059-1 067; \n\nFakhry A. Schneider GB, Zaharias R, Senel S. 2004, Chitosan supports \n\nthe initial attachment and spreading of osteoblasts preferentially over \n\nfibroblasts, Biomaterials, 25:2075-2079; \n\nHuang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV. 2005, In vitro \n\ncharacterization of chitosan-gelatin scaffolds for tissue engineering, \n\nBiomaterials, 26:7616-7627; \n\nHynes RO, Zhao Q. 2000, The evolution of cell adhesion, J Cell Biol, \n\n150:89-96; \n\nlnternational Standard, 1992, Biological evaluation of medicai devices -\n\nPart 5- Tests for cytotoxicity: in vitro methods; \n\nKurita K. 1998, Chemistry and application of chitin and chitosan, Polym \n\nDegrad Stab, 59:117-120; \n\nLahiji A, Sohrabi A, Hungerford DS, Frondoza CG. 2000, Chitosan \n\nsupports the expression of extracellular matrix proteins in human \n\nosteoblasts and chondrocytes. J Biomed Mater Res, 51 :586-595; \n\nLineaweaver W, Howard R, Soucy D, et ai. 1985, Topical antimicrobial \n\ntoxicity, Arch Surg, 120:267-270; \n\nMadihally SV, Matthew HW. 1999, Porous chitosan scaffolds for tissue \n\nengineering, Biomaterials, 20:1133 - 1142; \n\nMao JS, Cui YL, Wang XH, Sun Y, Yin YJ, Zhao HM, et ai. 2004, A \n\npreliminary study on chitosan and gelatin polyelectrolyte complex \n\n54 \n\n\n\ncytocompatibility by cell cycle and apoptosis analysis, Biomaterials, \n\n25:387- 391; \n\nMei N, Chen G, Zhou P, Chen X, Shao Z-Z. 2005, Biocompatibility of \n\nPoly(e-caprolactone) Scaffold Modified by Chitosan - The Fibroblasts \n\nProliferation in vitro, J Biomater Appl, 19: 323-339; \n\nMori T, Okumura M, Matsuura M, Ueno K, Tokura S, Okamoto Y, Minami \n\nS, Fujinaga T. 1997, Effects of chitin and its derivatives on the proliferation \n\nand cytokine production of fibroblasts in vitro, Biomaterials, 18:947-951; \n\nMossmann T J. 1983, Rapid colorimetric assay for cellular growth and \n\nsurvival: application to proliferation and cytotoxicity assays, J lmmunol \n\nMethods, 65:55-63; \n\nMuzzarelli R, Baldassarre V, Conti F, Ferrara P, Biagini G, Gazzanelli G, et \n\nai. 1988, Biological activity of chitosan: ultrastructural study, Biomaterials, \n\n9:247-52; \n\nMuzzarelli RAA. 1997, Human enzymatic activities related to the \n\ntherapeutic administration of chitin derivatives, Cell Moi Life Sei, 53:131-\n\n140; \n\nMuzzarelli RA, Biagini G, Bellardini M, Simonelli L, Castaldini C, Fratto G. \n\n1 993, Osteoconduction exerted by methylpyrrolidinone chitosan used in \n\ndental surgery, Biomaterials, 1 4:39-43; \n\nSarasam A, Madihally SV. 2005, Characterization of chitosan-\n\npolycaprolactone blends for tissue engineering applications, Biomaterials, \n\n26:5500-5508; \n\nSynowiecki J, AI-Khateeb N A.2003, Production, properties, and some new \n\napplications of chitin and its derivatives, Crit Rev Food Sei Nutr, 43:145-\n\n171; \n\nUeno H, Yamada H, Tanaka I, Kaba N, Matsuura M, Okumura M, \n\nKadosawa T, Fujinaga T. 1999, Accelerating effects of chitosan for healing \n\nat early phase of experimental open wound in dogs, Biomaterials, 20:1407-\n\n1414; \n\n55 \n\n\n\nYamane S, lwasaki N, Majima T, Funakoshi T, Masuko T, Harada K, \n\nMinami A, Monde K, Nishimura S-1. 2005, Feasibility of chitosan-based \n\nhyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue \n\nengineering, Biomaterials, 26:611-619; \n\n7 FIGURE LEGENDS \n\nFigure 1. lndirect Cytotoxicity Test for Chitosan Membranes. \n\nFigure 2. Direct Cytotoxicity Test for Chitosan Membranes. \n\nFigure 3. Morphology of Vero cells cultured on different chitosan \n\nmembranes, obtained by light microscopy. \n\nA) Negative contrai for cytotoxicity (CT-); \n\nB) Positive contrai for cytotoxicity (CT +); \n\nC) Chitosan membrane (CA); \n\nD) chitosan plasticized membrane (CP); \n\nE) chitosan neutralized membrane (CN). Ali assays were performed for 48, \n\n120 and 240hs of cultured. \n\nFigure 4. Morphology of Vero cells cultured on different chitosan \n\nmembranes, obtained by scanning electron microscopy. A) Chitosan \n\nmembrane (CA); 8) chitosan plasticized membrane (CP); C) chitosan \n\nneutralized membrane (CN). \n\n56 \n\n\n\nContrai-\n\nContrai -\n\nFigure 1 \n\nlndiret cytotoxicity evaluation \n\nContrai+ Chitosan mem brane Chitosan plastidzed Chitosan neutralizecl \n\nSamples studied \n\nFigure 2 \n\nDirect cytotoxicity evaluation \n\nContrai+ Chitosan membrane Chitosan plasticized Chitosan neutralized \n\nSamples studied \n\n57 \n\n\n\nFigure 3 \n\n48h 120h 240h \n\nCT~ \n\nCT+ \n\nCA \n\nCP \n\nCN \n\n58 \n\n\n\nFigure 4 \n\n59 \n\n\n\n4.5 Crystallinity versus Water Vapor Permeability of Chitosan \nMembranes for Wound Dressing \n\nPublicado nos anais da Advances in Materiais and Processing Technology \n(AMPT) Conference, 2006. \n\nCristalinidade versus Permeabilidade ao Vapor D'\u00e1gua de Membranas \n\nde Quitosana para recobrimento de feridas \n\nMaria Gabriela Nogueira Campos \u2022:, Carlos Raimundo Ferreira Grosso b \n\nand Lucia Helena lnnocentini-Mei a \n\na Universidade Estadual de Campinas, Faculdade de Engenharia Qu\u00edmica, Departamento \n\nde Tecnologia de Pol\u00edmeros, Cidade Universit\u00e1ria \"Zelerino Vaz\" Caixa Postal 6066, \n\nCEP: 13.083-970, Brasil. \n\nAutor correspondente. Tel.: + 55 19 3521 -3939/Fax: + 55 19 3521-3938. \n\nb Universidade Estadual de Campinas, Faculdade de Engenharia de Alimentos, Brasil. \n\nRESUMO \n\nOs efeitos da cristalinidade na permeabilidade ao vapor de \u00e1gua das \n\nmembranas de quitosana foram avaliados neste presente estudo. D-\n\nsorbitol, um poli-\u00e1lcool biocompat\u00edvel, foi usado como plastificante para \n\navaliar seu efeito nas propriedades das membranas de quitosana. As \n\nmembranas de quitosana foram morfologicamente caracterizadas por \n\nmicroscopia eletr\u00f4nica de varredura e difractometria de raios-X. As \n\npropriedades t\u00e9rmicas foram avaliadas por calorimetria diferencial \n\nexplorat\u00f3ria e as propriedades mec\u00e2nicas, tais como tra\u00e7\u00e3o e deforma\u00e7\u00e3o \n\nna ruptura tamb\u00e9m foram medidas. As membranas plastificadas \n\napresentaram maior permeabilidade ao vapor d'\u00e1gua e deforma\u00e7\u00e3o ao \n\nromper, por\u00e9m menor tra\u00e7\u00e3o e cristalinidade. Este comportamento pode \n\nser atribu\u00eddo \u00e0 maior mobilidade das cadeias polim\u00e9ricas promovida pela \n\nadi\u00e7\u00e3o de plastificante. \n\nPALAVRAS-CHAVE: quitosana, D-sorbitol, barreira ao vapor d'\u00e1gua, \n\ndifractometria de raios- X. \n\n60 \n\n\n\nCrystallinity versus Water Vapor Permeability of Chitosan Membranes \n\nfor Wound Dressing \n\nMaria Gabriela Nogueira Campos a:, Carlos Raimundo Ferreira Grosso b \n\nand Lucia Helena lnnocentini-Mei a \n\na State University of Campinas, Faculty of Chemical Engineering, \n\nOepartment of Polymer Technology, Cidade Universit\u00e1ria \"Zeferino Vaz\" \n\nP.O.Box 6066, Zip code: 13.083-970, Brazil. \u2022 Corresponding author. Tel.: \n\n+55 19 3521-3939/Fax: + 55 19 3521-3938 \n\nEmail: gabi@feg.unicamp.br \n\nb State University of Campinas, Faculty of Food Engineering, Cidade \n\nUniversit\u00e1ria \"Zeferino Vaz\" Rua Monteiro Lobato, 80 P.O.Box 6121, Zip \n\ncode:13.083-862, Brazil. \n\nABSTRACT \n\nEffects of crystallinity on water vapor permeability of chitosan membranes \n\nwere evaluated in this present study. 0-sorbitol, a biocompatible poly-\n\nalcohol, was used as plasticizer to evaluate its effects on chitosan \n\nmembranes' properties. Chitosan membranes were morphologically \n\ncharacterized by Scanning Electron Microscopy and X-Ray Oiffraction \n\nanalyses. Thermal properties were evaluated by Oifferential Scanning \n\nCalorimetry and mechanical properties, such as tensile strength and \n\nelongation at break, were also measured. Plasticized membranes showed \n\nhigher water vapor permeability and elongation at break, but lower tensile \n\nstrength and crystallinity. This behavior can be attributed to the higher \n\nmobility of polymer chains promoted by plasticizer addition. \n\nKEYWORDS: Chitosan, 0-sorbitol, water vapor barrier, X-ray \n\ndiffractometry. \n\nINTRODUTION \n\nChitosan is a polysaccharide derived from chitin that is the second most \n\nabundant polysaccharide found in nature. Chitin is largely found in externai \n\nskeleton of insets and in shell of crustaceans. Chitosan is mainly obtained \n\n61 \n\n\n\nby deacetylation of chitin but it can also be found in lhe cell wall of some \n\nfungi, such as Mucor rouxii [1). Both chitin and chitosan have been widely \n\nstudied because of their interesting biological properties. \n\nChitosan interesting properties include biocompatibility, biodegradability, \n\nbacteriostatic effect, hemostatic and antitumoral activities, besides promete \n\nwound healing [2,3). Oue to its unique properties, chitosan has found wide \n\napplication in biomedical area, such as: implants, drug delivery matrix, \n\nscaffolds for tissue engineering, skin substitutes and wound dressings [4,5 \n\nand 6). \n\nChitosan is soluble in acetic acid solution and can easily form films and \n\nmembranes by solvent evaporation technique. However, depending on \n\ndesired properties, plasticizer can be added to 1mprove flexibility and \n\nplasticity of membranes [7). Polyols, such as sorbitol and glycerol, \n\nplasticize effectively due to their ability to reduce internai hydrogen bonds \n\nwhile increasing intermolecular space [8). \n\n0-sorbitol is naturally found in berries and fruits and is synthetically \n\nprepared by high-pressure catalytic hydrogenation of glucose. Besides, \n\nsorbitol is also produced by lhe human body. Oue to its low toxicity and \n\nconsequently high biocompatibility, 0-sorbitol was used as plasticizer in \n\nthis study. \n\nCrystallinity probably is the major physical characteristic that determines \n\nthe functional properties of polymers. lt plays an important role in \n\nadsorption efficiency and swelling behavior [9). Besides, mechanical, \n\nthermal and barrier properties are also affected by crystallinity. Therefore, \n\nlhe goals of this present study were to evaluate lhe effectiveness of 0-\n\nsorbitol as plasticizer, as well as to investigate lhe effects of plasticizer \n\naddition on chitosan membranes' crystallinity, and hence, on their thermal, \n\nmechanical and barrier properties. \n\n62 \n\n\n\nEXPERIMENTAL \n\nMateriais \n\nHigh molecular weight chitosan (Mw - 1 00,000), more than 75% \n\ndeacetylated, and 0-sorbitol were purchased from Aldrich Chemical \n\nCompany (USA). Glacial acetic acid was purchased from Synth (Brazil). \n\nPreparation of Membranas \n\nChitosan membranes were prepared by solvent evaporation technique by \n\nusing acetic acid (1.0 % w/w) as solvent. Chitosan solution was prepared \n\nby dissolving 1.5g of chitosan in 100 ml of solvent. After total dissolution, it \n\nwas filtered to remove impurities. \n\nChitosan membrane (CA) was obtained by casting the chitosan solution in \n\na Petri dish and drying in an oven at 40\u00ba C. Neutralized chitosan \n\nmembrane (CN) was prepared by immersing CA into NaOH (2% w/w)-\n\nNa2Co3 (0.05% w/w) aqueous solution for 1 hour. After immersion, CN was \n\nrepeatedly washed with distillated water and dried at 40 o C. \n\n1.0g of 0-sorbitol was added to chitosan solution in order to prepare the \n\nplasticized membrane (CP), which was obtained by casting the plasticized \n\nsolution in a Petri dish and drying at 40\u00ba C. \n\nDifferential Scanning Ca/orimetry (DSC) \n\nOSC analyses were performed on a OSC 2920 -TA lnstruments. OSC \n\ncurves of chitosan membranes were obtained by heating samples from -\n\n130 'C up to 200 o C, at heating rate 2 o C min\u00b71 and modulation rate \u00b11 o C \n\nmin\u00b71 , under nitrogen atmosphere, in order to estimate glass transition and \n\nmelting temperatures. \n\nX-Ray Diffractometry \n\nX-ray diffraction of chitosan membranes was performed in a Powder \n\nOiffractometer HZG/4A (Freiberger Preazisionsmechanik, Freiberg, \n\nGermany). The relative intensity was recorded in the scattering range (29) \n\nof 4 to 40\u00ba. \n\n63 \n\n\n\nScanning Electron Microscopy (SEM) \n\nChitosan membranes samples were cut and kept in vacuum desiccators \n\nfor 48 hours. Then, samples were coated with gold/palladium using a SC \n\n7620 Sputter Coater - POLARON under high vacuum and 4 mA for 180 \n\nseconds. Coated samples were examined using a LEO 440i Scanning \n\nElectron Microscopic. \n\nWater Vapor Permeability (WVP) \n\nWVP of chitosan membranes was measured according to ASTM 96-00 \n\n[1 O] by the Desiccant method. Chitosan membranes were sealed to the \n\nopen mouth of a test dish containing anhydrous calcium chloride, and the \n\nassembly was placed in a desiccators with controlled atmosphere (75 \u00b1 2% \n\nRH) at room temperature. The dish assembly was daily weighted and the \n\nwater vapor transmission rate was calculated. Tests were carried out in \n\ntriplicates. \n\nMechanical Properties \n\nElectronic Digital Caliper (Fowler &amp; NSK - Max-Cal) was used to measure \n\nmembranes thickness and TA-XT2 (SMS, Surrey, UK) lnstrument was \n\nused to measure tensile strength (TS) and elongation at break (E). Tests \n\nwere carried out according to ASTM D-882 [11], with initial grip separation \n\nof 30 mm forCA and CN and 50 mm for CP. Cross head speed was fixed \n\nin 1 mm/s in ali tests. \n\nRESUL TS ANO DISCUSSION \n\nDifferential Scanning Calorimetry and X-ray Diffractometry \n\nAccording to Table 1, CA showed higher melting fusion enthalpy that \n\nindicates higher crystallinity. These results were confirmed by X-ray \n\nDiffraction analysis (Figure 1 ), in which CA showed strong reflection at 29 \n\naround 10-12\u00ba and 18-20\u00ba, besides a small peak around 16\u00ba that has been \n\nattributed to the anhydrous crystallattice [12]. \n\nMoreover, CA showed lower glass transition temperature when compared \n\nto CN, which can be attributed to the residual acetic acid present in CA that \n\nacts as plasticizer (13]. Thus, neutralization process removed residual \n\n64 \n\n\n\nacetic acid from CN and promoted a molecular rearrangement that was \n\nresponsible for decreasing the free volume around the polymer chains. \n\nTherefore, CN showed higher glass transition temperature and lower \n\nmelting one. \n\nBesides, according to Figure 1, CN showed small peak around 1 0-12Q and \n\nreflection at 28 around 20-22Q, as observed by Srinivasa et a/[14), which \n\nindicates some crystallinity. \n\nTable 1. Thermal Properties of chitosan membranes. \n\nSample Tg1 {\"C) Tg2{\"C) Tg3{ \"C) Tm(\"C) 8H{J/g) \nCA -81.70 -84.1 o -73.69 101.95 458.70 \nCN -76.90 -75.63 -73.16 88.39 418.50 \nCP -87.51 -85.65 -74.02 102.70 76.82 \n\nAs expected, CP showed the most amorphous behavior that can be \n\nattributed to the plasticizer addition. \n\nArvanitoyannis et ai [15] observed low values of fusion enthalpy and glass \n\ntransition temperatures in chitosan and gelatin edible films when different \n\namounts of sorbitol were added. \n\nCP showed lower fusion enthalpy and glass transition temperature and this \n\namorphous behavior was confirmed by X-ray diffractometry, since CP did \n\nnot show any strong reflection around 28. \n\nScanning Electron Microscopy \n\nAlthough thermal and x-ray analyses showed considerable differences \n\namong CA, CN and CP, no significant structural changes among samples \n\nwas observed by SEM analysis (Figure 2). Ali samples were dense and \n\npackage membranes. Nevertheless, CN showed some superficial rugosity, \n\nwhich can be attributed to neutralization treatment. \n\n65 \n\n\n\n4 10 16 22 28 34 40 \n\nPosition (2 Theta) \n\nFigure 1. X-ray Diffractometry of chitosan membranes. \n\nWater Vapor Permeability and Mechanical Properties \n\nPlasticizers are theorized to decrease the intermolecular forces along \n\npolymer chains, increasing flexibility while decreasing the barrier properties \n\nof films. Thus, as expected, D-sorbitol addition increased WVP and \n\nelongation at break of CP by decreasing its crystallinity and hence \n\nincreasing the mobility of the polymer chains. On the other hand, CP \n\nshowed lower tensile strength when compared to CA and CN that can be \n\nexplained by its lower degree of crystallinity and glass transition \n\ntemperature. \n\nTable 2. Barrier and Mechanical Properties of chitosan membranes. \n\nSample Thickness{mm) WVP{g*mm/m2*dKPa) TS {MPa) E{%) \n\nCA 0.0436 \u00b1 0.0028 5.07 \u00b1 0.32 \n58.62 \u00b1 18.85 \u00b1 \n\n1.87 2.43 \n\nCN 0.0704 \u00b1 0.0043 5.74 \u00b1 0.05 \n79.83 \u00b1 \n\n8.30 \u00b1 2.14 \n4.49 \n\nCP 0.0718 \u00b1 0.0089 6.67 \u00b1 0.60 \n14.70 \u00b1 83.12 \u00b1 \n\n0.15 1.66 \n\n66 \n\n\n\nAccording to T able 2, CA showed lower WVP due to its higher density of \n\ncrystals that obstructs lhe penetrant's (water vapor) diffusion. In addition, \n\nCN showed the highest tensile strength and the lowest elongation at break. \n\nThis mechanical behavior can be attributed to the neutralization process \n\nthat promoted a molecular rearrangement in CN, increasing its glass \n\ntransition temperature by decreasing the free volume around the polymer \n\nchains. \n\nFigure 2. Micrographs of chitosan membranes. \n\nCONCLUSIONS \n\nPlasticizer addition to CP decreased its crystallinity by reducing internai \n\nhydrogen bonds (intermolecular forces) while increasing the free volume \n\naround the polymer chains. Moreover, D-sorbitol addition improved WVP \n\nand flexibility of chitosan membranes that are very important skills for \n\nwound dressing. \n\nAlthough tensile strength had been decreased by plasticizer addition, it still \n\ncan be considerate for wound dressing, since an average tensile strength \n\nof 17.6 MPA for normal skin was quoted by Wohlish [16]. Moreover, the \n\ntensile strength of wounds is lower than the skin one and it also varies \n\nduring the wound healing process [17]. \n\n67 \n\n\n\nFinally, 0-sorbitol was effective as plasticizer but future studies must be \n\ndone to evaluate its stability in chitosan membranes. \n\nACKNOWLEDGENTS \n\nThe authors thank CNPq and CAPES for financiai support. \n\nREFERENCES \n\n[1] Mi, F.L., Shyu, S.S., Wu, Y.B., Lee, S.T., Shyong, J.Y.and Huang, R.N. \n\n(2001 ). Fabrication and characterization of a sponge-like asymmetric \n\nchitosan membrane as a wound dressing, Biomaterials, 22: 165-173. \n\n[2] Kurita, K. (1998). Chemistry and Application of chitin and chitosan, \n\nPolymer Degradation and Stability, 59: 117-120. \n\n[3] Berger, J., Reist, M., Mayer, J.M., Felt, 0., Peppas, N.A. and Gurny, R. \n\n(2004). Structure and lnteractions in covalently and ionically crosslinked \n\nchitosan hydrogels for biomedical applications, European Journal of \n\nPharmaceutics and Biopharmaceutics, 57:19-34. \n\n[4) Hoemann, C.D., Sun, J., Legare, A., McKee, M.D. and Buschmann, \n\nM.D. (2005). Tissue engineering of cartilage using an injectable and \n\nadhesive chitosan-based cell-delivery vehicle, Osteoarthritis Cartilage, 13: \n\n318-329. \n\n[5] Denkbas, E.B., Ozturk, E.,Ozdemir, N.,Kececi, K. and Agalar, C. \n\n(2004).Norfloxacin-loaded chitosan sponges as wound dressing material, \n\nJournal of Biomaterials Applications, 18(4):291-303. \n\n[6] Ueno, H., Mo ri, T. and Fujinaga, T. (2001 ). Topical formulations and \n\nwound healing applications of chitosan, Advanced Drug Delivery Review, \n\n52(2): 105-115. \n\n[7] Suyatma, N.E., Tighzert, T., Copinet, A. and Coma, V. (2005). Effects of \n\nHydrophilic Plasticizers on Mechanical, Thermal, and Surface Properties of \n\nChitosan Films, Journal of Agricultura! and Food Chemistry, 53: 3950-\n\n3957. \n\n68 \n\n\n\n[8] MacHugh, T.H. and Krochta, J.M. (1994). Sorbitol- vs glycerol-\n\nplasticized whey protein edible films: lntegrated oxygen permeability and \n\ntensile property evaluation, Journal of Agricultura! and Food Chemistry, 42: \n\n841-845. \n\n[9] Trung, T.S., Thein-Han, W.W., Qui, N.T., Ng, C.H. and Stevens, \n\nW.F.(2006) Functional characteristics of shrimp chitosan and its \n\nmembranes as affected by the degree of deacetylation, Bioresource \n\nTechnology, 97: 659-663. \n\n[1 O] ASTM- Standard Test Methods for Water Vapor Transmission of \n\nMateriais, Annual Book of ASTM Standards, American Society for Testing \n\nand Materiais, E 96-00 (2000). \n\n[11] ASTM - Tensile properties of thin plastics sheeting. Annual Book of \n\nASTM Standards, American Society for Testing and Materiais, D 882 \n\n(1995). \n\n[12] Ogawa,K. (1991 ). Effect of heating an aqueous suspension of chitosan \n\non the crystallinity and polymorphs, Agricultura! and biological chemistry, \n\n55:2375-2379. \n\n[13] Campos, M.G.N., Grosso, C.R.F., C\u00e1rdenas, G. and Mei, L.H.I. \n\n(2005). Effects of neutralization process on preparation and \n\ncharacterization of chitosan membranes for wound dressing, \n\nMacromolecular Symposia, 229: 253-257. \n\n[14] Srinivasa, P.C., Ramesh, M.N., Kumar, K.R. and Tharanathan, R.N. \n\n(2004 ). Properties of chitosan films prepared under different drying \n\nconditions, Journal of Food Engineering, 63: 79-85. \n\n[15] Arvanitoyannis, I.S., Nakayama, A. and Aiba, S. (1998) Chitosan and \n\ngelatin based edible films: state diagrams, mechanical and permeation \n\nproperties, Carbohydrate Polymer, 37: 371-382. \n\n[16] Wollisch, E. and Kolloid-Z (1943). Vol.14, pg.1 04. \n\n[17] Elden, H.L. (1971 ). Biophysical Properties of the Skin, John Wiley &amp; \n\nSons, Vol. 13 pg. 453. \n\n69 \n\n\n\n4.6 In Vitro Gentamicin Sustained and Controlled Relesse from \nChitosan Cross Linked Films \n\nSubmetido \u00e0 revista Carbohydrate Polymers - manuscript number: \n\nCARBPOL-D-07-00347. \n\nLibera\u00e7\u00e3o sustentada e controlada in vitro de gentamicina a partir de \n\nfilmes reticulados de quitosana \n\nCampos, M.G.NY, Rawls, H.R. 1, Mei, L.H.I. 2 and Satsangi, N. 1 \n\n1 Divis\u00e3o de Biomateriais, Escola de Odontologia, Centro de Sa\u00fade da Universidade do \n\nTexas em San Antonio, TX, EUA \n\n2 Departamento de Tecnologia de Pol\u00edmeros, Faculdade de Engenharia Qu\u00edmica, \n\nUniversidade Estadual de Campinas, SP, Brasil \n\nRESUMO: A gentamicina \u00e9 um antibi\u00f3tico pertencente \u00e0 fam\u00edlia dos amino-\n\nglicos\u00eddeos usada no tratamento de infec\u00e7\u00f5es causadas por v\u00e1rios tipos \n\ndiferentes de bact\u00e9ria, particularmente as infec\u00e7\u00f5es por bact\u00e9rias Gram-\n\nnegativas. As prepara\u00e7\u00f5es t\u00f3picas de gentamicina s\u00e3o usadas no tratamento de \n\ninfec\u00e7\u00f5es de pele; entretanto, elas devem ser aplicadas \u00e0 \u00e1rea infectada pelo \n\nmenos 3 vezes ao dia. Neste trabalho, um novo recobrimento de ferida foi \n\nestudado para liberar gentamicina enquanto cobre e protege a ferida, reduzindo a \n\ndosagem e o n\u00famero de doses do antibi\u00f3tico. A quitosana, um biopol\u00edmero \n\nbiocompat\u00edvel e biodegrad\u00e1vel, com atrativas caracter\u00edsticas biol\u00f3gicas, foi \n\nutilizada na prepara\u00e7\u00e3o dos filmes carregados com antibi\u00f3tico. O hexametileno \n\n1 ,6-Di(aminocarboxisulfonato), um diisocianato bloqueado sol\u00favel em \u00e1gua, foi \n\nusado como agente reticulante e o \u00e1cido ac\u00e9tico dilu\u00eddo como solvente. O \u00e1cido \n\nac\u00e9tico residual foi neutralizado em uma solu\u00e7\u00e3o NaOH-Na2C03 e os efeitos do \n\ntempo de neutraliza\u00e7\u00e3o foram investigados. Al\u00e9m disso, a libera\u00e7\u00e3o controlada de \n\ngentamicina in vitro foi observada por duas semanas e os efeitos da \n\nconcentra\u00e7\u00e3o inicial deste antibi\u00f3tico, do grau de reticula\u00e7\u00e3o da quitosana e do \n\ntempo de neutraliza\u00e7\u00e3o das membranas na cin\u00e9tica de libera\u00e7\u00e3o da gentamicina \n\nforam avaliados. \n\nPALAVRAS-CHAVE: gentamicina, quitosana, recobrimento de feridas, \n\nreticula\u00e7\u00e3o, libera\u00e7\u00e3o sustentada e controlada. \n\n70 \n\n\n\nIn vitro Gentamicin Sustained and Controlled Release \n\nFrom Chitosan cross linked Films \n\nM. G. N. Campos 1' 2 , Ralph H. Rawls 1 , L. H. I. Mei2 , Neera Satsangi 1 \n\n1 \nDepartment of Restorative Dentistry, Biomaterials Division, Dental \n\nSchool, University of Texas Health Science Center at San Antonio, TX, \n\nUSA \n\n2 Department of Polymer Technology, Faculty of Chemical Engineering, \n\nState University of Campinas, SP, Brazil \n\nAbstract \n\nGentamicin, an amino-glycoside antibiotic used to treat infections caused \n\nby many types of bacteria, is used topically to treat skin infection; however, \n\nthese formulations should be applied to affected area at least three times a \n\nday with mandatory cleaning at each application. In this work, a novel \n\nwound dressing film was investigated for controlled and sustained delivery \n\nof gentamicin while covering and protecting the wound. Chitosan, a \n\nbiocompatible and biodegradable biopolymer with attractive wound healing \n\nproperties, was crosslinked with Hexamethylene 1 ,6-\n\nDi(aminocarboxysulfonate) to contrai the retention and release of \n\nencapsulated gentamicin from the formulated film. In vitro gentamicin \n\nrelease from the above antibiotics loaded films in phosphate buffered \n\nsaline at physiological pH and temperatura was studied for 2 weeks. The \n\neffects of gentamicin initial concentration, and cross-linking ratio on the \n\nkinetics of gentamicin release were evaluated. \n\nKeywords: gentamicin, chitosan, wound dressing film, cross-linking, \n\ncontrolled and sustained drug release. \n\n1. lntroduction \n\nGentamicin is one of the most consumed antibiotics because of its low \n\ncost, broad antibacterial spectrum of action, low rate of primarily resistant \n\npathogens, low allergy rate, good stability and water solubility (Virto, \n\nFrutos, Torrado, &amp; Frutos, 2003). Gentamicin binds to components in the \n\n71 \n\n\n\nbacterial cell and causes the production of abnormal proteins; the \n\nproduction of these abnormal proteins is ultimately fatal to the bacteria. \n\nGentamicin can treat many types of bacterial infections, particularly Gram-\n\nnegative infection; it eliminates bacteria that cause infections in lung, skin, \n\nbone, joint, stomach, blood, and the urinary tract infections. However, it is \n\nnot absorbed from the gut and is consequently only given by injection or \n\ninfusion. \n\nGentamicin topical preparations are used to treat the infections of skin. \n\nTopical preparations are available in two dosage forms: cream and \n\nointment. Skin wound treatment with topical gentamicin includes three \n\nbasic steps: 1- washing the affected area with water and soap; 2-\n\napplication of a small amount of the cream or ointment to the affected area \n\nand, finally, 3- covering the treated area with a gauze dressing. This \n\nprocedure should be repeated at least three times a day, or in accordance \n\nwith a physician's prescription. Thus, traditional gentamicin topical \n\ntreatment is painstaking, besides which it can lead to failure in infection \n\ncontrol or delay in wound healing, since the dosage is imprecise and \n\ndelivered discontinuously. For these reasons, a novel antibiotic-releasing \n\nwound dressing was investigated in lhe present work. \n\nAs most of the common polymers are synthetic, their biocompatibility and \n\nbiodegradability are quite limited compared to the natural polymers such as \n\ncellulose, chitin, chitosan and their derivatives. However, many naturally \n\nabundant polymeric materiais also exhibit a limitation in their reactivity, \n\nbiodegradability and processability (Mass, Mass, &amp; Tighe, 1998; lllum, \n\n1998), but chitosan is recommended as suitable functional material, \n\nbecause of its excellent biocompatibility, biodegradability, non-toxicity, and \n\nadsorption properties, etc. In addition, chitosan can accelerate wound \n\nhealing and has shown hemostatic and bacteriostatic activities (Mass, \n\nMass, &amp; Tighe, 1998; Berger, 2004). The source of chitosan is chitin, the \n\nnatural waste derived from the discarded shells of crab and shrimp etc. \n\nand the second most abundant polysaccharide. Chitosan finds wide \n\napplications such as implants, drug delivery matrix, scaffolds for tissue \n\n72 \n\n\n\nengineering, skin substitutes and wound dressings (Hoemann, 2005; \n\nDenkbas, 2004; Ueno, Mo ri, &amp; Fujinaga, 2001 ). In bio-delivery applications, \n\nchitosan has been used as a vehicle for drug, protein and gene delivery \n\n(Chen, Wu, Mi, Lin, YU, &amp; Sung, 2004; Yuan, Chesnutt, Utturkar, Haggard, \n\nYang, Ong, &amp; Bumgardner, 2007; Sinha Singla, Wadhawan, Kaushik, \n\nKumria, &amp; Bansal, 2004). \n\nChitosan is soluble in acid solutions and can easily form films and \n\nmembranes by solvent evaporation. However, due to its positive charge in \n\nacid medium, caused by amino group protonation, it becomes extremely \n\nhygroscopic hydrogel; the retention and lhe release of a biomolecule \n\ndepends on the swelling/deswelling of hydrogel, which may vary by severa! \n\nfactors including the amount of water in hydrogel. To increase the time \n\ntrame and consistency of kinetics of drug delivery, hydrophilic polymers \n\nneed to be cross-linked (Jameela, Kumary, Lal, &amp; Jayakrishnan, 1998). \n\nSevera! methods are available for the cross-linking of chitosan, the most \n\ncommon being the one using glutaraldehyde as lhe cross-linker (Hirano, \n\nYamaguchi, Matsuda, Miura, &amp; Kondo, 1977). However, there are \n\nconcerns over lhe toxicity of the cross-linking agents used, especially the \n\nglutaraldehyde, the residual retention of which may compromise the \n\nbiocompatibility of chitosan delivery system. \n\nRecently, a novel water-soluble, bisulfite blocked diisocyanate has been \n\nprepared and used as a cross-linking agent for lhe network formation of \n\nchitosan gel (Welsh, Schauer, Qadri, &amp; Price, 2002; Lin-Gibson, Walls, \n\nKennedy, &amp; Welsh, 2003). In fact, the bisulfite blocked diisocyanate is the \n\nanalogous Di-aminocarboxysulfonate, which must be devoid of any toxic \n\neffects of the relative diisocyanate. Also, the bisulfite derivatization of a \n\ndiisocyanate group makes the blocked crosslinker soluble in water to allow \n\nfor easy processability of crosslinked chitosan gel formations. Thus, 1 ,6-\n\nHexamethylene dilsocyante (HMDI), a well studied diisocyanate was \n\nselected as cross-linking agent and reacted with sodium bisulfite to \n\nprepare the analogous blocked diisocyanate: Hexamethylene 1 ,6-Di-\n\n(aminocarboxysulfonate) (HDACS; Fig. 1 ). \n\n73 \n\n\n\no H \nl'\u2022uro SJlN~Nf(SO\u00e3 Na+ \n\n3 H O \n\nFig. 1: Structure of Hexamethylene 1,6-\nDi(aminocarboxysulfonate) \n\nTherefore, this research designs a chitosan formulation, crosslinked \n\nthrough the aforesaid water soluble blocked diisocyante crosslinker, and \n\nloaded with gentamicin in a mild acidic solution and eventually casted into \n\na film, for sustained and consistent delivery of the antibiotic. The residual \n\nacid was neutralized with NaOH-Na2C03 aqueous solution for varied time \n\nlengths. The resultant biomaterial was characterized for crosslinkage by \n\nFTIR, for hydrophilicity and swelling behavior and for the in vitro \n\ngentamicin controlled release over an extended period of 2 weeks; the \n\neffects of gentamicin initial concentration, cross-linking ratio and \n\nneutralization time on the kinetics of gentamicin release were also \n\nevaluated. \n\n2. Experimental \n\n2. 1 Materiais and lnstrumentation \n\nHigh molecular weight chitosan (Mw -100,000, >75% deacetylated), \n\nAcetone, acetic acid, sodium bisulfite, ninhydrin, sodium hydroxide, sodium \n\ncarbonate and hexamethylene diisocyanate (HMDI) were purchased from \n\nAldrich Chemical Co., Milwauki, Wisconsin. Gentamicin sulfate and \n\nphosphate buffered saline (PBS) were purchased from Sigma Chemical \n\nCo. St. Louis, MO. \n\nFTIR analyses were performed on a MIDAC - M series FTIR instrument \n\nfrom MIDAC Corporation (Costa Mesa, California); Contact angle \n\ninstrument (Model: VCA-2000) was obtained from AST Products, Billerica, \n\nMA. \n\n2.2 Synthesis of Hexamethylene 1,6-0i(aminocarboxysu/fonate) \n\nIn a 100 ml round-bottom flask containing a magnetic stir bar, 6.73 g (40 \n\nmmol) of HMDI was added to 8.36 g Na2S20s (44 mmol) dissolved in 15.53 \n\n74 \n\n\n\nml H20 and stirred for 20h. The product was precipitated with acetone \n\nand dried in vacuum. lnsoluble polymeric byproducts were removed by \n\ndissolving the product in water (30 ml) followed by filtration. Product was \n\nisolated from the filtrate by precipitation in acetone and dried in vacuum, \n\nresulting in a white powder, as described earlier (Lin-Gibson, Walls, \n\nKennedy, &amp; Welsh, 2003). \n\n2.3 Experimental Design for in-vitro gentamicin release from crosslinked \n\nchitosan \n\nThe effects of cross-linking ratio (0, 30 and 50%), initial antibiotic \n\nconcentration (0, 1 and 1 0%) and neutralization time (0, 30 and 60 \n\nminutes) on lhe kinetics of in vitro release of gentamicin were investigated \n\nin a 3x3 factorial design (Table-1). The drug release was followed for 2 \n\nweeks and a colorimetric procedure, based on the ninhydrin reaction with \n\namines present in gentamicin, was employed for released gentamicin \n\nquantification. \n\nTable 1 -Experimental Design. \n\nSample# Concentration of Concentration of Neutralization time, \n\nHDACS,%* Gentamicin Sulfate, %** (min.) \n\n1 o o o \n\n2 o 1 30 \n\n3 o 10 60 \n\n4 30 o 30 \n\n5 30 1 60 \n\n6 30 10 o \n\n7 50 o 60 \n\n8 50 1 o \n\n9 50 10 30 \n\n*based on NH2 availability on chitosan; **based on chitosan concentration. \n\nThis outline uses the Taguchi \"robust\" statistical design in which the main \n\neffects are identified. \n\n75 \n\n\n\n2.4 Cross-linking reaction \n\nCrosslinking was performed by a modification in the procedure as \n\ndescribed earlier (Lin-Gibson, Walls, Kennedy, &amp; Welsh, 2003). Briefly, in a \n\n250 ml flask, 1.5g of chitosan was dissolved in 100 ml of 1.0% aq. acetic \n\nacid with vigorous stirring. After total dissolution, the desired amount of \n\nHexamethylene 1 ,6-Di(aminocarboxysulfonate) was added and the \n\nsolution was heated to 60 \"C under stirring for 24 h. \n\n2.5 Preparation of gentamicin loaded films \n\nAfter cross linking reaction, the desired amount of gentamicin sulfate was \n\nadded to the solution and stirred for 24 h. One ml of the resultant solution \n\nwas placed in each of the circular plastic molds of 16 mm diameter. The \n\ncontents in the molds were allowed to dry at roam temperature to form the \n\ncircular films. The dried samples were then treated with aqueous NaOH \n\n(2.0% w/w)-Na2C03 (0.05% w/w) solution to remove residual acetic acid. \n\nThe time for alkaline treatment was chosen for different samples according \n\nto schedule shown in Table-1 above. \n\n2.6 FTIR analyses \n\nFTIR analyses on above thin film samples were performed on a MIDAC -\n\nM series FTIR instrument. The samples were scanned in the range of 500 \n\nto 2000 cm\u00b71 . \n\n2.7 Contact Angle \n\nThe experiments for contact angle measurements were performed in arder \n\nto evaluate water affinity (hydrophilicity), an important parameter for wound \n\ndressings. The water contact angle with chitosan films was obtained by \n\ncarefully placing a drop of water on the film surface and then, after 30 \n\nseconds, both right and left angles of contact were measured by the \n\ncontact angle instrument, using a reported method (Zhang, \n\nRadomyselskiy, Datta, Zhao, &amp; van Ooij, 2003). \n\n76 \n\n\n\n2.8 Swelling Behavior \n\nSwelling behavior of the above films was assessed by the gravimetric \n\nmethod. Samples films were kept in a vacuum desiccator for 24 h before \n\ndetermining dry mass (mO) by weighing to +1-0.0001 g places on an \n\nelectronic balance. Then, the samples were immersed for 24 h in 0.1 M \n\nPBS maintained at pH 7.4 at 37\"C. The soaked samples were then blotted \n\nwith filter paper to remove non-absorbed surface water and then weighed \n\nagain to determine wet mass (mW). Swelling ratio (S) was calculated, \n\nusing the following equation: \n\nS (%) = [(mw- mo)/mw] X 100 \n\nReported values are averages of three samples. \n\n2. 9 In vitro release \n\nExperiments on In vitro release of gentamicin from the above chitosan \n\nfilms were performed at 37\"C in 0.1 M PBS, pH 7.4. The release medium \n\nwas collected after each 24 h and replaced with fresh buffer each time. \n\nThis procedure was repeated for 14 days and the experiment was carried \n\nout in triplicate. Gentamicin concentration was measured indirectly by \n\nreaction with ninhydrin for 15 minutes at 95 \"C, followed by determination of \n\nultraviolet absorbance at 400 nm by an established method (Frutos, \n\nTorrado, Perez-Lorenzo, &amp; Frutos, 2000). \n\n3. Results and discussion \n\nTopical formulations of chitosan for wound healing and related applications \n\nand their effects on wound related components are being intensely \n\ninvestigated (Ueno, Mo ri, &amp; Fujinaga, 2001 ). The use of chitosan for the \n\ncontrolled delivery of biomolecules is on rise recently (Yuan, Chesnutt, \n\nUtturkar, Haggard, Yang, Ong, &amp; Bumgardner, 2007; Sinha, Singla, \n\nWadhawan, Kaushik, Kumria, &amp; Bansal, 2004). But, it forms extremely \n\nhygroscopic hydrogels and the controlled retention and release of a \n\nbiomolecule from chitosan could be achieved by an appropriate \n\n77 \n\n\n\nbiocompatible cross-linker that has physicochemical compatiobility with \n\nchitosan. This work evaluates such a crosslinked chitosan based controlled \n\nrelease device to be later used for wound dressing film for sustained \n\ngentamicin release. \n\n3. 1 Cross-Jinker and cross-/inking \n\nTo attain lhe crosslinking, first HDACS was synthesized as a crosslinker by \n\na known method; it was then incorporated in required amounts (Table-1) in \n\nacidic solution of chitosan and the crosslinking, by the formation of urea \n\nlinkage between HDACS and preferably the amino group of chitosan, was \n\nrealized by mild heating for 24 h. Apparently, crosslinking must affect lhe \n\nhydrophilic behaviors of lhe crosslinked chitosan film, therefore after \n\nneutralization of residual acid, lhe water-contact angles and swelling \n\nbehavior of the resultant films were measured. However, confirmation of \n\nchitosan crosslinking with HDACS was dane by FTIR. The examination of \n\nlhe Hexamethylene 1 ,6-Diurea crosslinked chitosan films through various \n\nparameters used in this work is described as follows: \n\n3.1.1 FTIR \n\nThe development of cross-linking was shown by a well resolved peak \n\nbetween 1565 cm-1 and 1475 cm-1, characteristic of NH deformation in \n\nsecondary amides (Amide 11 band). In addition, a peak at about 1600 cm-1, \n\nrepresenting C=O stretch in secondary amides (Amide I band), was only \n\nobserved for cross linked films, and its resolution was greater for the 50% \n\ncross linked samples (Welsh, Schauer, Qadri, &amp; Price, 2002). \n\n3. 1.2 Contact angle measurement \n\nThe results obtained for lhe non-cross linked chitosan film were Right: \n\n85.7\u00b0 and Left: 85.2\u00b0. However, for both cross linked films (30% and 50% \n\ncross linked), the contact angles were 0\u00b0, since the water drop spread on \n\nthe films. Thus, cross-linking increased the hydrophilic character of \n\nchitosan films. \n\n3. 1.3 Swelling behavior \n\n78 \n\n\n\nThe swelling behavior of chitosan films is presented in Figure 2. As \n\nexpected, cross-linking suppressed swelling. However, this effect was \n\ninversely proportional to lhe degree of cross-linking, which can be \n\nattributed to the hydrophilic character of lhe cross linking agent. \n\nSwelling Behavior \n100 \n\n90 \n80 \n70 \n\n~ 60 \n~ \n~ 50 \nrJ) 40 \n\n30 \n20 \n10 \no \n\nO% cross linked 30% cross linked 50% cross linked \nchitosan chitosan chitosan \n\nSamples \n\nFigure 2 - Swelling behavior of Chitosan and HDACS cross-linked \n\nsamples. \n\n3.2 In vitro gentamicin re/ease study \n\nResults of in vitro release of gentamicin are presented in Figure 3. \n\nSamples 1, 4 and 7 were not plotted because !hei r gentamicin initial \n\nconcentration was O (Table 1 ). \n\n79 \n\n\n\nGentamicin Cumulativa Release \n100 --\u00b7 ----\u00b7\u00b7--\u00b7\u00b7-\u00b7-\u00b7- \u00b7\u00b7\u00b7\u00b7\u00b7-\u00b7---\u00b7------------- --\u00b7\u00b7\u00b7-------------- -------\n\n1 \n\n00~---------------------------~~~~~ \njX-Iink, [Gent], Neut time I \n\n~ 00~----------------------------------~==~=r----~ \nm i m ~r----------------------------------------\n\u00e3i ~ 30,>60 \na: 60 \n~ ~ i \n:~50 ~ \n.! 40 \n~ 30 ~ \n~20 ~~ 8 ~ \n\n10 r 9 \nob \" \n\n50,1,0 \n\n-\" 30,10,0 \n\n... 0,1,30 \n\n50,10,30 \n\n0,10,60 \n\no 2 3 4 6 7 8 9 10 11 12 13 14 \n\nDays \n\nFigure 3- Gentamicin cumulative release. \n\nSince samples 2 and 3 were not cross linked, a considerable high amount \n\nof initial release of gentamicin was expected form these samples \n\ncompared to those with crosslinking. However, the contrary effect was \n\nobserved. Because of the good solubility of gentamicin in aqueous \n\nmedium, probably most of gentamicin was released to the neutralization \n\nmedia when these samples were neutralized. Thus, after neutralization, the \n\ninitial concentration of gentamicin for in vitro release experiment was lower \n\nthan expected. However, this effect was not observed for cross-linked \n\nsamples, because cross-linking created a polymeric network that might \n\nhave acted as a barrier to fast diffusion of gentamicin during neutralization \n\nprocess. \n\nComparing sample pairs with the same degree of cross linking and \n\ndifferent amounts of gentamicin (5 and 6; 8 and 9), it was observed that \n\nhigher gentamicin initial concentration promoted slower percent release \n\nand the lower gentamicin initial concentration showed higher percent \n\nrelease. Therefore, the mechanism of gentamicin diffusion was mainly \n\ngoverned by its initial concentration. lndeed, the diffusion rate was \n\ninversely proportional to gentamicin initial concentration. \n\n80 \n\n\n\nComparing couples of sample pairs with the same gentamicin initial \n\nconcentration, but different degrees of cross linking (5 and 8; 6 and 9), \n\nhigher cross linking produced slower release. This was of course expected \n\nas lhe higher cross-link density increases the barrier for gentamicin \n\ndiffusion. Thus, the diffusion rale was inversely proportional to the degree \n\nof cross-linking. \n\nPseudomonas aeruginosa, Escherichia co/i and Staphy/ococcus aureus \n\nare the mos! common pathogens found in skin infected wounds. Minimal \n\ninhibition concentration of gentamicin for Pseudomonas aeruginosa and \n\nEscherichia co/i varies between 0.06 through 8 IJg/mL and for \n\nStaphylococcus aureus, it is between 0.12-1.0 IJgfuL (Skundrik, Medovic, \n\n&amp; Kostic, 2002). Therefore, lhe initial concentration of gentamicin should \n\nbe selected according to pathogen in target and also to the treatment \n\nperiod. Prolonged treatments require slow diffusion and hence higher \n\ngentamicin initial concentration; for short treatments, lhe minimal inhibition \n\nconcentration is reached even with lower gentamicin initial concentrations. \n\n4. Conclusions \n\nChitosan - HDACS cross-linking reaction was efficient and confirmed by \n\nFTIR and hydrophilic behavior analyses. Cross-linked films swell less than \n\nchitosan film itself; however, this effect was inversely proportional to cross \n\nlinker concentration, due to lhe hydrophilic character of the cross linking \n\nagent. Moreover, according to contact angle analysis, cross-linked films \n\nbecame more hydrophilic than the chitosan film itself. \n\nIn vitro gentamicin controlled release was carried out at 37\u00b0 C and in pH \n\n7.4 in arder to simulate the body conditions. Results showed that the \n\ndiffusion rale is governed by initial concentration of gentamicin and degree \n\nof cross-linking. Higher gentamicin initial concentration and degree of cross \n\nlinking promoted the slower release: after 14 days of release, less than \n\n20% of gentamicin initial concentration had been delivered (sample 9). On \n\nthe other hand, lower gentamicin initial concentration and degree of cross-\n\n81 \n\nUNlCAV;'? \nBIBliOTECA CENTRAL \n\nCtSAR LAfTES \n\nDESENVOLVlMENTO DE COLE\u00c7\u00c1O \n\n\n\nlinking promoted lhe faster release, with almost 70% of lhe gentamicin \n\ninitial concentration released after 14 days (sample 5). \n\nThe process of neutralization seems to be limiting for non-crosslinked \n\ngentamicin loaded chitosan films. In this case, gentamicin initial \n\nconcentration was altered by neutralization, since gentamicin was rapidly \n\nremoved by dissolving into lhe neutralization media. \n\nAdditional experiments on wound healing were carried out with selected \n\nsamples and will be published in communication later. \n\nAcknowledgements \n\nThe authors are thankful to lhe department o f Restorative Dentistry, \n\nUniversity of Texas Health Science Center at San Antonio, TX, USA and \n\nlhe department of Polymer Technology, Faculty of Chemical Engineering, \n\nState University of Campinas, SP, Brazil for providing necessary facilities \n\nfor this work. \n\nReferences \n\nBerger, J. (2004). Structure and lnteractions in covalently and ionically \n\ncross linked chitosan hydrogels for biomedical applications. Eur. J. \n\nPharmaceut. Biopharmaceut. 57, 19-34. \n\nChen, S. C., Wu, Y. C., Mi, F. L., Lin, Y. H., YU, L. C., &amp; Sung, H. W. \n\n(2004). A novel pH-sensitive hydrogel composed of N,O-carboxymethyl \n\nchitosan and alginate cross-linked by genipin for protein drug delivery. J. \n\nContrai. Rei. 96, 285-300. \n\nDenkbas, E. (2004). Norfloxacin-loaded Chitosan Sponges as Wound \n\nDressing Material. J. Biomat. Appl. 18, 291-303. \n\nFrutos, P., Torrado, S., Perez-Lorenzo, M. E., &amp; Frutos, G. (2000). A \n\nvalidated quantitative colorimetric assay for gentamicin. J. Pharmaceut. \n\nBiomed. Anal. 21, 1149-1159. \n\nHirano, S., Yamaguchi, R., Matsuda, N., Miura, 0., &amp; Kondo, Y. (1977). \n\nChitosan-aldehyde gel a novel polysaccharide gel produced from chitosan \n\nand aldehydes. Agric. Biol. Chem. 41, 1547-1548. \n\n82 \n\n\n\nHoemann, C. (2005). Tissue engineering of cartilage using an injectable \n\nand adhesive chitosan-based cell-delivery vehicle. Osteoarthritis \n\nCartilage. 13, 318-329. \n\nlllum, L. (1998). Chitosan and its use as pharmaceutical excipient. Pharm. \n\nRes. 15, 1326. \n\nJameela, S. R., Kumary, T. V., Lal, A. V., &amp; Jayakrishnan, A. (1998). \n\nProgesterone-loaded chitosan microspheres: a long acting biodegradable \n\ncontrolled delivery system. J. Control. Rei. 52, 17-24. \n\nKurita, K. (1998). Chemistry and Application of chitin and chitosan. Polym. \n\nDegradation and Stability. 59,117-120. \n\nMass, W. A., Mass, A., &amp; Tighe, 8. (1998). A review of biodegradable \n\npolymers: uses, current developments in the synthesis and \n\ncharacterization of biodegradable polyesters. 81ends of biodegradable \n\npolymers and recent advances in biodegradation studies, Polym. lnt. 47, \n\n89. \n\nLin-Gibson, S., Walls, H. J., Kennedy S. 8., &amp; Welsh E. R (2003). Reaction \n\nkinetics and gel properties of blocked diisocyanate cross linked chitosan \n\nhydrogels. Carbohydrate Polymers 54, 193-199. \n\nSinha, V. R., Singla, A. K., Wadhawan, S., Kaushik, R., Kumria, R., &amp; \n\n8ansal, K. (2004). Chitosan microspheres as a potential carrier for drugs. \n\nlnternational J. Pharmaceut. 274, 1-33. \n\nSkundric, P., Medovic A., &amp; Kostic, M. (2002). Fibrous systems with \n\nprogrammed biological-activity and their application in medicai practice. \n\nAUTEX Res. J. 2, 78-84. \n\nUeno, H., Mori, T., &amp; Fujinaga, T. (2001 ). Topical formulations and wound \n\nhealing applications of chitosan. Advanced Drug Del. Rev. 52, 105-115. \n\nVirto, M. R., Frutos, P., Torrado, S. &amp; Frutos, G. (2003). Gentamicin \n\nrelease from modified acrylic bone cements with lactose and \n\nhydroxylpropylmethylcelullose. 8iomaterials. 24, 79-87. \n\n83 \n\n\n\nWelsh, E. R., Schauer, C. L., Qadri, S. 8., &amp; Price, R. R. (2002). Chitosan \n\ncross-linking with a water-soluble, blocked diisocyinate. 1. Solid state. \n\nBiomacromolecules. 3, 1370-137 4. \n\nYuan, V., Chesnutt, B.M., Utturkar, G., Haggard, W.O., Vang, V., Ong, J.L., \n\n&amp; Bumgardner, J.D. (2007). The effect of cross-linking of chitosan \n\nmicrospheres with genipin on protein release. Carbohydrate Polym. 68, \n\n561-567. \n\nZhang, J., France, P., Radomyselskiy, A., Datta, S., Zhao, J., van Ooij, W. \n\nJ. (2003). Hydrophobic cotton fabric coated by a thin nanoparticulate \n\nplasma film. J. Appl .Polym. Sei. 88, 1473-1481. \n\n84 \n\n\n\n4.7 In vitro Silver sulfadiazine Controlled Release from Chitosan \ncross linked Films \n\nLibera\u00e7\u00e3o Controlada de Sulfadiazina de Prata In vitro a partir de \n\nFilmes Reticulados de Quitosana \n\nCampos, M.G.NY, Rawls, R.H. 1 , Mei, L.H.I. 2 and Satsangi, N. 1 \n\n1 \nDepartamento de Odontologia Restaurativa, Divis\u00e3o de Biomateriais Division, Escola de \n\nOdontologia, Centro de Sa\u00fade da Universidade do Texas em San Antonio, TX, EUA \n\n2 Departamento de Tecnologia de Pol\u00edmeros, Faculdade de Engenharia Qu\u00edmica, \n\nUniversidade Estadual de Campinas, SP, Brasil \n\nRESUMO: A sulfadiazina de prata \u00e9 um agente antibacteriano eficiente e \n\namplamente utilizado no tratamento de queimaduras, devido ao seu amplo \n\nespectro de atividade contra bact\u00e9rias Gram positivas e Gram negativas. A \n\npomada de sulfadiazina de prata tem sido usada para tratar feridas de \n\nqueimadura infeccionadas; entretanto, este tratamento \u00e9 doloroso, \n\npodendo levar \u00e0 falha ou ao atraso da cicatriza\u00e7\u00e3o, al\u00e9m de ter que ser \n\nrepetido pelo menos duas vezes ao dia. Neste trabalho, desenvolveu-se \n\num recobrimento de ferida carregado com sulfadiazina de prata , com a \n\nfun\u00e7\u00e3o de cobrir e proteger a ferida, al\u00e9m de liberar o princ\u00edpio ativo aol \n\nlongo do tempo, reduzindo a dosagem e o n\u00famero de doses do do \n\nmesmo. A quitosana, um biopol\u00edmero biocompat\u00edvel e biodegrad\u00e1vel com \n\natrativas caracter\u00edsticas biol\u00f3gicas, foi utilizada na prepara\u00e7\u00e3o dos filmes \n\ncarregados de sulfadiazina de prata. Como agente reticulante, utilizou-se o \n\nhexametileno 1 ,6-Di(aminocarboxisulfonato), que \u00e9 um diisocianato \n\nbloqueado e sol\u00favel em \u00e1gua. A libera\u00e7\u00e3o de sulfadiazina de prata in vitro \n\nfoi acompanhada por 2 semanas. Os efeitos da concentra\u00e7\u00e3o inicial da \n\nsulfadiazina de prata, do grau de reticula\u00e7\u00e3o da matriz polim\u00e9rica e do \n\ntempo de neutraliza\u00e7\u00e3o na cin\u00e9tica de libera\u00e7\u00e3o da sulfadiazina de prata \n\nforam avaliados. \n\nPALAVRAS-CHAVE: sulfadiazina de prata, quitosana, recobrimento de \n\nferidas, reticula\u00e7\u00e3o. \n\n85 \n\n\n\nIn vitro Silver sulfadiazine Controlled Release from Chitosan cross \n\nlinked Films \n\nCampos, M.G.NY, Rawls, R.H.\\ Mei, L.H.I. 2 and Satsangi, N. 1 \n\n1 Department of Restorative Dentistry, Biomaterials Division, Dental \n\nSchool, University of Texas Health Science Center at San Antonio, TX, \n\nUSA \n\n2 Department of Polymer Technology, Faculty of Chemical Engineering, \n\nState University of Campinas, SP, Brazil \n\nABSTRACT: Silver sulfadiazine is an effective and widely used \n\nantibacterial agent for treatment of burn injuries, due to its broad spectrum \n\nof activity against Gram-negative and Gram-positive bacteria. Silver \n\nsulfadiazine cream has been used to treat burn wound infections; however, \n\nthis treatment is painstaking, can lead to failure in infection treatment or \n\ndelay in wound healing and should be repeated at least twice a day. In this \n\nwork, a novel wound dressing was developed to controlled delivery silver \n\nsulfadiazine while covering and protecting the wound, as well, reducing the \n\ndrug dosage and dosing times. Chitosan, a biocompatible and \n\nbiodegradable biopolymer with attractive biological characteristics, was \n\nused to prepare the antibiotic loaded films. Hexamethylene 1 ,6-\n\nDi(aminocarboxysulfonate), a water soluble and blocked diisocyante, was \n\nused as cross-linker agent. In vitro sulfadiazine release was observed for 2 \n\nweeks. The effects of silver sulfadiazine initial concentration, cross-linking \n\nratio and neutralization time on the kinetics of sulfadiazine release were \n\nevaluated. \n\nKEYWORDS: silver sulfadiazine, chitosan, wound dressing, cross-linking. \n\nINTRODUCTION \n\nSulfadiazine (Figure 1) is a sulfonamide antibiotic which eliminates bacteria \n\nthat cause infections by stopping the production of folic acid inside the \n\nbacterial cell. lt is commonly used in combination with silver to treat skin \n\n86 \n\n\n\nwounds. Silver sulfadiazine has been a standard treatment for burns, \n\nulcers and infected wounds due to its broad spectrum of activity against \n\nboth Gram positive and negative bacteria, besides fungus, even at low \n\nconcentration.[1] Silver sulfadiazine cream has been traditionally applied to \n\nwounds; however, it can not allow long-term protection of lhe wound from \n\ninfection. For this reason, topical silver sulfadiazine should be applied to \n\nlhe wound at least twice a day, according to doctor prescription. Thus, \n\ntraditional treatment can lead to failure in infection treatment or delay in \n\nwound healing, since lhe dosage is not precisely and continuous. \n\nMoreover, absorption of silver ions has been a major concerned during \n\nusage of silver sulfadiazine cream in deep burns that may be cytotoxic for \n\ntreated tissues. [2] \n\nDue to ali these reasons, a novel silver sulfadiazine loaded wound \n\ndressing was developed, in arder to protect the wound, while releases \n\nantibacterial agent to treat or avoid bacterial infection. \n\nChitosan is a biopolymer derived from chitin, the second most abundant \n\npolysaccharide found in nature. Chitosan has been extensively studied in \n\nbiomaterials field. lt is biocompatible and biodegradable. In addition, \n\nchitosan can accelerate wound healing and has shown hemostatic and \n\nbacteriostatic activities.[3,4] Due to its unique properties, chitosan has \n\nfound wide application in biomedical area, such as: implants, drug delivery \n\nmatrix, scaffolds for tissue engineering, skin substitutes and wound \n\ndressings.[5,6 and 7] \n\nChitosan is soluble in acid solutions and can easily form films and \n\nmembranes by solvent evaporation technique. However, due to its positive \n\ncharges in acid medium, caused by its amino group protonation, chitosan \n\nis extremely hygroscopic. In this way, it is necessary to crosslink its chains, \n\nin arder to prepare an efficient drug delivery matrix. \n\nDiisocyanates are usually used as cross-linker agent in Chemical \n\nlndustries. However, because of reactivity with and insolubility of most \n\ncommercially available diisocyanates in water, it should be reacted with a \n\n87 \n\n\n\nbisulfite to protect, or block, reactivity and to increase water solubility \n\nbefore be reacted with chitosan. Thus, the product of block reaction, stable \n\nin acidic aqueous solutions, with increased pH or temperature, readily \n\nreacts with amines, forming a urea linkage, at a rate much greater than \n\nthat characteristic of competing reactions with alcohols or water. \n\nFurthermore, stability in the presence of amines and consequent long-term \n\nstorage may be increased by the choice of an aliphatic diisocyanate, rather \n\nthan a more reactive aromatic one. For this reason, HMDI (1 ,6-\n\nHexaMethylene Dilsocyante), a well studied diisocyanate frequently used \n\nin the Polyurethane lndustry, was selected as cross-linker agent and hence \n\nreacted with sodium bisulfite, in order to prepare a blocked diisocyanate: \n\nHexamethylene 1 ,6-Di(aminocarboxysulfonate). \n\nThe effects of cross-linking ratio (0, 30 and 50%), silver sulfadiazine initial \n\nconcentration (O, 1 and 1 0%) and neutralization time (0, 30 and 60 \n\nminutes) on the in vitro release of silver sulfadiazine were evaluated. The \n\nrelease was followed for 2 weeks and sulfadiazine concentration was \n\ndetermined by UV Spectrophotometry. \n\nFigure 1- Sulfadiazine and silver sulfadiazine structures. \n\nMATERIALS ANO METHODS \n\nMateriais \n\nHigh molecular weight chitosan (>75% deacetylated), silver sulfadiazine \n\nand hexamethylene diisocyanate were purchased from Aldrich. Sodium \n\nbisulfite Reagent Plus\u00ae was purchased from Sigma-Aidrich. \n\nSynthesis of Hexamethylene 1 ,6-Di(aminocarboxysulfonate) \n\nIn a 1 00 ml round-bottom flask containing a magnetic stir bar, 6. 73 g ( 40 \n\nmmol) of HMDI was added to 8.36 g Na2S205 (44 mmol) dissolved in 15.53 \n\nml H20 and was stirred for 20h at roam temperature. The product was \n\n88 \n\n\n\nprecipitated in acetone and dried in vacuum. lnsoluble polymeric \n\nbyproducts were removed by dissolving the product in water (30 ml) \n\nfollowed by filtration. Product was isolated from the filtrate by precipitation \n\nin acetone and dried in vacuum, resulting in a white powder.[S] \n\nExperimental Design for in vitro controlled release \n\nMatrix experiments using orthogonal arrays were applied for experiment \n\ndesign. Samples were prepared according to Table 1. \n\nCross linking reaction \n\nIn a 250 ml flask, 1.5g of chitosan was dissolved in 1.0% acetic acid \n\nsolution. After total dissolution, the desired amount of Hexamethylene 1 ,6-\n\nDi(aminocarboxysulfonate) was added and the solution was heated up to \n\n40 \"C under stirring for 24 h. \n\nPreparation of si/ver sulfadiazine loaded films \n\nAfter cross linking reaction, the desired amount of silver sulfadiazine was \n\nadded to the solution and stirred for 24 h. Then, the resulted solution was \n\ncast in the molds and dried at roam temperature. Dried samples were then \n\nneutralized in Ethanol 70% solution according to Table 1. \n\nTable 1 -Experimental Design. \n\nSample Concentration of Hexamethylene lnitial Concentration Neutralization \n1 ,6-Di (aminocarboxysulfonate), of Silver time, min. \n0/o* Sulfadiazine, %** \n\n1 o o o \n2 o 5 30 \n3 o 10 60 \n4 30 o 30 \n5 30 5 60 \n6 30 10 o \n7 50 o 60 \n8 50 5 o \n9 50 10 30 \n\n*based on NH2 availability on chitosan; **based on chitosan concentration. \n\nFTIR \n\nFTIR analyses were performed in a MIDAC- M series FTIR instrument in \n\nthe range of 500 up to 2000 cm\u00b71 . \n\n89 \n\n\n\nContact Angle \n\nContaet angle measured was performed in an AST model VCA 2000 \n\ninstrument, in order to evaluate samples' water affinity (hydrophilieity) that \n\nis an important parameter for wound dressings. \n\nSwelling Behavior \n\nSwelling behavior of ehitosan films was determined by the gravimetrie \n\nmethod. Samples (D= 1 em) were kept in a vaeuum desieeators for 24 h \n\nand then, their dry mass (mD) were determined by weighting them on an \n\neleetronie seale. After this proeedure, samples were immersed in 0.1 M \n\nPBS pH 7.4 at 37\"C. Past 24 h, samples were blotted with filter paper to \n\nremove the adsorbed water on the surfaee, and weighted again in order to \n\ndetermine their wet mass (mw). The swelling ratio (S) of chitosan films was \n\ncalculated according to the following Equation: \n\nS (%) = [(mw- mo)imw] *100 \n\nIn vitro release \n\nIn vitro release of sulfadiazine from ehitosan films was performed at 37'C \n\nin 0.1 M PBS, pH 7.4. The release medi um was collected at predetermined \n\ntime intervals (24 h) and replaced with fresh buffer. This procedure was \n\nrepeated for 14 days and carried out in triplieates. Samples were analyzed \n\nby UV Spectrophotometer at 236 nm to determine the concentration of \n\nreleased sulfadiazine. \n\nRESULTS \n\nFTIR \n\nAccording to the infra red spectra, cross linking reaction could be \n\nsupported by the presence of a peak better resolved in between 1565 em\u00b71 \n\nand 1475 cm\u00b71, that represents NH deformation in seeondary amides \n\n(Amide li band). In addition, a peak around 1600 em\u00b7\\ that represents C=O \n\nstreteh in seeondary amides (Amide I band), was only observed for eross \n\nlinked films, and its resolution was greater for the 50% cross linked \n\nsample.[9] \n\n90 \n\n\n\nContact Angle \n\nThe water contact angle with chitosan films was obtained by dropping 1 \n\ndrop of water on lhe film surface and then, after 30 seconds, both right and \n\nleft angles of contact were measured. The results obtained for the not \n\ncross linked chitosan film were R: 85.7\u00b0 and L: 85.2\u00b0. However, for both \n\ncross linked films (30% and 50% cross linked), the contact angles were o o, \nsince the water drop spread on the films. lt means that cross linking \n\nreaction increased the hydrophilic character of chitosan films. \n\nSwelling behavior \n\nSwelling behavior of chitosan films is presented in Figure 2. As expected, \n\ncross linking reaction decreased the swollen of films. However, this effect \n\nwas inversely proportional to the degree of cross linking. lt can be \n\nattributed to the cross linking agent hydrophilic character. \n\nSwelling Behavior \n100 \n90 \n80 \n70 \n\n,-._ \n60&lt;f \n\n~ 50 \n\n\"' \n40 \n30 \n20 \n10 \no \n\nO% cross linked 30% cross linked 50% cross linked \nchitosan chitosan chitosan \n\nSamples \n\nFigure 2- Swelling behavior of samples. \n\nIn vitro release \n\nSilver sulfadiazine is poorly water soluble (0.34 mg/1 00 ml) and after \n\ndissociation, releases silver as well as sulfadiazine ions. Thus, silver \n\nsulfadiazine release can be divided in two steps: sulfadiazine release and \n\nsilver release. Because there is no interaction between sulfadiazine and \n\nchitosan, sulfadiazine release depends on the solubility of silver \n\nsulfadiazine in the dissolution medium. However, chitosan contains amino \n\ngroups which are capable of binding silver and hence, silver release \n\n91 \n\n\n\ndepends also on the chemical interactions between silver ions and \n\nchitosan. Moreover, both releases depend on the mass transport \n\nresistance caused by chitosan tilms. \n\nAccording to Figure 3, ali samples displayed a burst release in the tirst \n\ndays. This initial release is very important to tast contrai bacterial intection \n\nin wounds treatment. After this initial period, slow release ot sultadiazine \n\nwas observed. \n\nFigure 4 well illustrated sultadiazine cumulative release. Samples 2, 5 and \n\n8, containing 5% silver sulfadiazine initial concentration, showed similar \n\nbehavior and have released around 30% of theirs initial concentration after \n\n14 days, while samples 3, 6 and 9 (1 0% silve r sultadiazine initial \n\nconcentration) have released more than 15%. \n\nAccording to these results and due to silver sulfadiazine low molecular \n\nweight, chitosan tilms mass transport resistance did not control \n\nsulfadiazine release, but silver sulfadiazine solubility did. Samples 3, 6 and \n\n9 that contained twice the silver sulfadiazine initial concentration of \n\nsamples 2, 5 and 8 showed approximately half of cumulative silver \n\nsulfadiazine release observed for samples 2, 5 and 8. \n\nStaphylococcus aureus, Pseudomonas aeruginosa and Escherichia co/i \n\nare the most common pathogens found in burns and skin wounds. Silver \n\nsulfadiazine minimal inhibition concentration (MIC) was found to be 32 \n\n11g/ml for Escherichia co/i, 44.8 11g/ml for Pseudomonas aeruginosa and \n\n57.6 119/ml for Staphy/ococcus aureus. [1] Besides, minimal bactericida! \n\nconcentration (MBC) was 40.2 11g/ml and 51.2 11g/ml for Escherichia co/i \n\nand Pseudomonas aeruginosa, respectively. For Staphylococcus aureus \n\nMBC was equal to MIC. \n\nThus, samples 2, 5 and 8 released enough amount of silver sulfadiazine to \n\ninhibit these three pathogens just in the first day, while samples 3, 5 and 9 \n\nonly did not release enough silver sulfadiazine to inhibit Staphylococcus \n\naureus. From the second day on, ali samples have kept minimum inhibitory \n\nconcentration for ali three pathogens. Therefore, the presence of infection \n\n92 \n\n\n\nas well as the \u00eddent\u00edf\u00edcat\u00edon of pathogen should be cons\u00eddered before \n\nsample select\u00edon s\u00ednca m\u00edn\u00edmal s\u00edlver sulfad\u00edaz\u00edne should ba released to \n\navo\u00edd silvar axcess and body absorpt\u00edon. \n\nSulfadiazine Cumulative Release \n\n35 \n\n30 :l \n\nJ. \n\n5 \n\nft-\nj \n\n-~ \nj \n\n~-\u00b7-\u00b7- - -- --- - - l 7!\" --\u00b7 \n; \n\n71V \nj \ni \n\n\u2022 \n\n7/V -sample2 -sample3 \nf/ ..,.._sample5 ~sample6 \n\n-9-sample 8 ~sample9 \n\n25 \n\n10 \n\no \no 2 3 4 5 6 7 8 9 10 11 12 13 14 \n\nDays \n\nFigure 3 - Sulfad\u00edaz\u00edna cumulativa relaase. \n\nSulfadiazine cumulative release after 14 days \n\n35 \n\n30 \n\n25 \n\n~ 20 \no \n\n~ \nr$- 15 \n\n10 \n\n5 \n\no \n2 3 5 6 8 9 \n\nSamples \n\nFigure 4 - Sulfad\u00edaz\u00edna cumulativa raleasa aftar 14 days. \n\n93 \n\n\n\nCONCLUSION \n\nChitosan - Hexamethylene 1 ,6-Di (aminocarboxysulfonate) cross linking \n\nreaction was efficient and confirmed by FTIR and swelling analyses. Cross \n\nlinked films swollen less than chitosan one and this effect was inversely \n\nproportional to cross linker concentration, due to the hydrophilic character \n\nof the cross linking agent. Moreover, according to contact angle analysis, \n\ncross linked films became more hydrophilic than chitosan film. Besides, the \n\neffect of cross linker concentration could not be evaluated because the \n\nwater drop spread on both cross linked films. \n\nSilver sulfadiazine release was controlled by its solubility in the dissolution \n\nmedium. Because of silver sulfadiazine low molecular weight, mass \n\ntransport resistance did not govern the diffusion process. \n\nSamples with higher silver sulfadiazine initial concentration should be used \n\nto treat infected wounds, while the samples with lower one could be used \n\nto avoid wound infections. \n\nAdditional experiments such as in vitro and in vivo wound healing were \n\ncarried out with selected samples and will be published in a further paper. \n\nREFERENCES \n\n[1] N. Shanmugasundaram, J. Sundaraseelan, S. Uma, D. Selvaraj, Mary \n\nBabu. Design and delivery of silver sulfadiazine from alginate \n\nmicrospheres-impregnated collagen scaffold. 2005. \n\n[2] Tsipouras N, Rix CJ, Brady PH. Solubility of silver sulfadiazine in \n\nphysiological media relevance to treatment of thermal burns with silver \n\nsulfadiazine cream. Clin Chem 1995; 41 :87-91. \n\n[3] K. Kurita, Chemistry and Application of chitin and chitosan. Polymer \n\nDegradation and. Stabifity 59 (1998) 117-120. \n\n[4] J. Berger, Structure and lnteractions in covalently and ionically cross \n\nlinked chitosan hydrogels for biomedical applications. European Journal of \n\nPharmaceutics and Biopharmaceutics 57 (2004) 19-34. \n\n94 \n\n\n\n[5] C. Hoemann, Tissue engineering of cartilage using an injectable and \n\nadhesive chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage 13 \n\n(2005) 318-329. \n\n[6] E. Denkbas, Norfloxacin-loaded Chitosan Sponges as Wound Dressing \n\nMaterial. Journal of Biomaterials Application 18 (2004) 291-303. \n\n[7] H. Ueno, Topical formulations and wound healing applications of \n\nchitosan. Advanced Drug Delivery Review 52 (2001) 105-115. \n\n[8] Sheng Lin-Gibson, Howard J. Walls, Scott B. Kennedy, Eric R. Welsh. \n\nReaction kinetics and gel properties of blocked diisocyanate cross linked \n\nchitosan hydrogels. Carbohydrate Po/ymers 54(2003) 193-199. \n\n[9] Eric R. Welsh, Caroline L. Schauer, Syed B. Qadri and Ronald R. Price. \n\nChitosan cross-linking with a water-soluble, blocked diisocyanate. 1.Solid \n\nstate. Biomacromolecules 3 (2002) 1370-1374. \n\n95 \n\n\n\n4.8 In Vitro Wound Healing Responses to Drug Loaded Cross Linked \nChitosan Films \n\nAvalia\u00e7\u00e3o in vitro da cicatriza\u00e7\u00e3o de feridas tratadas com filmes \n\nreticulados de quitosana carregados com f\u00e1rmacos \n\nCampos, M.G.NY, Rawls, R.H. 1 , Mei, L.H.I. 2 and Satsangi, N. 1 \n\n' Departamento de Odontologia Restaurativa. Divis\u00e3o de Biomateriais Division, Escola de \n\nOdontologia, Centro de Sa\u00fade da Universidade do Texas em San Antonio, TX, EUA \n\n2 Departamento de Tecnologia de Pol\u00edmeros, Faculdade de Engenharia Qu\u00edmica, \n\nUniversidade Estadual de Campinas, SP, Brasil \n\nRESUMO: Atualmente, o uso de cobaias em experimentos de pesquisa \n\ntem sido amplamente questionado pelas Institui\u00e7\u00f5es e Organiza\u00e7\u00f5es \n\nprotetoras de animais. Por outro lado, testes preliminares e valida\u00e7\u00e3o \n\ncient\u00edfica da hip\u00f3tese de pesquisa s\u00e3o requeridos antes de um teste in \n\nvivo ser aprovado. Devido \u00e0s numerosas etapas a serem completadas at\u00e9 \n\nse conseguir a aprova\u00e7\u00e3o de um estudo in vivo, este procedimento pode \n\nlevar muito tempo. Por todas estas raz\u00f5es, o desenvolvimento de um \n\nteste in vitro capaz de substituir a pesquisa em animais seria muito \n\ninteressante. Com esse objetivo, este trabalho dedicou-se ao \n\ndesenvolvimento de um novo modelo de ferida in vitro para a avalia\u00e7\u00e3o do \n\npotencial cicatrizante de filmes de quitosana carregados de antibi\u00f3ticos. \n\nMG-63, uma linhagem de c\u00e9lulas derivada de um osteosarcoma, foi usada \n\nno modelo in vitro, enquanto que os filmes de quitosana foram carregados \n\ncom gentamicina e sulfadiazina de prata, um antibi\u00f3tico e um agente \n\nantibacteriano, respectivamente. \n\nPALAVRAS-CHAVE: quitosana, antibi\u00f3tico, cicatriza\u00e7\u00e3o de ferida, cultivo \n\ncelular, in vitro. \n\n96 \n\n\n\nIn vitro wound healing responses to drug loaded cross linked \n\nchitosan films \n\nCampos, M.G.NY, Rawls, R.H.\\ Mei, L.H.I. 2 and Satsangi, N. 1 \n\n1 Department of Restorative Dentistry, Biomaterials Division, Dental \n\nSchool, University of Texas Health Science Center at San Antonio, TX, \n\nUSA \n\n2 Department of Polymer Technology, Faculty of Chemical Engineering, \n\nState University of Campinas, SP, Brazil \n\nABSTRACT: Currently, animais use in research experiments has been \n\nwidely questioned by Animal Protect lnstitutions and Organizations. \n\nMoreover, preliminary tests and scientific validation of research hypothesis \n\nare required before in vivo tests be approved. Due to the numerous steps \n\nto be accomplished before in vivo study approval, this procedure could \n\ntake a long time. For ali these reasons, the development of an in vitro test \n\nthat could replace animal research would be very interesting. Therefore, \n\nthe aim of this work was the development of a novel in vitro wound model \n\nfor evaluation of the healing potential of drug loaded chitosan films. MG-63, \n\na cell line derived from an osteosarcoma, was used in the in vitro model, \n\nwhile chitosan films were loaded with gentamicin and silver sulfadiazine, \n\nan antibiotic and an antibacterial agent, respectively. \n\nKEYWORDS: chitosan, antibiotic, wound healing, cell culture, in vitro. \n\nINTRODUCTION \n\nAnimal testing or animal research refers to the use of animais in research \n\nexperiments. Worldwide, about 100 million animais [1] are used annually \n\nand either killed during the experiments or subsequently euthanized. \n\nAnimal research is mainly carried out inside universities, medicai schools \n\nand pharmaceutical companies, although some commercial facilities \n\nprovide animal-testing services to industry. [2] \n\n97 \n\n\n\nGroups that supports animal research affirm that it has played a vital role in \n\nevery major medicai advance and that many major developments, such as \n\npenicillin (mice), organ transplant (dogs), and poliomyelitis vaccine (mice, \n\nmonkeys) involved animal research. [3] However, the topic is controversial. \n\nOpponent groups argue that animal testing is unnecessary, poor scientific \n\npractice, poorly regulated, that the costs outweigh the benefits, or that \n\nanimais have an intrinsic right not to be used for experimentation. \n\nNevertheless, most scientists and governments agree that animal testing \n\nshould cause as little suffering to animais as possible, and that animal \n\ntests should only be performed where necessary, respecting the three R's \n\nprincipie: Reducing, Replacement and Refinement. In this context, the \n\ndevelopment of in vitro tests that could replace preliminary animais testing \n\nis an interesting, current and crucial research field. \n\nChitosan is a biopolymer derived from chitin, the second most abundant \n\npolysaccharide found in nature. Due to its interesting biological properties \n\nsuch as: biocompatibility, biodegradability, antibacterial activity and bio-\n\nadhesion, it has been widely studied and applied as a biomaterial in the \n\nbiomedical area.[4 and 5] Biomedical applications of chitosan involve \n\nimplants, drug delivery matrix, scaffolds for tissue engineering, skin \n\nsubstitutas and wound dressings [6, 7 and 8]. In this present work, drug \n\nloaded chitosan films for wound dressing were prepared and their wound \n\nhealing potential was in vitro evaluated. \n\nGentamicin, an amino-glycoside antibiotic, and silver sulfadiazine, a \n\nstandard antibacterial agent for burns treatment, were used to prepare the \n\ndrug loaded chitosan films. They are topically used for treatment of skin \n\ninfections and burn wounds for a long time. Gentamicin is one of the most \n\nconsumed antibiotics in the world. lts high consumption is due to its low \n\ncost, wide antibacterial spectrum of action, low rate of primarily resistant \n\npathogens, low allergy rate, as well as good thermo-stability and water \n\nsolubility. [9] \n\n98 \n\n\n\nSilver sulfadiazine possesses a wide spectrum of activity against Gram \n\npositive and negative bacteria and fungus. [1 O] Besides, it is effective even \n\nat low concentrations due to the presence of silver \u00edons that kill bacteria \n\nand do not cause pathogen resistance. \n\nFor the in vitro model, human MG-63 cells, a cell line derived from an \n\nosteosarcoma, was cultured. Wounds were created and the healing \n\npotential of drug loaded chitosan films were qualitatively evaluated by the \n\nwound filling rate. \n\nMATERIALS ANO METHODS \n\nMateriais \n\nHigh molecular weight chitosan (>75% deacetylated), hexamethylene \n\ndiisocyanate and silver sulfadiazine were purchased from Aldrich. \n\nGentamicin sulfate salt was purchased from Sigma and sodium bisulfite \n\nReagent Plus\u00ae, from Sigma-Aidrich. MG-63 cell line was gently supplied \n\nby Dr. Cohen. \n\nSynthesis of cross linking agent \n\nIn a 100 ml round-bottom flask containing a magnetic stir bar, 6.73 g (40 \n\nmmol) of HMDI was added to 8.36 g Na2S20s (44 mmol) dissolved in 15.53 \n\nml H20 and was stirred for 20h at room temperature. The product was \n\nprecipitated in acetone and dried in vacuum. lnsoluble polymeric \n\nbyproducts were removed by dissolving the product in water (30 ml) \n\nfollowed by filtration. Product was isolated from the filtrate by precipitation \n\nin acetone and dried in vacuum, resulting in a white powder. (11] \n\nPreparation of chitosan film \n\n1.5g of chitosan was dissolved in 100 ml of 1.0% acetic acid solution. After \n\ntotal dissolution, solution was cast in the molds and dried at room \n\ntemperature. \n\n99 \n\n\n\nCross linking reaction \n\nIn a 250 ml flask, 0.8g of hexamethylene 1 ,6-di(aminocarboxysulfonate) \n\nwas added to 100 ml of 1.5% chitosan solution and heated up to 40 \"C \n\nunder stirring for 24 h. \n\nPreparation of chitosan cross linked film \n\nThe solution above described was cast in the molds and dried at room \n\ntemperature in order to prepare the chitosan cross linked film. \n\nPreparation of gentamicin loaded film \n\nAfter cross linking reaction, 1% gentamicin sulfate was added and \n\nhomogenized for 24 h. Then, the resulted solution was cast in the molds \n\nand dried at room temperature. Dried samples were then neutralized in \n\nEthanol 70% for 30 minutes and sterilized in UV light. \n\nPreparation of si/ver sulfadiazine loaded film \n\nThe same procedure was used to prepare silver sulfadiazine loaded films. \n\nHowever, 5% silver sulfadiazine was used instead of 1% gentamicin \n\nsulfate. \n\nCe/1 cu/ture \n\nMG-63 cells were seeded in six-well tissue culture plates (Corning Co, \n\nHouston, TX). The seeded cells were incubated in a-MEM (Minimum \n\nEssential Media Alpha Medium) with 5% fetal bovine serum (FBS) and \n\nhumidity atmosphere of 5% C02 and 95% air at 37\u00b0 C. After cells reached \n\nconfluence, wounds were created across the surface of each well (Figure \n\n1) and the media were changed. The wounds were then examined \n\nmicroscopically to ensure that cellular and extra-cellular materiais were \n\nremoved from the wound sites. \n\n100 \n\n\n\nFigure 1 - In vitro wounds. Figure 2- In vitro wound \nhealing atO day. \n\nAt this moment, chitosan films were placed in the wells and in each plate, \n\nthe positive control was a well with no film. In order to evaluate chitosan \n\neffect on wound filling rate, a chitosan film was incubated. Besides, a cross \n\nlinked chitosan film was also incubated to evaluate cross linking agent \n\neffect on in vitro wound healing. Gentamicin and silver sulfadiazine effects \n\nwere evaluated by incubation of drug loaded cross linked chitosan films. \n\nSamples were identified according to Table 1 and the experiment was \n\ncarried out on duplicates. At every two days, culture media were replaced \n\nin order to provide essentials nutrients for cellular growth. \n\nTable 1 - Samples identification. \n\nSamole Content \nA No film !Positive controTl \nB Chitosan film \nc Chitosan cross linked film \nD Gentamicin loaded chitosan cross linked film \n\nE \nSilver sulfadiazine loaded chitosan cross linked \nfilm \n\nDetermination of wound filling rate \n\nWound filling rate was qualitatively measured after O, 7, 14 and 21 days of \n\nincubation by using a microscope with photography apparatus. \n\nAfter each desired period, films were removed from the wells and kept in \n\nformol for 24 hours for further investigation. Then, the cells were stained \n\nwith 20 ml of T-blue for 2 minutes at 37\" C. After staining, ali media were \n\nremoved and cells were washed with 1 ml of 0.1 M phosphate buffer \n\nsolution (PBS) pH 7.4. Then, PBS was removed and 1 ml of formol was \n\n101 \n\n\n\nadded. Cells were kept at 4\"C for 24 hours and, after this procedure, \n\nformal was replaced for ethanol 70%. At this moment, cells were ready to \n\nbe photographed and the wound filling rate was qualitatively determined by \n\nthe amount of cells that grown in each wound site. \n\nRESULTS \n\nFigure 2 illustrates the wound at O day. As expected, cells were stained, \n\nwhile the wound site was not. In vitro wound healing results for 7, 14 and \n\n21 days are presented in Figure 3. According to Figure 3, samples D and E \n\nshowed inferior wound filling rate when compared to positive contrai \n\n(sample A) in the first week. However, this effect was not observed for \n\nsample D in the next week. At 21 days, excepted for sample E, wound \n\nsites were almost totally filled by cells. \n\nLee et a/ [12) reported the cytotoxic effect o f silve r sulfadiazine on HaCa T \n\ncells and delayed epithelialization in animal model. Besides, a marked \n\ninhibition of 3T3 fibroblasts growth, caused by 1% silver sulfadiazine \n\ncream, was observed by Mi et ai [13). However, according to authors, this \n\ninhibition was significantly reduced by the use of a silver sulfadiazine \n\nincorporated asymmetric chitosan membrane. \n\nGentamicin ototoxicity and neuphrotoxicity have been extensively studied. \n\n[14 and 15) Nevertheless, these deleterious effects seem to be dosing \n\ndependent and have not been well established yet. Lin et ai [16) reported \n\nthat application of 2% gentamicin eye drops in porcine cornea disturbed \n\nthe corneal epithelial healing rate significantly. Bertolaso et ai [17) reported \n\nthe biochemical mechanism underlying gentamicin cytotoxicity in OC-k3 \n\ncells. However, cytotoxic effect of gentamicin on fibroblast growth is not \n\nwell discussed. According to figure 3, gentamicin deleterious effect only is \n\nsignificant in the first week of in vitro wound healing. Probably, this is an \n\nadaptation period to the cells and after that, wound filling rate is recovered. \n\nPast 21 days, sample D wound filling is almost equivalent to sample A \n\n(positive contrai). \n\n102 \n\n\n\n7DAYS 14DAYS 21 DAYS \n\nA \n\nB \n\nc \n\nD \n\nE \n\nFigure 3- In vitro wound healing results. \n\nLee et ai [i 2] reported the cytotoxic effect of silver sulfadiazine on HaCaT \n\ncells and delayed epithelialization in animal model. Besides, a marked \n\ninhibition of 3T3 fibroblasts growth, caused by i% silver sulfadiazine \n\ncream, was observed by Mi et ai [i 3]. However, according to authors, this \n\n103 \n\n\n\ninhibition was significantly reduced by the use of a silver sulfadiazine \n\nincorporated asymmetric chitosan membrane. \n\nGentamicin ototoxicity and neuphrotoxicity have been extensively studied. \n\n[14 and 15] Nevertheless, these deleterious effects seem to be dosing \n\ndependent and have not been well established yet. Lin et a! [16] reported \n\nthat application of 2% gentamicin eye drops in porcine cornea disturbed \n\nthe corneal epithelial healing rate significantly. Bertolaso et a! [17] reported \n\nthe biochemical mechanism underlying gentamicin cytotoxicity in OC-k3 \n\ncells. However, cytotoxic effect of gentamicin on fibroblast growth is not \n\nwell discussed. According to figure 3, gentamicin deleterious effect only is \n\nsignificant in the first week of in vitro wound healing. Probably, this is an \n\nadaptation period to the cells and after that, wound filling rate is recovered. \n\nPast 21 days, sample O wound filling is almost equivalent to sample A \n\n(positive control). \n\nChitosan and cross linked chitosan films (samples B and C, respectively) \n\ndid not show cytotoxicity, but stimulated cells growth. Ueno et a! [18] \n\nreported that chitosan stimulated migration and proliferation of fibroblast \n\nand also collagen production in dogs' wound healing. Moreover, wound \n\nhealing experiments using mouse model have shown that the application \n\nof chitosan hydrogel onto an open wound induced significant wound \n\ncontraction and accelerated wound healing. [19] \n\nCONCLUSION \n\nIn vitro wound healing model results have shown to be comparable to \n\nthose obtained in previous animal studies. Therefore, the presented in vitro \n\nwound healing model could replace preliminary animal testing, \n\ncollaborating to the three R principies: reduction, replacement and \n\nrefinement. \n\nAs expected, chitosan films enhanced cells growth. In addition, cross \n\nlinked chitosan films was not cytotoxic for MG-63 cells and thus, \n\nhexamethylene 1 ,6-di(aminocarboxysulfonate) can be considered a safety \n\ncross linking agent. \n\n104 \n\n\n\nWound healing deleterious effects of drug loaded chitosan films on in v\u00edtro \n\nwound healing were more pronounced for silver sulfadiazine that disturbed \n\nwound filling during ali 21 days. Cells growth was initially delayed by \n\ngentamicin, however, after this adaptation period, cells started to grow fast. \n\nIn this context, the use of drugs in wound treatments should be carefully \n\nevaluated since it could delay wound healing, instead of accelerate it. \n\nREFERENCES \n\n[1) \"The Ethics of research involving animais\", Nuffield Council on \n\nBioethics, p. 45. \n\n[2) Use of Laboratory Animais in Biomedical and Behavioral Research\", \n\nlnstitute for Laboratory Animal Research, The National Academies Press, \n\n1988. \n\n[3) \"FBR's Position on Animal Research\", Foundation for Biomedical \n\nResearch. \n\n[4) K. Kurita. Chemistry and application of chitin and chitosan. Polymer \n\nDegradat\u00edon and. Stab\u00edl\u00edty 59 (1998) 117-120. \n\n[5) J. Berger, Structure and lnteractions in covalently and ionically cross \n\nlinked chitosan hydrogels for biomedical applications. European Journal of \n\nPharmaceutics and Biopharmaceut\u00edcs 57 (2004) 19-34. \n\n[6) Hoemann, C.D., Sun, J., Legare, A., McKee, M.D. and Buschmann, \n\nM.D. (2005). Tissue engineering of cartilage using an injectable and \n\nadhesive chitosan-based cell-delivery vehicle, Osteoarthritis Cartilage, 13: \n\n318-329. \n\n[7] Denkbas, E.B., Ozturk, E.,Ozdemir, N.,Kececi, K. and Agalar, C. \n\n(2004).Norfloxacin-loaded chitosan sponges as wound dressing material, \n\nJournal of Biomaterials Applications, 18(4):291-303. \n\n[8] Ueno, H., Mo ri, T. and Fujinaga, T. (2001 ). Topical formulations and \n\nwound healing applications of chitosan, Advanced Drug Delivery Review, \n\n52(2): 105-115. \n\n105 \n\n\n\n[9] M.R. Virto, P. Frutos, Susana Torrado and G. Frutos. Gentamicin \n\nrelease from modified acrylic bane cements with lactose and \n\nhydroxylpropylmethylcelullose. Biomaterials 24 (2003) 79-87. \n\n[1 O] N. Shanmugasundaram, J. Sundaraseelan, S. Uma, D. Selvaraj, Mary \n\nBabu. Design and delivery of silver sulfadiazine from alginate \n\nmicrospheres-impregnated collagen scaffold. 2005. \n\n[11] Sheng Lin-Gibson, Howard J. Walls, Scott B. Kennedy, Eric R. Welsh. \n\nReaction kinetics and gel properties of blocked diisocyanate cross linked \n\nchitosan hydrogels. Carbohydrate Polymers 54(2003) 193-199. \n\n[12] Ae-Ri Cho Lee, Hyunju Leem, Jaegwan Lee, Kyung Chan Park. \n\nReversal of silver sulfadiazine-impaired wound healing by epidermal \n\ngrowth factor. Biomaterials 26 (2005) 4670-4676. \n\n[13] Fwu-Long Mi, Yu-bey Wu, Shin-Shin Shyu, An-chong Chao, Yuin-Yih \n\nLai, Chia-Ching Su. Asymmetric chitosan membranes prepared by dry/wet \n\nphase separation: a new type of wound dressing for controlled antibacterial \n\nrelease. Journal of Membrane Science 212 (2003) 237-254. \n\n[14] Aminoglycoside-lnduced Hearing Loss in Humans. ROBERT E. \n\nBRUMMETT ANO KA YE E. FOX. ANTIMICROBIAL AGENTS ANO \n\nCHEMOTHERAPY, June 1989, p. 797-800 \n\n[15] J. Marais and J. A.Rutka. Ototoxicity and topical ear drops. Clin. \n\nOtolaryngol. 1998, 23, 360-367. \n\n[16] Gentamicin-lnduced Cytotoxicity lnvolves Protein Kinase C Activation, \n\nGlutathione Extrusion and Malondialdehyde Production in an lmmortalized \n\nCell Line from lhe Organ of Corti. Lucia Bertolasoa, Debora Bindinib, \n\nMaurizio Previatia, Daniela Falgioneb, lrene Lanzonib, Alina Parmeggianib, \n\nCristina Vitalia, Elisa Corbacellab, Silvano Capitania,b, Alessandro \n\nMartinib. Audiology &amp; Neurotology, V oi. 8, No. 1, 2003. \n\n106 \n\n\n\n[1 ?]_Effect of Fortified Antibiotic Solutions on Corneal Epithelial Wound \n\nHealing. \n\nBasic lnvestigation. Cornea. 1 9(2):204-206, March 2000.Lin, Chang-Ping \n\nM.D.; Boehnke, Matthias M.D. \n\n[1 8] Ueno, H., Yarnada, H., Tanaka, 1., Kaba N., Matsura M., Okumura M., \n\nKadosawa, T., Fujinaga, T. Accelerating effects of chitosan for healing at \n\nearly phase of experimental open wounds in dogs. Biomaterials 1999; 20: \n\n1407-1414. \n\n[1 9] Masayuki lshihara, Kuniaki Nakanishi, Katsuaki Ono, Masato Sato, \n\nMakoto Kikuchi, Yoshio Saito, Hirofurni Yura, Takemi Matsui, Hidemi \n\nHattori, Maki Uenoyama, Akira Kurita. Photocrosslinkable chitosan as a \n\ndressing for wound occlusion and accelerator in healing process. \n\nBiomaterials 23 (2002) 833-840. \n\n107 \n\n\n\n6. CONCLUS\u00d5ES \n\n\u2022 As solu\u00e7\u00f5es de quitosana apresentaram atividade antibacteriana \n\ncontra a bact\u00e9ria Escherichia co/i, e a inibi\u00e7\u00e3o do crescimento foi \n\ninversamente proporcional \u00e0 concentra\u00e7\u00e3o de quitosana; \n\n\u2022 A solu\u00e7\u00e3o de plastificante (d-sorbitol), bem como a solu\u00e7\u00e3o \n\nsolvente (\u00e1cido ac\u00e9tico 1.0%) tamb\u00e9m apresentaram atividade \n\nantibacteriana contra a bact\u00e9ria E. co/i; \n\n\u2022 A membrana de quitosana (CA) apresentou a menor \n\npermeabilidade ao vapor d'\u00e1gua devido \u00e0 sua alta cristalinidade; \n\n\u2022 Apesar de apresentar propriedades mec\u00e2nicas aceit\u00e1veis, CA \n\napresentou citotoxicidade direta \u00e0s c\u00e9lulas Vero devido \u00e0 presen\u00e7a \n\nde \u00e1cido ac\u00e9tico residual; \n\n\u2022 A neutraliza\u00e7\u00e3o foi uma etapa muito importante na prepara\u00e7\u00e3o das \n\nmembranas de quitosana, pois: \n\n1- Neutralizou o \u00e1cido ac\u00e9tico residual que \u00e9 diretamente citot\u00f3xico; \n\n2- Diminuiu o grau de hidrata\u00e7\u00e3o das membranas, evitando a forma\u00e7\u00e3o \n\nde gel ap\u00f3s contato com a \u00e1gua; \n\n3- Aumentou a permeabilidade ao vapor de \u00e1gua; \n\n\u2022 A membrana neutralizada (CN) apresentou o menor grau de \n\nhidrata\u00e7\u00e3o e permeabilidade ao vapor d'\u00e1gua intermedi\u00e1ria quando \n\ncomparada \u00e0s membranas plastificada (CP) e n\u00e3o-neutralizada \n\n(CA); \n\n\u2022 O D-sorbitol \u00e9 um plastificante seguro para as c\u00e9lulas, por\u00e9m, \n\ndevido ao seu car\u00e1ter altamente higrosc\u00f3pico, o grau de hidrata\u00e7\u00e3o \n\ndas membranas de quitosana aumentou muito com a adi\u00e7\u00e3o deste \n\nplastificante; \n\n\u2022 A adi\u00e7\u00e3o de plastificante tamb\u00e9m aumentou a permeabilidade ao \n\nvapor de \u00e1gua e a flexibilidade das membranas de quitosana; \n\n108 \n\n\n\n\u2022 As membranas de quitosana CN e CP mostraram-se satisfat\u00f3rias \n\npara uso como recobrimentos de feridas; entretanto, as mesmas \n\ndevem ser reticuladas a fim de serem utilizadas como sistemas de \n\nlibera\u00e7\u00e3o controlada de f\u00e1rmacos; \n\n\u2022 A rea\u00e7\u00e3o de reticula\u00e7\u00e3o da quitosana com o hexametileno 1 ,6-di-\n\n(aminocarboxisulfonato) foi bem sucedida. Os graus de reticula\u00e7\u00e3o \n\nforam 30 e 50%; \n\n\u2022 O hexametileno 1 ,6-di-(aminocarboxisulfonato) mostrou-se um \n\nexcelente agente reticulante. Como o material reticulado n\u00e3o ficou \n\nquebradi\u00e7o, a adi\u00e7\u00e3o de plastificante n\u00e3o foi necess\u00e1ria; \n\n\u2022 O grau de hidrata\u00e7\u00e3o das membranas de quitosana reticuladas foi \n\ninversamente proporcional \u00e0 concentra\u00e7\u00e3o de agente reticulante, \n\ndevido \u00e0 elevada hidrofilicidade do mesmo; \n\n\u2022 A reticula\u00e7\u00e3o aumentou o car\u00e1ter higrosc\u00f3pico das membranas de \n\nquitosana, e consequentemente, a biocompatilidade do material; \n\n\u2022 De acordo com os testes , as membranas reticuladas de quitosana \n\nmostraram-se eficientes na libera\u00e7\u00e3o controlada de gentamicina e \n\nsulfadiazina de prata; \n\n\u2022 O modelo de cicatriza\u00e7\u00e3o de feridas in vitro utilizando a linhagem \n\ncelular MG - 63, mostrou-se um excelente m\u00e9todo para se estudar \n\nos efeitos dos agentes antimicrobianos no processo de \n\ncicatriza\u00e7\u00e3o; \n\n\u2022 As membranas de quitosana, reticuladas ou n\u00e3o, favoreceram o \n\ncrescimento in vitro das c\u00e9lulas MG -63 quando adicionadas ao \n\nmeio de cultivo celular; \n\n\u2022 A membrana de quitosana 30% reticulada, carregada com 1% de \n\ngentamicina, inibiu inicialmente o crescimento in vitro das c\u00e9lulas \n\nMG- 63; \n\n109 \n\n\n\n\u2022 A membrana de quitosana 30% reticulada, carregada com 5% de \n\nsulfadiazina de prata, inibiu parcialmente o crescimento in vitro das \n\nc\u00e9lulas MG - 63; \n\n\u2022 A utiliza\u00e7\u00e3o ou n\u00e3o de antibi\u00f3ticos ou agentes antimicrobianos \n\ndeve ser seriamente considerada durante o tratamento de feridas, \n\numa vez que a utiliza\u00e7\u00e3o dos mesmos pode comprometer o \n\nprocesso de cicatriza\u00e7\u00e3o. \n\n110 \n\n\n\n7. SUGEST\u00d5ES PARA TRABALHOS FUTUROS \n\n\u2022 Estudar a libera\u00e7\u00e3o controlada de agentes antiinflamat\u00f3rios e \n\noutros tipos de medicamentos, utilizando os mesmos sistemas de \n\nlibera\u00e7\u00e3o \u00e0 base de quitosana reticulada; \n\n\u2022 Avaliar as propriedades mec\u00e2nicas, t\u00e9rmicas e de permeabilidade \n\ndos sistemas de libera\u00e7\u00e3o obtidos; \n\n\u2022 Desenvolver sistemas de libera\u00e7\u00e3o controlada de f\u00e1rmacos para \n\nrecupera\u00e7\u00e3o de cartilagem de eq\u00fcinos. \n\n111 \n\n\n\n8. REFER\u00caNCIAS \n\n\u2022 ARVANITOYANNIS, I.S., NAKAYAMA, A. ANO AIBA, S. Chitosan \n\nand gelatin based edible films: state diagrams, mechanical and \n\npermeation properties. Carbohydrate Polymer, v.37, p.371-382, \n\n1998. \n\n\u2022 BLACK, J.M., MATASSARIN-JACOBS, E.M., LUKMAN, S. \n\nEnfermagem m\u00e9dico-cir\u00fargica: uma abordagem Psicofisiol\u00f3gica. 4\u00aa \n\ned. Rio de Janeiro (RJ): Guanabara 1996; \n\n\u2022 CHO LEE, A. R. Effects of Silver Sulfadiazine on the skin cell \n\nproliferation and wound healing process in Hairless mouse 2nd \n\ndegree burn model. Journal ot Korean Pharmaceutical Science, \n\nv.32, p.113-117, 2002. \n\n\u2022 Cidade Sustent\u00e1vel, 2004 \n\nDispon\u00edvel em: \n\nhttp://www.gabeira.com.br/cidadesustentavel/atitudes/mostra.atit.as \n\np?id=15 \n\nAcesso em: 10/02/2005. \n\n\u2022 CRUZ, MARIA CLARA PINTO. Influ\u00eancia do Poli (Etileno Glicol) \n\n(PEG) no Processo de Microencapsula\u00e7\u00e3o da Oxitetraciclina no \n\nSistema Alginato/ Quitosana: Modelamento \"IN VITRO\" da \n\nLibera\u00e7\u00e3o Oral. Campinas: Faculdade de Engenharia Qu\u00edmica, \n\nUniversidade Estadual de Campinas, 2004. Tese (Doutorado). \n\n\u2022 DENKBAS, E. B., \u00d3ZT\u00dcRK, E., \u00d3ZDEMIR, N., KE\u00c7ECI, K. \n\nNorfloxacin-loaded chitosan sponges as wound dressing material. \n\nJournal of Biomaterials App/ications, v.18, p.291-303, 2004. \n\n\u2022 FERRAZ, E.M., FERRAZ, A.A.B., BACELAR, T.S., \n\nD'ALBUQUERQUE, H.S.D., VASCONCELOS, M.D.M.M., LE\u00c3O, \n\nC.S. Controle de infec\u00e7\u00e3o em cirurgia geral -resultados de um \n\nestudo prospectivo de 23 anos e 42.274 cirurgias. Revista do \n\nCol\u00e9gio Brasileiro de Cirurgi\u00f5es, v.28, p.17-26, 2001. \n\n112 \n\n\n\n\u2022 lnventaBrasiiNet, 2002 \n\nDetector de bact\u00e9rias, mar\u00e7o/2002 \n\nDispon\u00edvel em:http://inventabrasilnet.t5.com.br/infecmw.htm \n\nAcesso em: 11/02/05. \n\n\u2022 KLUYTMANS, J. Surgical infections including burns. In: Wenzel PR, \n\neditor. Prevention and contrai of nosocomial infection. Baltimore: \n\nWilliams &amp; Wilkins; 1997,841-65. \n\n\u2022 KURITA, K. Chemistry and Application of chitin and chitosan. \n\nPo/ymer App/ication and Stability, v. 59, p.117 -120, 1998. \n\n\u2022 LAVA, 2005 \n\nDispon\u00edvel \n\nem:http://www.lava.med.br/vascular _geral/gazeta1211 OO.htm \n\nAcesso em: 10/02/2005. \n\n\u2022 LIN-GIBSON, S., WALLS, J. H., KENNEDY, S. B., WELSH, E. R. \n\nReaction kinetics and gel properties of blocked diisocyanate cross \n\nlinked chitosan hydrogels. Carbohydrate Polymers, v.54, p.193-199, \n\n2003. \n\n\u2022 LOKE, W-K., LAU, S-K., YONG, L. L., KHOR, E., SUM, C. K. \n\nWound Dressing with Sustained Anti-Microbial Capability. Journal \n\not biomedica/ materiais research, v.53, p.8-17, 2000. \n\n\u2022 MAEDA, Y, KIMURA, Y. Antitumor Effects of Various Low-\n\nMolecular-Weight Chitosans Are Due to lncreased Natural Killer \n\nActivity of Intestinal lntraepithelial Lymphocytes in Sarcoma 180 -\n\nBearing Mice. Journal of Nutrition, v.134, p.945-950, 2004. \n\n\u2022 MANGALA, E, SURESH KUMAN, T, BASKAR, S AND \n\nPANDURANGA RAO, K. Development of chitosan/poly(vinyl \n\nalcohol) blend membrane as burn dressing. Trends Biomaterials in \n\nArtificial Organs, v.17, n.1, p.34-40, 2003. \n\n113 \n\n\n\n\u2022 Ml, F-L., WU, Y-8., SHYU, S-S., CHAO, A-C., LAI, J-Y., SU, C-C. \n\nAsymmetric chitosan membranes prepared by dry/wet phase \n\nseparation: a new type of wound dressing for controlled antibacterial \n\nrelease. Journai o f Membrana Science, v.212, p.237 -254, 2003. \n\n\u2022 NARAHARISETTI, P. K., LEE, H. C. G .. , FU, Y-C, LEE, D-J, \n\nWANG, C-H. In Vitro and In Vivo release of Gentamicin from \n\n8iodegradable Discs. Journai of biomedicai materiais research. Part \n\n8, Appiied biomateriais, p.329-337, 2006 \n\n\u2022 OZKAYNAK, M. U., ATALAY-ORAL, C., TANTEKIN-ERSOLMAZ, S. \n\n8., G\u00dcNER, F. S. Polyurethane Films for Wound Dressing \n\nApplications. Macromoiecuiar Symposia, v.228, p.177, 2004. \n\n\u2022 Polymar, 2004 \n\nDispon\u00edvel em: http:llwww.polymar.eom.br/empresalempresa.php \n\nAcesso em: 10/02/2005. \n\n\u2022 Portal Sa\u00fade.Gov, 2005 \n\nSa\u00fade cria Redes Estaduais de Assist\u00eancia a Queimados \n\nData: 2211112000 \n\nDispon\u00edvel em: \n\nhttp :1 I portal web02. saude. gov. b r/saudei aplicacoes/noticiaslnoticias \n\nAcesso em: 10102/2005. \n\n\u2022 PURNA, S.K., 8A8U, M. Collagen based dressing: a review. Burns, \n\nv.26, p.54-62, 2000. \n\n\u2022 SHANMUGASUNDARAM, N., SUNDARASEELAN, J., UMA, S., \n\nSELVARAJ, D., MARY 8A8U. Design and delivery of silver \n\nsulfadiazine from alginate microspheres-impregnated collagen \n\nscaffold, Journai of biomedicai materiais research. Part B, Appiied \n\nbiomateriais, v.77, n.2, p.378-88, 2006. \n\n\u2022 SILVA, R.M., SILVA, G.A., COUTINHO, O.P., MANO, J.F., REIS, \n\nR.L.. Preparation and characterization in simulated body conditions \n\n114 \n\n\n\not glutaraldehyde crosslinked chitosan membranes. Journal of \n\nMateriais Science: Materiais in Medicine, v.15, p.11 05-1112, 2004. \n\n\u2022 SKUNDRIC, P., MEDOVIC, A., KOSTIC, M .. Fibrous systems with \n\nprogrammed biological activity and their application in medicai \n\npractice. AUTEX Research Journal, v.2, p.78, 2002. \n\n\u2022 SUYATMA, NE, TIGHZERT, L and COPINET, A. Effects of \n\nHydrophilic Plasticizers on Mechanical, Thermal, and Surface \n\nProperties of Chitosan Films. Journal of agricultura/ and food \n\nchemistry, v.53, p.3950, 2005. \n\n\u2022 SYNOWIECKI, J., AL-KHATEEB, N. A. Production, Properties and \n\nsome new applications of chitin and its derivatives. Criticai Reviews \n\nin Food Science and Nutrition, v.43, n.2, p.145-171, 2003 \n\n\u2022 Universia, 2004 \n\nDispon\u00edvel em: http://www.universiabrasil.net/html!noticia_iehib.html \n\nAcesso em: 08/02/2005. \n\n\u2022 VIRTO, M.R., FRUTOS, P., TORRADO, S., FRUTOS, G. \n\nGentamicin release from modified acrylic bane cements with lactose \n\nand hydroxypropylmethylcellulose. Biomaterials, v.24, p.79-87, 2003 \n\n\u2022 WELSH, E. R., SCHAUER, C. L., QADRI S. B. AND PRICE, R. R. \n\nChitosan cross-linking with a water-soluble, blocked diisocyanate. \n\n1.Solid state. Biomacromolecules, v.3, p.1370-1374, 2002. \n\n\u2022 WENLING, C., CHENG, M., AO, 0., GONG, Y., ZHAO, N., ZHANG, \n\nX. Physical, mechanical and degradation properties, and schwann \n\ncell attinity ot cross-linked chitosan films. Journal of Biomaterials \n\nScience, v.16 (6), p. 791-807, 2005. \n\n\u2022 YU, S-H., Ml, F-L., WU, Y-B., PENG, C-K., SHYU, S-S. Antibacterial \n\nActivity of Chitosan-Aiginate Sponges lncorporating Silver \n\nSulfadiazine: Effect of Ladder-Loop Transition of lnterpolyeletrolyte \n\n115 \n\n\n\nComplex and lonic Crosslinking on lhe Antibiotic Release. Journal \n\nof App!ied Polymer Science, v.98, p.538-549, 2005. \n\n\u2022 ZHANG, X., WYSS, U. P., PICHORA, D., GOOSEN, M. F. A. \n\nBiodegradable Controlled Antibiotic Release Devices for \n\nOsteomyelitis: Optimization of Release Properties. The Journal of \n\npharmacy and pharmacology, v.46, p.718-724, 1994. \n\n\u2022 ZHANG, Y., ZAHANG, M. Calcium phosphate/chitosan composite \n\nscaffolds for controlled in vitro antibiotic drug release. Journal of \n\nbiomedical materiais research, p.378-386, 2002. \n\n116 \n\n\n\n9. AP\u00caNDICES \n\n9.1 TESTE IN VIVO \n\nComo parte complementar ao presente estudo, foi feito um teste prel iminar \n\nqualitativo in vivo. O animal indicado e utilizado para tal teste foi o rato, \n\ndevido ao seu tamanho/porte adequado e ao curto per\u00edodo de cicatriza\u00e7\u00e3o \n\ndestes animais. O teste in vivo foi conduzido da segui nte forma: \n\n1- Foram selecionados 1 O animais adultos, sadios, de sexo aleat\u00f3rio, \n\npesando cerca de 500 g cada; \n\n2- Os animais foram anestesiados e depilados na parte dorsal; \n\n3- Oito feridas foram feitas no dorso de cada animal com o aux\u00edlio de um \n\naplicador de cola quente, com a finalidade de simular uma queimadura; \n\nFigura 8- Aplica\u00e7\u00e3o da cola quente. \n\n4- Ap\u00f3s 24 horas da aplica\u00e7\u00e3o da cola quente, os animais foram \n\nnovamente anestesiados para a remo\u00e7\u00e3o do tecido morto e aplica\u00e7\u00e3o dos \n\nseguintes tratamentos: A- sem tratamento (controle); B - membrana \n\nde quitosana; C - membrana de quitosana 30% reticulada carregada \n\ncom gentamicina a 1% e D- membrana de quitosana 30% reticulada \n\ne carregada com 1% de sulfadiazina de prata. \n\n11 7 \n\nUNICAMI' \nOI R! IOF( A C ti Nl RAL \n\nCts:\\R LATTES \n\n0 ESEN VOL'v!MESTO OE COLC\u00c7\u00c1\u00fa \n\n\n\nFigura 9 - Aplica\u00e7\u00e3o dos tratamentos nas feridas. \n\n5- Depois de aplicados os tratamentos, foi passada bandagem para \n\ngarantir que os tratamentos n\u00e3o fossem removidos pelos animais. Os \n\nanimais foram ent\u00e3o acondicionados em gaiolas individuais, com regime \n\nde 12 horas de luz/dia e alimentados normalmente; \n\n6- Ap\u00f3s 7 dias, as bandagens foram retiradas e a cicatriza\u00e7\u00e3o das feridas \n\nfoi avaliada de acordo com os tratamentos aplicados. \n\nFigura 1 O - Cicatriza\u00e7\u00e3o das feridas ap\u00f3s 7 dias. \n\n118 \n\n\n\nOs sinais de cicatriza\u00e7\u00e3o observados para os tratamentos \u00e0 base de \n\nquitosana foram: diminui\u00e7\u00e3o do raio da ferida e presen\u00e7a de p\u00ealos. Em \n\ntodas as situa\u00e7\u00f5es, as feridas tratadas evolu\u00edram melhor que a ferida \n\ncontrole. Entretanto, n\u00e3o foi poss\u00edvel observar diferen\u00e7a significativa entre \n\nos tratamentos B, C e D. \n\nO ensaio in vivo foi feito na University of Texas Health Science Center, \n\nrespeitando os protocolos internacionais e as normas para a realiza\u00e7\u00e3o de \n\ntestes com animais. \n\n2.6 CURVAS DE DSC \n\nEst\u00e3o apresentadas a seguir, as curvas de DSC das membranas de \n\nquitosana (CA), quitosana neutralizada (CN) e quitosana-D-sorbitol (CP). \n\n:,,,~,. \n\n'''\"' ,, \n\nCA \n\nFigura 11 - Curva de DSC para a membrana de quitosana. \n\n119 \n\n\n\n\"\"\"'\"\"' \n'\"' ''\"\"\"'\"'\" \u2022,u,, , \"'\" 4\" \n\n;; \n\nCN \n\n\u00b7~\u00b7 \n\nFigura 12- Curva de DSC para a membrana de quitosana neutralizada. \n\ng \n;;_ \n~ \n\n1 \n\n\u00b7,~\u00b7o;\u2022\" \n\n'\" '\u00b7 ,,,.,, '\"' \n\"'<\"\"' ~~-~' \n\nO&amp;:: '\u00b7'\"\"'\"'' '\u00b7 \u2022\u00b7no~ irM, \"' > \n\nCP \n\n- ---~-~--~-- \u00b7\u00b7~~__,-.. , \n',\"',;: \"''~' \n\nFigura 13- Curva de DSC para a membrana de quitosana plastificada. \n\n120"}]}}}